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CHAPTER I 
INTRODUCTION 

INTRODUCTION 
The^e ¡s aburdant evidence that along with other carcirogens o' physical 
or chemical origin, viruses can induce tumors and are associated with 
neoplasia in a broad spectrum of vertebrate species (1-4). Since the f ', rst 
succesfU demonstration of tJTor induction by a virus in the early 1910s 
(5-7), numerous tumor inducing or oncogenic viruses have been isolated, 
both DMA viruses and RNA viruses. The oncogenic DNA viruses include papova 
viruses, adenoviruses, and herpesviruses while oncoviruses are the only 
group of RNA viruses able to cause tumors (4). Upon in vivo inoculation 
into appropriate hosts, oncogenic viruses induce neoplasms of a large va-
riety of histological types. Details about the oncogenic effects of tumor 
inducing viruses on animals are described by Gross (1). 
Tne oncoviruses, which are studied in the present thesis, induce mainly 
neoplasms of hemopoietic origin (leukemias) or neoplasms of connective 
tissue (sarcomas) but they can also induce neoplasms of epithelial origin 
(carcinomas) (1,4). The mechar:sm of neoplastic transformation has still 
to be settled. However, there are theories postulating that the transition 
of a cell from a normal to a transformed phenotype may be either the con-
sequence of a modified expression of the cel'ular genome (oncogene theo-
ry postulated by Huebner and Todaro (8)), or of a modification of the 
genetic content of the cell (protovirus theory postulated by Temin (9)). 
Thus, tne geretic information for neoplastic transformation may already 
be present in the cell but is generally under repression. Alternatively, 
geretic information Is introduced into the cell genome by genetic trans-
formation (i.e the integration of new genes) or mutation. In the last 
decade, these two not completely exclusive alternatives, have strongly 
influenced the development of theories on cancer and attempts to solve 
the problem of its etiology. 
In early studies on the pathogenesis of the oncoviruses, basic aspects 
of neoplastic transformation were examinee ir animals (5-7). At the pre-
sent time, however, most of the research on these viruses.can be pe'-formed 
in tissue culture although neoplasia is a disease which is defined only 
in whole organisms. An analog of neoplastic transformation, called cel-
lular transformation, has provided an in vitro model for quantitative 
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studies on neoplastic transformation (10-12). Thus, cells altered in 
vitro by oncoviruses or by other oncogenic agents are essentially the 
sane in many newly acquired biological and biochemical properties as 
cells cultured from neoplasms induced in animals by those agents. More­
over, they often develop into tumors wher transferred to healthy animals 
under proper conditions (13). The introduction of in vitro models for 
cell-virus systems was a major improvement of the research on the virus-
induced transformation. The role of viruses in human cancer is still 
obscure. Yet, the study of virus-induced transformation is relevant to 
a better understanding of cancer in general because many crcogenic vi­
ruses are vehicles of transforming genes with functional or structural 
homology to cellular genetic information. The viral genome is less corn-
pi ex than the cellular genome by several orders of magnitude. Thus, 
through the isolation of viruses, transforming genes are directly acces­
sible to experimentation. "It is indeed this aspect of viruses tnat 
makes them invaluable to the biologist, whom they present with the uni­
que opportunity to observe in relative isolation the active determinants 
cf biological specificity, which are truly the stuff of which all life 
is made". 
The aim of the study described in this tnesis was to investigate the 
structure and assemblage of oncoviruses, and to cnaracter;ze the expres­
sion of the viral genomes in order to provide further insight in the 
molecular biology of oncoviruses. Therefore, we analyzed viral and sub-
viral structures by el ectronmi oroscopi с and biocherr'cal techniques and 
we studied the synthesis of virus-specific structural and nonstructural 
polypeptides in vi rus-infected tissue cultjre cells and in a protein 
synthesizing system (oocytes of Xenopus laevis). Moreover, we studied 
the viral genome in transfection experiments. 
We described a method for the preparation ard purification o x oncovi^al 
substructures, which is in fact the first method for the isolation of 
pure viral envelopes. It enabled us to further characterize the struc­
tural virus-specific polypeptides in these viral substructures. In stu­
dies on gene expression of Rauscher murine leukemia virus either under 
normal physiological conditions or under conditions o' impaired glyco-
sylation we contributed to the elucidation of the pattern of viral 
к 
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structural polypeptide synthesis. Subsequently, using a similar experi­
mental approach, we could further characterize temperature-sensitive 
mutants of Rauscher murine leukemia virus of differert classes. Moreover, 
in an extension of studies on gene expression, we could identify trans­
forming virus-coded polyprote'ns containing Іеикетіа virus-specific 
structural components covalently bound to nonstructural components, 
possibly representing transformation-specific sequences. Finally, in 
another approach to study viral genes, we showed that by transfecting 
mouse cells with purified DNA isolated from cells releasing high titers 
of oncoviruses, we could introduce new viral genes into tne cellular 
genome. In virus rescue experiments we showed the rescue of oncoviruses 
from cells infected with a temperature-sensitive oncovirus and transac­
ted with low molecular weight proviral DNA fragTents of a w;Id-type 
oncovi rus. 
As an introduction to the exDeriTental work described ir this thesis 
we will present some relevant aspects of the molecular biology of onco­
viruses, followed by a preface το the papers. 
CLASSIFICATION AND STRUCTURE OF ONCOVIRISES 
TaxcnomicalIy, oncoviruses or oncovirinae constitute one of the three 
subfamilies of the retroviridae; the two other subfamilies are repre­
sented by the spumavirirae tfoamy virus group) and the lentivirinae 
(Maedi/visna group) C15). Oncoviruses, are enveloped, spherical viruses 
with a diameter of approximately 100 nm; they contain a virus-coded RNA-
dependent DNA polymerase and a diploid RNA genome encapsidated within 
a protein core (16,17). They consist of proteins (about 65?), lipids 
(about 50%), carbonydrates (aoout 3%) and RNA (about 2%) (2). The majo­
rity of the virion polypeptides are virus-specific and are coded for by 
the high тоіесиіаг weight genomic RNA of the virus; in contrast most of 
the other components such as RNA species with lower molecular weights 
than the genomic RNA, carbohydrates and lipids are mostly cellular compo­
nents derived fron the infected cell. 
Since their initial discovery by Ellerman and Bang (5) and Rous (6), 
oncoviruses have been isolated from a large number of species; they 
are apparently ubiqu'tous among vertebrates. Representative isolates 
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have been obtained from primates (baboons), domestic animals including 
avian species (chickens, sheep, pigs, cattle), small rodents (mice, 
hamsters, rats), reptiles (snakes), and piscine species. 
The oncoviruses have been classified primarily on the basis of morpho­
logical criteria and, according to this classification, they have been 
designated as type-Α, type-B, type-C or type-D (18,19,20). The design­
ation "type-Α" is used for virus-like particles that are present intra-
cellularly in a variety of mouse tumors (21). These particles are often 
found associated with the endoplasmic reticulum (22). Туре-B oncoviru­
ses, characterized by their eccentrally located nucleoids and the pre­
sence of characteristic spikes on their envelopes (23), have been iso­
lated from tumors of the mouse (24), the quinea pig (25,26) and cattle 
(27,28). Most extensively studied is the type-B virus of the mouse, the 
Fig. 1) XC-plaque assay on mouse embryo fibroblasts infected with Rauscher 
murine leukemia virus. Mouse embryo cells were infected with Rauscher 
murine leukemia virus (plate A) or mock infected (plate B). After incu­
bation for 6 days, the mouse cells were UV irradiated and XC cells were 
added. XC cells are derived from a rat tumor induced by the avian Rous 
sarcoma virus. These cells form syncitia when aocultivated with murine 
leukemia virus producing mouse embryo cells. Three days later cells were 
fixed with methanol and stained with hematoxylin. The development of 
visible syncitial plaques in the infected preparation is evident. No 
plaques appear in the control, uninfected preparation. 
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mouse rrammary tumor virus (29,30,37). Based upon similar serological 
characteristics of their major structural proteins, type-B particles 
probably represent maturational products of intracellular type-Α parti­
cles (31,32). The main morphological characteristic of type-C oncoviru­
ses are tneir centrally located nucleoids and the virion assembly pat­
tern during the bude Ing process at the plasma membrane of the infected 
cell (23). Type-C viruses are widely spread among mammals. Moreover, 
all known non-mammalian oncoviruses belong to this Torprolog'caI group. 
Finally, type-D oncoviruses are larger In diameter than type-B or type-C 
viruses and have pleomorphic shaped nucleoids (20). Representative Iso­
lates of this type are the Mason-Pfizer monkey virus (33,34), an onco­
virus endogenous to the langur mcrkey (35) and possibly a number of 
isolates of squirrel monkey origin (35,36). 
Another classification criterion is pathogenicity. The mouse irammary 
tumor virus mentioned above is the only oncovirus associated with a 
carcinoma (37). Other oncoviruses cause leukenias of various types or 
sarcomas. Most leukemia viruses and avian sarcoma viruses are indepen­
dent viral entities. Some avian oncoviruses, the тэттаМаг sarcoma 
viruses and several other mammalian viral isolates require leukemia 
viruses as helper viruses -Or their replication (38,39,40). They occur 
as so-called pseudotypes, that is their genomes are encapsidated with 
the aid of their helper viruses. И the abserce of helper virus they 
can be latently present in so-called nonproducer cells from which they 
car be rescued agalr upon infection by a helper virus (2). ~he replica­
tion-defective oncoviruses appear to have arisen as a result of genetic 
recombination between type-C oncovlral and host cell geretlc sequences, 
that nay code for malignant transformation (41-44). Representative iso­
lates have beer obtained fron four different таптаііап species Including 
two rodent species, the mouse (45-48) and rat (49,50), one carnivore 
species, the cat (51,52), and one primate species, the woolly monkey (53). 
The leukemia and sarcoma viruses include viruses that do not occur in 
natLre but apparently originated from recombinational everts that were 
selected for during decades of cancer research in experimental animals. 
Finally, it should be mentioned that a large питЬег of type-B, type-C 
or type-D viruses are endogenous, i.e. thoir proviruses are stably inte­
grated 'n the germ line of many if not all avian and mammalian species. 
Sometimes they can be detected in hybridization experiments using cDNA 
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Fig. 2) 
Л) Syncitia in an XC-plaque induced by Rauscher murine leukemia 
В) Focus of transformed mouse embryo fibroblasts after exposure 
Kirsten sarcoma virus. 
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of related viruses as a probe; sometimes virus expression is induced in 
various ways. In other cases endogenous viruses are released "spontare-
ously". Although for historical reasons, endogenous type-C viruses are 
sometimes referred to as leukemia viruses, their implication in the de­
velopment of tumors is only well documented for endogenous mouse viruses 
The biological significance of endogenous viruses is not understood. 
И view of the fact that crly marmai ian type-C oncoviruses ard +ype-C 
pseudotypes of replication-defective transforming oncoviruses were used 
in cur stucies, we will restrict this irtroduct;cr тзi г I у to these cate­
gories. Oncoviruses of both categories can be assayed in tissue culture 
by various techniques (2). A generally appl'ec assay for autoroTOJsly 
replicating ecotropic murine leukemia viruses is the XC-plaque assay. 
Tnis assay is based on the observation -"-hat mouse cells releasing these 
viruses form syrcitia when cocuItivaxec with XC cells (Figu-e 'Α*3 and 
Figure 2A). In general, autonomously replicating murine leukemia viruses 
do rot transform mouse embryo fibroblasts in tissue culture. However, 
some selected cell lines are susceptible to transformation by some of 
these viruses and can thus be jsed in a focus assay (2). In contrast to 
autonomously replicating murine leukemia viruses, murine sarcoma viruses 
transform mouse emoryo fibroblasts in tissue culture and therefore, they 
are generally assayed by focus assay (Figure 2B). It should be noted 
here that Abelson leukemia virus is a replication-defective virus that 
causes Іеикет'а and transforms fibroblasts ir tissue culture. ~herefore, 
it resembles the murine sarcoma v;ruses. Furthermore, we want to mention 
a focus assay in wnich эопе narrow eel Is are used as indicator eel Is. 
In •'•his assay foci are induced upon infection with the Friend leukemia 
vi rus compi ex (54). 
RELATEDNESS OF DIFFERENT "YPE-C ONCOVIRUS ISOLATTS 
Based upon the observation that complete, infectious type-C oncoviruses 
a
r
e released spontaneously by animals of certain mammalian species and 
by cultureo cells of tnese animals, the hypothesis has been postulated 
tra4- the information for the production of these viruses mich-1 be trans­
mitted genetically from parent to offspring along with other cellular 
genes (8,9,55,55). Apparently, type-C orcoviral seqjences are integrated 
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within the genome of a great number of different species Their expression 
being subjectec to the same regulatory processes that affect cellular 
genes. Although normally repressed, these endogenous viral genes can be 
activated by a variety of factors (genetic factors, hormones, radiat'cr, 
chemical carcinogens, infecting viruses) (57). Following activation, the 
viral geres can sometimes escape f'-om host control and the released in-
fectious type-C oncoviruses can be transmitted horizontally to animals 
of the sarre species (58-64). Moreover, during the course of evoluì ion 
type-C viruses have been transmitted to and become stably associated 
wiTh The germ lire of species that are only remotely related phylo-
genetically (65-70). An implication of these findings is that oncovirus 
isolates of taxonómica ; I y distant species may be close'y re'ated. 
Based upon nucleic acid hybridization studies, it appears that there are 
two lineages of ancestral ~ype-C viruses, one represented by the ~ype-C 
viruses found in rodents, and one represented by those found in certain 
primates. Within the first I ineage oncovi га I ¡sclaTes re'aTed to one 
group of endogenous rodent viruses include endogenous viruses within the 
pig genome (68), a group of isolates of gibbon apes (61) and a woolly 
monkey isolate (71). All these isolates are supposed to be evolutionary 
related to ancestral mouse viruses (72). Arother highly related group 
seems ~o be endogenous rodent viruses of the rat (73) and the harster 
(69,74,75). In addition, a horizontally-transmitted type-C virus of cats 
seems to be derived originally from another endogenous rodent virus (69). 
Representative viruses of the second lineage include isolaTes from old 
world primates (76,77), a class of endogenous feline oncoviruses (78) 
and probably a group of oncoviruses endogenous to ungulates (79,80). 
The data mentioned above are consistent with numerous serological data 
and with recent amino acid sequence studies of structural proteins (Dr. 
S. C""oszlar, personal commun i сат i or) and, in tne case of the avian vi­
ruses, nucleotide sequence studies, al I providing evidence for the evo­
lutionary relatedness of the d'fferent isolates of -ype-C orcovi-uses. 
The whole family of retroviruses has so many basic properties in common 
as far as their morphology and replication cycle is concerned, that we 
are convinced that they have evolved from a common ancestor. The same 
may be true for a number of other families of viruses but іг го other 
family one encounters so many viruses that are so closely related. 
20 
RfPLI CATION CF ONCOVIRUSES 
The mechanism of infection of a susceptible host cell by mammalian type-
C oncoviruses is not yet completely understood. Entry may occur by ν iго-
Dexis, by fusion of -""he viral envelope wit.n tne plasma membrane or by lo­
calized dissolution of the viral and cellular membrane (81,82,83). Fur­
thermore, a specific interaction between the ceil surface ana the viral 
envelope seems tc be involved in the ent^y of tie virus into """be host 
cell (84,85). 
An infecting oncovirus introcuces tne RNA-dependent DNA polymerase (re­
verse transcriptase) together with *he viral genome into the cytoplasm 
of the cell. This enzyme is capable of DNA synthesis on an RNA or DNA 
template ard cortains RNAse Η activity (degradation of the RNA in a RNA-
DNA hybrid) (86,87,88). After entry of the virus into the cell, the high 
molecular weight genorric RNA is transcribed with the help of the reverse 
transcriDtase and this synthesis OCCLTS in the cytoplasm curing the first 
hours after infection (89,90). 
Based upon data from in vitro and in vivo experiments, it appears that 
the ^everse transcription begins rear the 5'-end of one of the two geno­
mic RNA subunits (91,92,93), progresses a short distance to the 5'-end 
of the RNA molecule (94,95) and, subsequently, continues at the 3'-end 
of the sarre or another RNA subuni+ (88,93,96,97,98). The initial inter-
med;ate in the reverse trarscription reaction is probably an RNA-DNA 
hybrid consisting of viral RNA hydrogen-bonded to full length (-)strand 
DNA (96). Next, a doub'e-stranded linear DNA intermediate is synthesized, 
consisting of the long (-)strand DNA hydrogen-bonded to relatively short 
(+)strand DNA fragments (88). Thereafter, a complete linear double-
stranded DNA molecule is formed (99,100. This full length ' irear DNA 
apparently contains the entire genetic information of the virus, since 
upon transfection of appropriate reci ρ i ent cells, progeny virus was 
released (101,102). Only full geromic length Tolecules are Hfec^ous 
and can gi.ve rise to progeny virus production (103). Subsequent to the 
formation of tne l;near dsDNA prov*rus, a closed circular dsDNA form 
of the viral genome is found. This form was first identified in cells 
infected with the avian oncovirus Rous sarcoma virus (100,104) but later 
also in mammalian ceils infected with rramrralian oncoviruses (105,106). 
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The circular form has been visualized by electron microscopy (106,107, 
108). Ci rcu I arizat ion is probably necessary for integration ; n_o ""he 
cellular genome (88). In contrast to the linear Rous sarcoma virus DNA 
molecules, whose accumulation has been demonstrated ir enucleated cells 
(89), closed-circular DNA 's found only in the nuclei of ;n-ected cells 
(107). From transfectior experiments, it appears that the closed-c i rcu lar 
DNA molecule is of full genome size (99,102,107). However, the closed-
circular DNA has a 5 fold lower specific infectiv'ty than the I¡rear 
form (102). In the last step of the infection process, the newly synthe-
sized oncoviral DNA ¡ε integrated into the cellular genome. There Is 
some suggestive evidence that integration of """he vira' genome into cel­
lular DNA is necessary for transformation ard for virus production (104). 
However, the possibility that some provirus remains unintegrated and 
can function in that state has го4" been ruled out definitively. 
Upon transcription of the integrated proviral DNA,viral RNA is synthe­
sized. Cellular RNA polymerase II is probably involved in this process, 
since synthesis of vira, RNA is sensitive to a-amani~in (109,110,111). 
Furthermore, mitosis is required for the initiation of the viral RNA 
synthesis (112,113). The synthesized viral RNA can be found as messenger 
RNA associated with poIyr'bosomes ard becomes incorporated in progeny 
virus. Both messenger RNA and virion RNA have the same plus polarity. 
However, there is substant:al evidence tnat they constitute separate 
pools (114). Bas'c properties of the viral genome, the character ist'es 
of the viral messenger RNA and the synthesis of the virus-specific poly­
peptides will be described separately. 
Assemblage of the virus particles and virus -"elease takes place by bud­
ding from the plasma membrane. In a process of extracellular maturation 
which can be followed in an electron microscope, newly releasee virus 
particles undergo a "Transition from particles with an electron ' ucent 
to an electron dense core ((22) see also chapter II). Concomitantly, 
tne viral RNA, present in newly released virions in the form o~ 30S-40S 
components which are not or only weakly linked to each other, become 
more extensively linked resulting in a 60-70S RNA complex (115,116,117). 
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PROPERTIES OF THE ΤΥΡΕ-C ONCOVIRUS GENOME 
The RNA present in type-C oncoviruses is composed of different RNA spe­
cies. The RNA species with the highest molecular weight sed;Tents in a 
neutral sucrose gradient of about 50-7OS (118,119) and appears to carry 
all viral genetic .Taterial. RNA species of lower molecular weight include 
ribosomal RNAs and RNA species sedimenting in the range of 4-7S (119-122). 
With the exception of part of the 4S RNAs no virus-specific function can 
be attributed to the lower molecular weight species present in the viri­
ons. The 4S RNA class consists of a selected population of cellu'ar tRNA 
species which are free inside the virus-particle or hydrogen bonded to 
the 50-70S сотрI ex (121,123,124). Ore specific tRNA no'ecule per haploid 
genome can serve as a ргітег in the RNA-dependent DNA synthesis in vitro 
and presumably has the same function in ν ivo (125,126). In Rous sarcoma 
virus and Moloney murine leukemia virus +he initiator rRNAs have been 
identified as tRNA T r p and tRNA P r o respectively (127,128), they are at­
tached by basepairing with their З'-end closely to the 5'-end of the 
geromic RNA (128-131). 
Based upon particle weignt deterni rat'on (132), equ'librijT sedimentation 
(133), electron microscopic measurements (134,135) and gel electrophore­
sis (136), the estimated molecular weight of the 50-70S RNA is between 
4.5x10 and 7.0x10 daltons. By dimethyl su Ifoxide treatment or heating 
the high molecular weight 50-70S RNA complex can be dissociated into 
30-40S suounits (137). This indicates that the 50-70S RNA is a complex 
whose components are hold together by hydrogen bonds. La^er evidence 
indicated that there are two 30-40S subunits per 50-70S complex (138-142). 
In electron microscopic studies on the structure of partially denatured 
50-70S vir:on RNAs, I'near complexes were observed and, as could be visu­
alized by tagging with SV40 DNA both free ends contained poly(A) (143). 
These complexes called diner linkage structures are Y-shaped and possess 
a loop in each subunit (143-145). The molecular weight c* the 30-40S RNA 
subunits estimated by gel electrophoresis varies in the range of 2.2x10 -
3.5x10 daltons (146-147). Tne higner values represent RNA species from 
nondefective transforming viruses. These type of orcovi-"uses, with Rous 
sarcoma virus as the prototype, have the largest genomes. The lower va­
lues are characteristic for defective oncoviruses from which one or more 
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genes are deleted. 
The 30-40S virion RNAs have a poly(A) track of about 200 residues at the 
З'-ends С148—150) and their 5'-ends possess the typical cap structure 
m7G5'ppp5'NrrpKp (151-153). Thus, they nave termini typical for eukaryotic 
mRNAs. Furthermore, the sequence of the 5'-end has additional interesting 
features which are probably ¡mportart characteristics of •'•he genome. As 
an exarrple we d'scuss here the 5'-enc of The avian sarcoma virus genome 
because this genome is studied in most detail at the moment. Mammalian 
oncov'rus genomes, however, are net basically different, hybridization 
studies and secjence analysis have -"evea I ed a terminal redundancy in the 
viral genome (98,154-156). About 20 nucleotides ат the 5'-end are repea­
ted at tne З'-end ¡Trediately adjacert ~o the terminal poly(A) track. 
In view of the observation that DNA synthesis starts at the tRNA site 
ard proceeds to the 5'-end of tne genome, terminal redundancy provides 
possible mechanisms for reverse trarscri p* ion of -""he rena i η ¡ rg genomic 
RNA (93,98). The 5'-end also contains a region complementary to the 
З'-end of eukaryotic 18S r'boscmal RNA (157-160). voreover, an initia­
tion codon AUG is located in "'•he direct neighborhood of this site (159, 
160). These sequences probably represent a ribosome binding site and 
an initiation site for tne translation of tne first gene at """he 5'-end 
of the genome. Finally, Inverted repeat sequences are observed at the 
5'-end. These structures may be 'nvolved in the formation of d'mer 
linkage structures (160). 
TYPE-C ONCOV'RAL GENES AND Th^ E IR EXPRESSION 
Oncovi raj__genes 
All autoroTOJsly replicat'ng type-C oncoviruses contain three genes which 
code for the virus-spec'f¡с vir on polypeptides (161,162). The gene co­
ding for the internal structural polypeptides is called the gag-gene; 
the pol-gene directs tne synthes's of tne virion associated reverse 
transcriptase and the env-gene codes for the envelope polypeptides. 
Furthermore, according to the currert conception about their genoTes, 
autonomously replica-ing and transformng type-C orcov'ruses, which ur­
ti I now have only been found in avian species, contain an additional gene. 
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This gene is termed src-gene and is involved in cellular transformation. 
Basée upon cl'gonucleotide napping and frequencies of geretic recombina-
tion, the gene order within the genome of these oncoviruses is 5'-gag-
pol-env-src-3' (161,163,164,165). Tne transformation-defective avian 
leukosis viruses lack the sre-gere but apart fгот that their gene order 
is the same. The gene order of the nontransformirg mammal ian type-C on­
coviruses is probably ¡cenrical to the one for avian viruses (166,167). 
The genes of transforming mammalian oncoviruses are d'scussed below. 
Typically, infection by oncoviruses hardly influences the cellular syn-
thetic apparatus quantitatively and does not result 'n cell lysis. Rela-
tive to the total cellular RNA and p-Ote'n synthesis, the oncovirus-spe-
cific synthesis of macromolecu I es is low accounting for only about 0.5?-2? 
of the total (168). Therefore, very sersitives techniques such as rucleic 
acid hybridization and competition or precipitation radioimmunoassays are 
required to detect the oncovirus-specific gene-products in a mixture with 
host eel I Liar components. 
Oncoviral TRNA sgecies 
Analysis of the transcriptional products of the v'ral genomes in nucleic 
acid hybridization studies revealed the presence of several virus-speci-
fic nRNA species in type-C oncovirus infected cells (169-175). In cells 
injected with autonomously replicating and transforming avian type-C 
oncoviruses, three different virus-specific mRNA species have been iden-
tified. The mRNA species are differen- in size and have sedimentation 
values of about 38S, 28S and 21S. With selected cDNA probes the geretic 
content of these mRNA species and of mRNA species in cells infected with 
various deletion mutants of the sane oncoviruses has эееп characterized 
(172). In studies on mammal ian oncovirus-specific mRNA species similar 
results were obtained (167,174,175). In Figure 3 a schematic representa­
tion of characrerized mRNA spec'es from mammalian oncovirus infected 
eel I s is depicted. 
Furthermore,- it appeared from hybridization studies that oncoviral TRNA 
spec;es present in type-C oncovirus infected cells contain noncontiguously 
coded sequences (167,172,176). This phenomenon due to splicing of RNA 
molecules appear to be a mere general fearure in eukaryotes. For instan­
ce the juxtaposition of RNA sequences encoded by noncontiguous sequerces 
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of DNA has also been obse-ved in adenovirus TRNAS and the mRNAs of SV40 
as wel I as ina number of eel Iular nRNAs (177-181). The molecular mecha­
nism responsible for this apparently very delicate and specific process 
is still completely unknown. In a recent hybridization and heterocuplex 
study by Rothenberg et al. (167), the 21S mRNA species in a Moloney mu­
rine leukemia virus infected cell was compared with the genomic RNA. It 
appeared +hat the 21S mRNA contained a 500 nucleotide sequence which 
rraps at the 5'-end of the genomic RNA ard a 2.8 kilobase sequence which 
maps at the З'-end of the genome. It is not yet clear whether or not 
this 5'-terminal sequence has a specific function in protein synthesis. 
genomic RNA 5 4 ' " flag1:,! Pol lV....En.v.VÏI C> |Роіу*|-3' 35 S 
gag-mRNA 5' н т т ^ т ш ш ^ і ^ ш і ш т ш і і і ш і і ^ poly A-3' 35S 
env-mRNA 5' -е=вггга.ч.ч.ч.-лч.: ліггггггшв- poly A3' 22 S 
0 5 k b from 5'-end 
of genome 
28 kb from 3'-end 
of genome 
Fig. 2) Schematic representation of intracellular oncovirus-specific mRNA 
species as identified in mammalian oncovirus infected cells. 
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Oncoviral structural p_°l YEeE^ 'α§§ 
Analysis of the biosynthesis of vi -"US-spec i f ic polypeptides in cells 
infected with type-C oncoviruses has led to the elucidation of synthetic 
processes involved (168-182). In almost all studies specific ant i sera 
prepared againsT disrupted virus particles of purified virion роіурерті-
des have been used. Therefore, prior to their synthesis, the properties 
and the serological characteristics of oncovirus-specific polypeptides 
are discussed. Although much is known about the polypeptides of the 
avian oncoviruses, we will restrict our discussion to the mammalian 
type-C oncoviruses. 
In prototype mammalian type-C virions, Rauscher murine leukemia virions, 
four different internal structural polypeptides and four envelope struc­
tural polypeptides have been identified (168). According to the nomen­
clature agreed upon at a Tumor V',~a\ Immunology Workshop ('83,184) these 
polypeptides are naTed рЗО, p15, p12, piO, gp70, gp45, p15(E) and p12(E) 
("p" standing for "protein", "gp" for glycoprotein, "(E)" for location 
In the viral ervelope; the figures ^efer to estimated тоіесиіаг weights 
in ki Ιο-da I tons). A similar nomenclature is used for other classes of 
oncovi ruses. 
Serologically, each virus-specific virion polypeptide of type-C oncovi­
ruses is characterized by mult:ple antigenic aeterrr. ¡nants (fer a review 
see reference 182). One polypeptide тау contain group-specific antigenic 
determinants (shared by certain viruses within a given host species), 
interspecies-specif i с antigenic determinants (shared by certain viruses 
of different animal species), and type-specific antigenic determinants 
(unique to an individual virus strain). Aviar and mammalian type-C orco-
viral polypeptides are serologically completely different. 
The largesT internal structural polypeptide of mammalian type-C virions 
is the major group-specific antiger рЗО. This most extensively studied 
internal polypeptide possibly forms the core shell of the virion (185). 
In addition to group-specific antlgen'c determlnanrs, it contains Inter-
species-specific and, although less pronounced, type-specific antigenic 
ceterminants. The isoelectric points of рЗО Isolated fron diverse mamma-
I¡an type-C viruses vary between 6.2 ard 8.0. 
The Internal structural polypeptide pi 5 ¡s a strongly hydrophobic poly-
peptide anc possesses type-specific, group-specific as well as broadly 
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reactive interspecies-speci f ic ant'genic deten-inants. The isoe'ectric 
points of the hydrophobic polypeptides from diverse type-C mammalian 
oncovirus isolates vary between 6.1 and 8.3. Its presence in the viral 
core as well as in the viral envelope is discussed in chapter II of· this 
thes!s. 
The internal structural polypeptide ρ 12 is a phosphoprotein (186). It is 
acidic; the isoelectric po'nts of ¡solares from diverse type-C таттаііап 
oncoviruses vary between 4.1 and 5.9. The phcsDhop^oteins bind specifi­
cally to homologous viral genomic RNA Dut net to RNAs of Heterologous 
type-C oncoviruses (187,188). Polypep+ide ρ 12 contains some group-speci­
fic antigenic determinants, but as appeared from competition immunoassays, 
it is highly ~ype-speci f i с and thjs provides a valuable tool to discrimi­
nate between mammalian type-C oncovirus isolates. 
The internal structural pc'ypeptide plO is an arginine-rich strorcly 
basic protein which has been reported to be associated with the viral 
RNA ir. the form of a ri bonucl eoprctei η complex within tne Tature viral 
core (185,189). The isoelectric poirt of isolates frcT diverse, type-C 
marrmalian oncoviruses, vary between 9.1 and 11.6. Group-specific and 
i.nterspecies-speci f 'с reactivity has been demonstrated in serological 
studies with these polypeptides. 
In addition to the interrai structural эоіypep-ides, the type-C crcoviral 
reverse transcriptase is also located in the viral core. In contrast to 
the avian type-C oncoviral ^everse trarscriptase which contains two sjb-
units, the enzyme from murine type-C oncoviruses consists of a single 
polypeptice with a тоіесиіаг weight of abojt 70,000 caltcrs (87,182). 
This polypeptide possesses type-specific, group-specific and in^erspe-
cies-specific antigenic determinants. 
The largest envelope structural oolypep~ide is gp7C, a glyecpro+ein with 
an apparent molecular weight of about 70,000 dalton based on sod i urn dode-
cyl sulfate Polyacrylamide gel electrophoresis. This pclypeDtide is loca­
ted on the cell surface (190,191,192) and possesses group-, interspecies-, 
and type-specific antigenic deten-inants which apparently reside ir the 
protein moiety (193). The isoelectric poin+s of ;solates from diverse 
mammalian type-C oncoviruses vary between 4.1 and 5.3. 
In addition to gp70 in some isolates one finds a 45,000 mclecUar weight 
glycoprotein, gp45. Based upon amino acid composition, serological pro-
peí— i es and peptide mapp'ng, this glycoprotein seeTS to be related to 
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cp70 (168,194). 
The envelope po'ypoptido ρ15(Ξ), which possesses croup- and :nterspecies-
specific antigenic determinants. Is a nonglycosyIated acidic polypeptide 
and has a tendency to aggregate ¡r the absence of dotergen~s С195). gp70 
Is probably linked by disulfide bonds to p'5(F) (196,197). 
Tne enve'ope polypeptide p12(i) Is related to p15(E) as арэеагеа from 
chymotryptic peptide analysis (192,198). 
Gag-gene trans I ationaI products 
In eariy studios on the synthesis of virus specific structural polypep­
tides in avian type-C oncovirus 'nfected cells. It was shown that the 
primary gag-gene product was a high molecular weight precursor polypep­
tide (199,200). Post-trans I aziona I c.'eavage of -his precursor Dolypeat'-
de resulted In the production of the nongIycosyIated internal structural 
polypeptides. Lare^, in БІТІІЭГ experiments, an analogous precursor-pro­
duct relationship was found in ггатгга I'an type-C oncovirus infected cells 
(168,182). In pulse-chase experiments witn Rausche1" гльгіпе leukemia in­
fected cells it appeared that the internal structural polypeptides p30, 
p15, ρ 12 and plO are cleavage products of a common precursor polypeptide 
of about 75,000 caltor termed Pr75 according to the current nomencla­
ture (182,201-208). The same results were obtained in in vitro transia-
tion studies using 35S geromic RNA (209-216) or the 35S mRMA soec'es 
from infected cells (217,218). From a number of intracistroni с mapping 
stucies the secuerce of the Rausche^ murire leuken'a subgene products 
was deduced as NH -p15-p12-p30-p10-C00H (182,219). At the moment the 
primary gag-gene precursor poIypept'des, their cleavage products and the 
order of these subgene products of a large number of different mammalian 
and avian oncov'ruses have beer desc^ined (182). The results of some of 
these studies are deaicted in Figure 4 which was obtained from Dr. J.R. 
Stepnenson. It is obvious from this figure that the identification of 
the subgene products according to +he current nomenclature is veny con­
fusing when relaten oncovlral isolates are corcerned. In order to over­
come this difficulty a nomenclature system taking Into account immuno­
logic, biochemical and genetic properties has been proposed by Stephenson 
et a I . (182). Acccrcing to this proposal the gag-subcere products are 
called gag-a, gag-b, gag-c and gag-d going from left to right on the map. 
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Fig. 4) Proposed arrangement of viral proteins withir representative 
marmalian type-C viral gag-gene-coded precursor polypeptides. The 
figures indicated in the bar graphs represent the isoelectric points 
of the гпаі гаиаі proteins, while the values between braakets represent 
the moleovlar weight as determined by agarose gel filtration in the 
presence of в M GuHl. (Figure obtained from Dr. J.'p. Stephenson; see 
reference 132). 
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Sofar, uncomplete knowledge about functional analogy between virus-speci-
f'c products of more distantly •"elated oncoviruses has hanoerec the ge­
neral introcuct'or of this useful пстепсI ature. 
Po I-gene trans' at¡era I croducts 
The enzyme reverse transcriptase seems to be synthesized according to a 
peculiar mechanism (207,213,220). In татггаііап type-C oncovirus infected 
cells a high molecular weight precursor polypeptide vvas observed which 
could be precipitated with antisera raised against the internal struc­
tural polypeptides as well as against the reverse trarscr'p~ase (207). 
Apparently, the primary transi ationaI product in the synthesis of rever­
se transcriptase is a gag-poI-precursor polypeptide. In 'n vitro trans­
lation sTjdies using 35S genomic RKA, the syrthesis of a simi ar high 
molecular weight precursor polypeptide was observed (213-216) and appea­
red to be mere pronourced wher certa'η suppressor tRMA species were added 
(213). "hese results suggest that the synthesis тзу be due to occasional 
readthrough at the gag-gene termination site which is sensitive to cer­
tain suppressor tRNA species. These observations also sjggest, that ~he 
35S mRNA species :s tne messenger for the internal structural polypepti­
des as well as for the reverse transcriptase. Furthermore, a readthrough 
mechanism at lew frequency could also exp'air the difference in the эго-
dLction of tne relatively large amounts of internal structural polypep­
tides and small amounts of the enzyme. 
Env-gene transi ationaI products 
Like the irte^nal structural polypeptides, the envelope polypeptides 
gp70, gp45, p15(E) and p12(F) are derived from a common precursor poly­
peptide (201,202,204-206,221). In Rauscher murine leukenva virus infected 
eel Is this pr'mary trans'at'ora I product of The erv-gene is a high no-
en ν 
lecular weight glycosylated polypeptide of about 82,000 daltons (gpPr82 ). 
The same precursor polypeptide is observed in translation studies using 
the 21S mRNA species (218). "he arrangèrent of the sjbgene products 
within the primary env-gene translat¡onal product is probably 
N4 -gp70-pl5(E)-COCH (221). 
In Figure 5 a schere of the expression of the таптаііап murine leukemia 
viral genes is depicted. 
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Fig. ЬА) Model for the synthesis and post-translational processing of the gag- and pol-gene coded 
precursor polypeptides. 
* Precursor polypeptides synthesized under artificial conditions (i.e. in the presence of canavanine). 
• The primary translational product of the gag-gene contains in addition to the four subgene products 
a 12,000-15,000 molecular weight polypeptide. This polypeptide is located at the amino terminal site 
of the precursor polypeptide (S. Oroszlan, personal communication). 
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Fig. SB) Model for the synthesis and post-translational processing of the emr-gene coded precursor 
polypeptide. 
^Precursor polypeptide synthesized under artificial conditions (i.e. in the presence of inhibitors 
of glycosylation). 
REPLICATION DEFECTIVE TRANSFORMING MAIWAIJAN ONCOVIRUSES 
Al I mammal ian oncoviruses capable to transform fibroblasts in ν i tro are 
-"ер I ¡cat ion-defect i ve (2) ard are believed to have orig'nated as a conse-
quence of genetic recombination between type-C he I pei—viruses and host 
cell genetic sequences coding for malignant transformation (41-44). Re-
presentative isolates of namnaI i an transforming oncoviruses have beer 
obtained from a number of mammalian species including the mouse, rat, 
cat and woolly monkey. Some isolates are from naturally occurring sarco-
mas but mos- Turine transforming viruses wore isolared from m'ce or rats 
after inoculation of murine leukemia viruses. 
Initially hybriGizat¡on studies have deronstrated partial nonology be-
Tween the transforming replication-defective encov'ruses and the type-C 
oncoviruses which have been used for their isolation (222-227). Further 
characterization of the genomes of the transforming oncoviruses has been 
performed using heteroduplex mapping, oligonucleotide mapping, restric-
tion enzym analysis, and TransfecTion and hybridization fechniques (228-
235). 
Until now, a characterization of polypeptides coded for by transforming 
genes has been limited. Recently, a 60,000 тоіес-ilar weigh"1" pro-ein nas 
been détectée in avian загсота v'rus transformed cells as well as in in 
ν i tro translation studies usirg the З'-terminal third of nondefective 
avian sarcoma vi^us RNA (236,237,238). Peptide mapping revea'ed that in 
both cases the same protein was detected (237). This protein appears to 
De the product of the avian src-ger.e and prooably possesses protein 
kinase activity (237). 
Polypeptides coded for by mammalian transforming genes have not yet been 
described but iaenti fica-icn of such polypeptides is the na i г goa1 о 4 a 
njTber of laboratories. Using cell-free translation systems, parks and 
Scolnick showed, that partially purifiea viral RNA of Harvey sarcoma 
virjs codec for a proteir of about 21,COO тоіесиіаг weight (239). This 
protein did not correspond with trans I ational products obtained with 
viral RNA of the helper type-C oncovirus but tnere is no evidence that 
this product is related to the transforTation-spec i f'с gene product. 
Since mammalian transforming oncoviruses seem to be evolved as the result 
of a genetic гесотЬІnat ion oetween type-C oncovirai sequences and cellu-
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TABLE I 
TYPF-C VIRAL ANTIGEN EXPRESS ION IN WAVVALIAN 
ONCOVIRUS TRANSFORMFD NCNPRODUCER CEU I INES 
Vi rus 
Orig i η 
Mouse 
Rat 
Cat 
Woo I ! y 
Monkey 
Vi rus 
1 sol ates 
NP-Mo-MSV 
Fr'end SFFV 
Balb-MSV 
Abolson-MuLV 
T8-MCF 
S*L~Mo-MSV 
KiMSV 
HaMSV 
FeSV 
WSV 
Transformed 
Nonproducer 
Cell Line 
M-NRK 
NP9 
MA 1-3206 
AP2-CCL64 
T8-CCL64 
MÌCI, 
K-NRK 
H-NRK 
FeSV/CCL64 
WSV-NRK 
Express ion 
gag-a 
(p15) 
-
+ 
+ 
+ 
+ 
+ 
-
-
+ 
+ 
of Type-
gag-ccded 
gag-b 
(p!2) 
-
-
+ 
+ 
+ 
+ 
-
-
+ 
+ 
gag-c 
(p30) 
-
-
-
-
-
+ 
-
-
-
+ 
-C Oncovi ra1 Gene 
gag-d 
(plO) 
-
-
-
-
-
-
NT 
NT 
-
-
PO 1-coded 
rt 
-
NT 
-
-
-
N7 
NT 
-
NT 
Products 
env-coded 
fgp70) 
-
-
-
-
-
+ 
-
-
-
-
(M ) * 
г 
-
NT 
NT 
120,000 
130,000 
58,000 
NT 
NT 
135,000 
55,000 
This table is adopted from Table 1 in reference 240 and other data in references 240-243. 
+ Molecular Weights of Polyproteins Containing Gag-gene Coded Antigenic Determinants. 
lar genetic sequences, studies on the expression of type-C cncoviral 
trans I ationaI products in cells nonprocjcti vel y transformed by тзптаііап 
oncoviruses were performed. From these studies it appeared that this 
frequently observée expression is generally restricted to a part of the 
gag-gene (182,240). The part which is expressed is always contiguous and 
includes the 5'-terminal gag-subgene for ρ 15. In Table I the expression 
of gag-coced oolypeptices in cells nonproducti vel y transformed by diver­
se mammalian transforming viruses is depicted. Further molecular size 
analysis of these viral antigens revealed that in some cases high mole­
cular weight polyproteins (50,000-130,000 dalton) containing gag-gene 
coded antigenic reactivity were present (see Таэіе I) (182,240-243). 
These observations suggest a reccmbirat!oraI event with'n the gag-region 
of the type-C oncovirus genome. Furthermore, the nonstructural components 
of the polyproteins may represent trarsformation-specif¡с cellular se­
quences. Evidence for this possibility may be obtained from the feline 
system, where the 60,000 molecu:ar weight cleavage product of the pre­
cursor polyprofein has been shown to possess 'mmunologic cross-reacti­
vity with certain antisera directed against the turror-speci f ic feline 
oncornavirus-associatec cell membrare antigen (FOCMA) (241,242). From 
heteroduplex napping it is known that some sarcoma viruses are the re-
suit of more than one recombi national event; presumably secundary recom­
binations occur during the cloning procedures used to ourify these viru­
ses (230). 
STRUCTURAL AND NONSTRUCTURAL TRANSLAT I CIMA'- PRODUCTS OF VAMMAI.IAN ONCO­
VIRUSES: INTRODUCTION TC THE PAPERS 
Upon expressior ir the host cell of 'ntegrated namnalian oncoviral genes, 
infectious typo-C oncovirus particles can be produced. Such particles 
are in facT vehicles of oncovi га I genes. The virus-specific structural 
components of these particles are characteristic for the oncovirus and 
they are encoded by "the encapsidated oncov i ral genome, however, in addi­
tion to oncov¡ral genes coding fer encovirus-specif¡с structura' poly­
peptides also other genes (some of them being probably involved in cel­
lular transformation) can be encapsidated and, upon infection, integra­
ted in host cell genome. Thus, oncovirus particles provide mechanisTS to 
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the cel I to transfer or to acquire new genetic sequences. In the experi- 
mental part of this thesis we describe some typical features of those 
mechanisms.
'V
We further characterized the structure of the type-C oncoviral particles 
in an eI eetronmicroscopic and biochemical study using Rauscher murine 
leukemia. virus as a prototype (Chapter II). We studied the synthesis of 
the oncovirus-specific structural polypeptides under natural as we II as 
artificial conditions in pulse-chase experiments with mouse cel Is infec- 
ted with Rauscher murine leukemia virus (Chapter I I !). Using a simi lar 
experimental approach, we characterized temperature-sensitive mutants of 
Rauscher murine leukemia virus (Chapter IV); In translation experiments, 
we studied the genomic RNA of some mammal ian transforming oncoviruses 
(Chapter V) and, finally, we examined in transfection experiments the 
biological activity of integrated oncoviral genetic sequences and _i_n 
vitro synthesized prov'ral DNA (Chapter VI).
Chapter II: Structural studies on Rauscher murine leukemia virus: 
Isolation and characterization of viral envelopes.
W.J.M. van de Ven, A.J.M. Vermorken, C. Onnekink, H.P.J. Bloemers and 
H. Bloemenda.l,
J. V'rol. In Press (1978). ^
Structural analysis of mammal ian type-C oncoviral particles has been 
limited mainly to studies on the outer surface of these particles or to 
studies on the centrally located spherical nucleoids or cores. In the 
latter cases, the viral envelopes were removed from the virions by dIs— 
ruption with detergents and ether. In this study we present a procedure 
for the isolation of oncoviral envelope structures from virions of 
Rauscher murine leukemia virus. Using a detergent in combination with 
ether, we carefully stripped the viral envelopes from the virions and 
fractionated the oncoviral structures through flotation in a disconti- 
nuous sucrose gradiënt in one centrifugation run. Flotation rather than 
sedimentation was a crucial step in obtaining pure viral envelope prepa- 
rations. The pur!fied'oncoviral envelope fraction contained in addition 
to the env-gene coded structural polypeptides, a gag-gene coded struc- 
turai polypeptide, namely p 15. According to Boiognesi et a I . (244),
This polypeptide is associated with the outer surface of 
Its presence in the purified envelope fraction can be due ι 
hydrophobic character of p15. However, it m!ght be possible ', 
linkage between ρ 15 and the viral envelope is a functional stef· 
assembly. In the perspective of the recent identification of mam 
transforming oncovirus-speci fic trans I ationaI products (see Chaptei 
Chapter V), encapsidation of these products into the pseddotype viric 
can be expected. Therefore, the pseudotype virions may be used as star­
ting material for preparative isolation of the polyproteins, which are 
probably involved in cellular transforrration. Preliminary results indi­
cate that indeed these polyproteins can be isolated from pseudotype vi­
rions (J.R. Stephenson and A.S. Kahn, personal communication). 
Chapter III: Effect of impaired g IyccsyI at ion on the synthesis of envelope 
proteins of Rauscher murine leukemia virus. 
W.J.M. van de Ven, С. Cnnekink, A.J.M. Vermorken, and H.D.J. Bloemers. 
Virology 82, 334-344 (1977). 
Oncovira! structural polypeptides are formed through post-t^ansl at iona I 
processing of precursor polypeptides (Chapter I). In the study described 
in chapter III, using JL.S-V9 cells productively injected with Rauscher 
murine leukemia virus, we examined in pulse-chase experiments the syn­
thesis and processing of virus-specific envelope precursor polypeptides 
under natural and artificial conditions. To detect the newly synthesized 
oncovi rus-speci f ic polypeptides, we applied a sensitive imrrunoprec i pi ta-
tion procedure in this study since onccvirus-speci fic polypeptides repre­
sent about 0.5-2? of the total cellular polypeptide content. 
In the presence of 2-deoxy-D-g!ucose or cytochalasin В g I ycosyI at ion was 
impaired and The synthesis of the env-gene coded precursor polypeptide 
gpPr82 ' was inhibited. Instead, the synthesis of a new glucosamine-
deficient polypeptide with a molecular weight of about 70,000 was Obser­
ven V 
ved. This polypeptide, Pr7C , appeared to carry antigenic determinants 
of the subgene products of gpPr82 and, thus, may represent the ungly-
cosylated primary trans lationaI product of the env-gene. GlycosyI at ion 
of the envelope precursor polypeptide is apparently a necessary condition 
for its proper processing, since in the presence of the inhibitors of 
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gIycosyI at ion production of the envelope structural polypeptides was 
inhibited, while proteolytic cleavage of the gag-gene precursor polypep- 
tide was not affected. Furthermore, after removaI of cytochalasin B, 
which in contrast to 2-deoxy-D-gIucose reversibly inhibits gIycosyI at ion,
^ env
glycosylated Pp70 -related polypeptides as well as the normal envelope 
structural polypeptides were formed.
Chapter IV: Impaired processing of precursor polypeptides of temperature- 
sensitive mutants of Rauscher murine ieukemia virus.
W.J.M. van de Ven, D. van Zaane, C. Onnekink, and H.P.J. Bloemers.
J. Virol. 25, 553-561 (1978).
A similar experimental approach as applied in chapter III was followed 
in this study on the characterization of temperature-sensitive mutants 
of Rauscher murine Ieukemia virus. These mutants of the Rauscher strain 
were obtained through the courtesy of Dr. J.R. Stephenson and they can be 
divided in the following classes: class I mutants, defective at 39°C in 
replication function before the synthesis of viral group-specific anti- 
gens, class II mutants, defective at 39°C in functions between the synthe­
sis of viral group-specific antigens and production of virions, and class
O ■ v, £
III mutants, defective at 39 C in the production of infectiqirs.Virions, 
a I thouglv v i rus- I i ke particles are formed. In our experiments, we have 
infected the mutants at the permissive temperature (31°C) and thereafter, 
we have studied the synthesis and processing of the virus-specific pre­
cursor polypeptides at the permissive and nonpermissive temperature.
It appeared that in cel I s■infected with a class I mutant (ts17 or ts29) 
or a class II mutant (ts25 or ts26), the processing of the primary gag- 
gene trans I ationaI product was impaired. The proteolytic cleavage was 
blocked beyond Pr65^a®. Concomitantly, the formation of the env-gene 
related polypeptide p12(E) of all four mutants was blocked at the nonper- 
missive temperature. In contrast, ceIIs infected with the class II t mutant 
ts28 showed a normal turnover of the gag- and env-gene coded precursor 
polypept i des.
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Chapter V: Translation of type-C viral RNAs in Xenopus 
Evidence that the 120,000 molecular weight polyprotein exf ξ 
D I — 
Abelson leukemia virus transformed cells is viral coded. 1 K"1 
о 
Roberta K. Reynolds, Wim J.M. van de Ven, and John R. Stephen о 
·< 
Submitted for publication. •+ 
Cells nonprodjctivel у transformed by mammalian type-C transforming 
viruses can express polypeptides related to the gag-gene of a leuke 
helper virus; these polypeptides are apparently derived progressive!, 
from the 5'-end of the leukemia helper virus genome (see Chapter I, 
Table I). In view o* tne fact that the replication-defective transformi 
oncoviruses appear to represent recombinants betweer a portion of a leu­
kemia helper virus genome and cellular genes presumably coding for malig­
nant transformation, expression of gag-gene polypeptides in nonprcducti-
vely transformed cells was further analyzed. From a number of studies 't 
appeared that cells nonproducti vely-transformed by each of several such 
viruses express polyproteins of 55,000-130,000 molecular weight contain­
ing amino terminal gag-gene polypeptides (Chapter I). These polyproteins 
sometimes contain nonstructural components covalently linked to the gag-
gene related structural components. To resolve whether or not these poly­
proteins are encoded by the transforming oncovirus genome, we encapsida­
ted the genomes of Abelson murine leukemia virus and woolly monkey sar­
coma virus with the aid of an appropriate leukemia helper virus in pseudo-
type virions, isolated the genomic RNAs of both isolates and translated 
them in Xenopus laevis oocytes. The primary trans I ationaI product of 
Abelson murine leukemia virus genomic RNA is a polyprotein corresponding 
in molecular weight and serological properties to a polyprotein expressed 
in Abelson murine leukemia virus transformed cells (243). This polypro­
tein contains in addition to the gag-gene coded structural components 
pi 5 and ρ 12 a nonstructural component. Translation of woolly monkey sai— 
coma virus genomic RNA resulted in the synthesis of a 55,000 molecular 
weight polyprotein containing the transi ationaI products of gag-a, gag-b, 
and gag-c of the woolly helper virus. A similar protein was expressed in 
woolly sarcoma virus transformed nonproducer cells. From this study, we 
conclude that the nonstructural component of the polyprotein expressed 
in Abelson murine leukemia virus-transformed cells is viral-coded and 
that such a polyprotein is either not present in woolly sarcoma virus-
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transformed cells or is subject to rapid post-trans Iational cleavage. 
Translation in Xenopus Iaevi s oocytes is a useful experimental approach 
for testing sera and fo·" characterizing the serological propert'es ox 
similar nonstructural components of various other transforming oncovirus 
isolates. In view of The fact that the nonstrLcturaI component in the 
Abelson murine leukemia virus-specific polyprotein could represent the 
proauct of eel 1jIar-acaui red transforming sequences which are etiologi-
cal I y involved in spontaneous tumors of their natural hosts, development 
of imnunolog¡ca! assays fo- this and other nonstructural components may 
lead to a better understanding of cancer. 
Chapter VI : Cells infected wi*h a temperature-sens i τ i ve murine leukemia 
virus and transfected with fragments of wild-type murine leukemia virus 
proviral DNA release progeny virus infectious at the nonpermissive tem­
perature. 
W.J.V. van de Ven, F.Α.v.J. van der Hoorn, h.J. Dodemont, and H.P.J. 
Bloemers. 
Submitted for publication. 
To study proviral DNA of oncoviruses, transfection experiments can be 
performed in which appropriate recipient cells are treated with purified 
DNA (245,246). In such experiments, we have studied DNA isolated froT 
cells releasing high titers of either wild-type or temperature-sensitive 
oncovirus. By generating specific oncovirus producing cells, we showed 
that by transfection oncovirus-specific genetic sequences can be intro­
duced into the recipient cells. 
Apparently, these studies are limited to experiments with DNA that con­
tains intacT viral genomes of auTonomously replicating oncoviruses (245, 
246). In an attempt to study non-infectious proviral DNA fragments (i.e. 
proviral DNA fragments that upon transfection do not give rise to pro­
geny virus release) we have coinfected recipient cultures with a tempe­
rature-sensitive oncovirus. At the nonperni ss i ve temperature, we could 
isolate progeny viruses. They contained antigenic determinants of the 
oncovirus that was used for the synthesis of the proviral DNA fragments 
and, furthermore, these viruses were irfectious at the restrictive tem­
perature. We conclude from these virus-rescue assays that some factors 
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necessary for the observed oncovirus release were prov'ded by the ther-
mosensitive mutant. 
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CHAPTER I I 
STRUCTURAL STUDItS CN RAUSCHER ,νυΡΙΝΓ LEUKEMIA VIRUS: 
ISOLATION AMD CliARACTRI/ATION OF VIRAL ENVELOPES 

the ce!! to transfer or to acquire new genetic sequences. !n the experi­
mental рагт of this thesis we describe some typical features of those 
mechan i srrs. 
We •'urtner characterized the structure of the type-C oncoviral particles 
in an electronmicroscopiс and biochemical study using Rauscher nurine 
leukemia virus as a prototype (Chapter II). We studied tne synthesis of 
the олсо irjs-spec'fic structural polypeptides under natural as well as 
artificial conditions in pulse-chase experiments with mouse cells infec­
ted with Rauscher muri ne leukemia virus (Chapter III). Using a similar 
experimenta, approach, we characterized temperature-sensitive mutants of 
Rauscher murine leukemia virus (Chapter IV); In translation exper'ments, 
we studied the genomic RNA of some mammalian transforming oncoviruses 
(Chapter V) and, finally, we examined in transfection experiments the 
biological activity of integrated oncovira! genetic sequences ard i η 
ν¡tro synthesized provici DNA (Chapter VI). 
Chapter Ι ι : Structural studies on Rauscher mjr'ne Іеи<етіа virus: 
Isolation and characterization of vi--al envelopes. 
W.J.M. van de Ven, A.J.M. Vermerken, С. Onnekink, tl.P.J. Bioemers and 
Η. Βloemerda I . 
J. Virol. In Press (1978). 
Structural analysis of mammalian type-C oncoviral particles has been 
limited ma'nly *c studies on the outer surface of these particles or to 
stjdies on the centrally located ssherical nucleoids or cores. In the 
latter cases, the viral envelopes were removed from the virions by dis­
ruption with detergents and ether. \n this study we present a procedure 
for the isolation of oncoviral envelope structures f гот virions of 
Rauscher murine leukemia virus. Using a detergent in combination with 
ether, we carefully stripped the viral envelopes from the virions and 
fractionated the oncoviral struc~ures through flotation in a aiscorti-
nuous sucrose gradient ir one centri fugation run. Flotat'or rather than 
sedimentation was a crucial step in obtaining pure viral envelope prepa­
rations. The purified oncoviral envelope fraction contained in adcition 
то the env-gene coded structural poIypept:des, a gag-gene coded struc­
tural Dolypeptide, namely pl5. According to Bolognesi et al• (244), 
37 
this polypeptide is associated with the outer surface of the viral cc^e. 
Its presence in the purified envelope fraction can be due To trie very 
hydrophobic character of p15. However, It night be possible that the 
linkage between p15 and the viral ervelope is a functional s^ep I г virion 
assembly. In the perspective of the recent ¡dent i f i сат ion of man-mal ¡an 
transforming oncov i rus-spoci f ic t'-ans I at Iona I procjcts (see Chapter I ard 
Chapter V), encapsI dation of these products Irto the pseudotype virions 
can be expected. Therefore, the pseudotype virions may be used as star-
ting material for preparative ¡so^atior o~ the pol yprotel r.s, which are 
probably Involved In cellular transformation. Frel'minary results indi-
cate that indeed these polyproteins can be isolated from pseudotype vi-
rions (J.R. Stephenson and A.S. Kahn, persoraI communication). 
Chapter III: Effect of impaired g IycosyI at ion on the synthesis cf envelope 
proteins of Rauscher murine leukemia virus. 
W.J.M. van de Ven, С. Qnnekink, A.J.M. Vermorken, and H.P.J. Bloemers. 
Virology 82, 334-344 (1977). 
Oncoviral structural polypeotides are formed through post-trans!ationaI 
processing of precursor polypeptides (Chapter I). In the study described 
in chapter III, using JLS-V9 cells productively infected with Rausche<-
nurlne leukemia virus, we examired in pulse-chase experiments the syn­
thesis and processing of virus-specific envelope precursor polypeptides 
under natural and artificial concitlons. To detect the newly synthesized 
oncovirus-specif¡с polypeptides, we applied a sensitive ¡mmunoprec1ρ¡ta-
tion procedure in this study since oncovirus-speci fic polypeptides repre-
sent about 0.5-2$ of the toxaI cellular polypeptide content. 
Ir the presence of 2-deoxy-D-g'ucose or cytochalasln В g IycosyI at¡on was 
impaired and the synthesis of the env-gene coded precursor polypeptide 
gpPr82 was inhibited. Instead, ~he synthesis of a new glucosam'ne-
deficient polypeptide with a molecular weight of about 70,000 was obser-
ven ν 
ved. This polypeptide, Pr70 , appeared to carry antigenic determinants 
of the subgere products of gpPr82 and, -nus, may represent the ungly-
cosyI atee primary trarsI at Iona I product of ~he erv-gene. GlycosyI at¡on 
of the envelope precursor polypeptide Is apparently a necessary condition 
for its proper processing, since ir the presence of the inhibitors of 
38 
g IycosyI at ion production of the envelope structural polypeptides was 
inhibited, while proteolytic cleavage of the gag-gene precursor polypep­
tide was not affected. Furthermore, after rerrova I of cytochalasin B, 
which ir contrast to 2-decxy-D-gljcose reversibly inhibits g Iycosylation, 
% en ν 
glycosylated Pr70 -related oolурертi des as we'I as the погтзі envelope 
structural polypeptides were forned. 
Chapter IV: Impaired D'Ocessing of precursor po'ypestides of toTpe'atLre-
sensit've rrutants of Rauscher Turine leukenis virus. 
W.-.M. van de Ven, D. van Zaane, C. Onnekirk, ard II.P.J. Rloeners. 
J. Virol. 25, 553-561 (1978). 
A sÍTÍlar experimental approach as applied ir chapter III was followed 
in this study on the characterization of tenrpera_ure-sens it i ve mutants 
of Rauscher murine leukemia virus. These mutants of the Rauscher strain 
were obtained through the courtesy of Or. J.R. Stephenson and they can be 
divided in the following classes: class I rrutants, defective at 39 С in 
replication function before the synthesis of viral group-specific anti­
gens, class II mutants, defecti ve at 39 С in functions between the synthe­
sis of viral group-specific antigens and production of virions, and class 
III mutants, defective at 39 С in the production of infectious virions, 
although virus-like particles are formed. Ir our experiments, we have 
infected the mutants at the perrr'ssive temperature (31 C) and thereafter, 
we have studied the synthesis and processing of the virus-specific pre­
cursor Dolypeotides at the perTÎssive ard ronpermiss i ve temperature. 
It appeared that in cells injected with a class I mjtanv (rs17 or xs29) 
or a class I' mutant (ts25 or ts26), the processing of xhe D'imary gag-
gene trans lationaI product was 'mpaired. The proteolytic c'eavage was 
blocked beyond Pr65 . Concomitantly, tie forTation of the e-iv-gere 
related polypeptide D12(E) of all four nutar_s was blocked at the nonper-
missive terpe^ature. In ccn_rast, cells irfected with the class III mutant 
ts28 snowed a normal turnover of the gag- and env-gene coced precursor 
polypeptides. 
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Chapter V: Translation of type-C viral RMAs in Xenopjs laev:s oocytes: 
Evidence that the 120,000 тоіесиіаг weight polyprotein expressed in 
Abelson leukemia virus transformed cells is viral coded. 
Roberta K. Reynolds, Wim J.M. van de Ven, and John R. Stephenson. 
Submitted for publication. 
Cells nonproductive!y transformed by mammalian type-C transforming onco­
viruses can express polypeptides related to the gag-gene of a leukemia 
helper virus; these polypeptides are apparently derived progressively 
from the 5'-end of the leukemia helper virus genome (see Chapter I, 
Table I). In view of the fact that the replication-defective transforming 
oncoviruses appear to represent recoTbinants between a portion of a leu­
kemia helper virus genome and cellular genes presumably coding for malig­
nant transformation, expression cf gag-gene polypeptides in nonprodjcti-
vely trarsfoTTed cells was further analyzed. F^om а гитЬег o* s^jc'es it 
appeared that ceils nonproduct; vely-transformed by each of several such 
viruses express polyp^oteins of 55,000-130,000 molecular weignt conta'n-
¡ng amino terminal gag-gene polypeptides (Chapter I). These polyprcteins 
sometimes contain ronstrucTjra I components ccvalent.'y linked to the gag-
gene related structural components. To resolve whether or not t.nese poly-
proteins are ercooed by the transforming oncovirus genome, we encapsi da-
ted the genomes of Abelson murine leukemia virus and woolly топкеу sar­
coma virus with the aid of an appropriate leukemia helper virus in pseudo-
type virions, isolated the genomic RNAs of both isolates and translated 
them in Xenopus laevis oocytes. The primary translationaI product of 
Abelson murine leukemia virus genomic RNA is a polyprotein corresponding 
¡n molecular weight and serological properties to a polyprotein expressed 
in Abelson murine leukemia virus transformed cells (243). This polypro-
tein contains in addition to the gag-gene coded structural components 
pi 5 and pi 2 a nonstructural comporent. Translation of woolly monkey sar-
coma virus genomic RNA resulted in the synthesis of a 55,000 molecular 
weight polyprotein contairirg the transi ationaI products of gag-a, gag-b, 
ard gag-c of the woolly helper virus. A s'milar protein was expressed in 
woolly sarcoma virus Transformed nonproducer cells. From this stjdy, we 
conclude thar the nonstructural comporent of the polyprotein expressed 
in Abelson murire leukemia ν irjs-t^ansformed cel¡s is viral-coded and 
that such a polyprotein is either not present in woolly sarccTa virus-
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transformed cells or is subject to rapid post-trarsI ational cleavage. 
Translation in Xenopus laevis oocytes is a useful experimental approach 
for test:ng sera ard for cha-acterizirg the serological properties of 
similar nonstructural components of various other transforming oncovirus 
isolates. In view of the fact thaT the nonstructural component in the 
Abelson murine leukemia virus-specific polyprotein could represent the 
product of cellular-acquired transform'ng sequences which are etiologi-
cal ly involved in spontaneous tumors of their natural hosts, development 
of inmune log¡cal assays for this and other nonstructura! components may 
lead to a better understanding of cancer. 
Chapter VI : Cells infected with a temperature-sensitive murine leukemia 
virus and transfected with fragments of wild-type murine leukemia virus 
proviral DNA release progeny virus infect'ous at the nonperm'ssive tem-
perature. 
W.J.M. van de Ven, P.Α.M.J. van der Hoon, H.J. DoceTont, and H.P.J. 
Bloemers. 
Submitted for publication. 
To STudy proviral DNA of oncoviruses, t'ansfection experiments can be 
performed in which appropriate rec:pient cells are treated with purified 
DNA (245,246). In such experiments, we have studied DNA isolated 'ron 
cells releasing high titers of either wild-type or temperature-sensitive 
oncovirus. By generating specific oncovirus producing cells, we showed 
that by transfection oncovirus-speci fic genetic sequences can be intro­
duced into the recipient cells. 
Apparently, these studies are limited to experiments with DNA that con­
tains intact viral geromes of autoromous'y replicating oncoviruses (245, 
246). In an attempt to study non-infectious proviral DNA fragments (i.e. 
provi-al DNA fragments tnat upon transfection do not give rise to pro­
geny virus release) we have coinfected recipient cultures with a tempe­
rature-sensitive oncovirus. At the nonpermissive temperature, we could 
isolate progeny viruses. They contained antigenic determinants of the 
oncovirus that was used for the synthesis of the proviral DNA fragments 
and, furthermore, these viruses were infectious at the restrictive tem­
perature. We conclude from these virus-rescue assays that some factors 
41 
necessary for the observed oncovirus •"elease were provided by the ther-
mosensitive mutant. 
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SUMMARY 
A preparative method for isolating pu^e viral envelopes from a type-C 
RNA tumor virus, Rauscher murine leukemia virus, is descnbed. Fraction­
ation of virions of Rauscher nurine leukemia virus was studied after 
disruption cf the virions with the detergents sodium dodecyl sulfate 
or Nonidet D-40 in combination wiTn ether. Fractionation was perforTed 
througn flotation in a d'scontinuous sucrose gradient and, as appeared 
from electrcr microscopic examination, а рь^е viral envelope fraction 
was obtained, in this way. Using sensitive competition radioimmuno­
assays о г sod i um dodecyl sulfate Polyacrylamide gel electrophoresis 
after irmurop-eci pitation with polyvalent and monospecific antisera 
directed againsr Rauscher mjrine lejkemia virus proteins, tne arrourt 
of the gag- and erv-gere encoded structural polypeptides in The virions 
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and the isolated envelope fraction was compared. The predominant viral 
structural polypeptides in the purified envelope fraction were the env-
gene encoded polypeptides, gp70, p15(E) and p12(E), while, except for 
p15, there was only a relatively srra I I amount of the gag-gene encoded 
structural polypeptides in this fraction. 
INTRODUCTION 
Methods for the fractionation of virions into an envelope-enriched 
fraction and a core-enriched fraction have been described for a number 
of oncornaviruses (19). The preparation of pure cores of certain type-C 
virions has been achieved by centri fugation of disrupted virions through 
continuous or с iscortinjous sucrose gradients (5,28). Based upon the 
data froT a number of such studies, the localization of the gag-gene 
encoded structural polypeptides of type-C viruses relative to the viral 
core was obtained (see ref. 3). 
Other viral proteins are apparently constituents of the viral envelope. 
They are derived from one precursor polypeptide encodec for by the env-
gere (13). Fron neutralizing (25), surface labeling (14), cytotoxic (10) 
and ¡mmunoelectron microscopic studies (24), there is now considerable 
evidence that a glycoprotein of about 70,000 daltons is localized on 
the viral envelope. Furthermore, a polypeptide of about 15,000 daltons 
described by Ikeda et a I. (12) as ρ 15(E) has also been local ized 'n or 
on the viral envelope (3,11) as well as probably p*2(F) (3), a polypep­
tide serologically related to p15(E) (13). However, the isolation of 
purified viral envelopes of type-C virions has not yet been described. 
In this paper we want to report the isolation and characterization of 
viral envelope structures from disrupted virions of Rauscher murine 
leukemia virus (R-vuLV) through flotation in a di scon*'nuous sucrose 
gradient in one centri fugation run. 
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MATERIALS AND METHODS 
CeJ_J__^_[nes_and_yjrus 
NIH-Sw'SS-3T3 Touse enbryo cells (29) infected with and producing 
R-MuLV, were grown as monolayers in Dulbecco's modified Eagle's medium 
completed with 10$ fetal calf serun. 
R-MuLV was isolated as described by Duesberg and Robinson (6). 
R-N'uLV labeled with L-( S)methionine (Radiochemical Contre, Amershan, 
England) was isolated from culture medium of monolayers labeled in 
Hank's basic salt solutior suopleTenTed witn 10$ dialyzed caI í serum 
and amino acids. 
Preparation e>f_subv|raj_ comgonents 
SLbv'rai components were préparée through treatment of R-MuLV with 
Nonidet P-40 (Shell Nederland Chemie, Rotterdam) or sodium dodecyl 
sulfate (N'erck, Darmstadt) in combination with ether. Basée on pilot 
experiments the following procedure was used for the preparation of 
subviral components through Nonidet P-40 and ether treatment. Five (jg 
of Nonidet P-40 were added to 200 ui of a virus suspension containing 
about 0.2 rig of purif'ed R-MuLV in TNE buffer. After an 'ncubation of 
5 minutes at 4 C, 2 volumes of cold ether were added and the suspension 
was shaken gently during 10 minutes. The aqueous phase separated by 
low speed centri fugation was centriguged in а Вескпап ТІ-5С rotor for 
3 hours at 50,000 гэт and the pellet was further processed for electron 
microscopic exarinat¡on. In o^der to purify subviral components, the 
d;srupted virions we--e layered onto a discontinuous grad;ent of sucrose 
in TNE buffer of the following composition: 2 ml 1.78 M sucrose (densi-
ty 1.3C g/cm3), 3 ml 1.70 M sucrose (density 1.28 g/cm3), 2 ml 0.94 M 
sucrose (densiTy 1.14 g/cm ), 2 ml 0.82 M sucrose (density 1.12 g/cm ), and 
1 ml 0.68 M sucrose (density 1.10 g/cm ). Centri fugation was performed 
in a Beekman SW-40 готег during 17 hours at 30,000 rprr. Subviral frag­
ments banded on the sucrose layers with densities of 1.28 g/cm , and 
1.12 g/cm were centrifuged after five-fold dilution with TNE Duffer in 
a Beekman Τ i-50 rotor for 3 hours at 50,000 rpm. Thereafter, the pel­
lets were processed for electron microscopic or gel electrophoresis 
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ara lys¡s. 
In order to oDtain a pure preoaration of viral ervelopes of R-Mul.V, flo-
tador rather than segmentation in the d i sconti nuojs sucrose gradien-!-
was preferred. In flotation experiments, the sane discontinuous sucrose 
gradients as cescr'oec above we~e used; in tnose exper'ments, however, 
the disrupted virions were suspended in the bot+om layer wi1h a final 
sucrose concentration of 1.8 M (density 1.30 g/cm ). Centri fugation was 
performec as describee above. Treatment with sod i urn doe'ecy I sulfare and 
ether was performed s i τ i I ar I y using 2 ug of sodium docecyl sulfate in­
stead of Nonidet P-40. 
J_Tmuncg^ec|2iîat icn_and_20_!_y_acry_! ami de gel _el ect'-ophores ¡ s 
R-MuLV-specif¡с polypeptides were detected by the inrrrunoprecipitat¡on 
procedure described by Van Zaane et a I. (31). Characterization of the 
antisera was performec by Tears of immunoprec ip itat ion of vi rjs-spec i f ic 
14 
polypeptides, labeled with a C-amino acic m x-^ ure (Radiocherr cal 
Centre, Amersharn, England). Anti-gp70 ard anti-p15 serum were a generous 
gift of Ors. M. Strand ard J.T. August. Characteristics of these sera 
were describee by Strand ard August (27). The other an-isera used were 
prepared and described by Van Zaane et al . (31). Analysis of the irrmu-
ropreciρ¡rates were perfornec by Polyacrylamide gel electropnoresis 
according to Lae-rml' (15) on sod i urn dodecyl sulfate containirg (.l-',8%) 
Polyacrylamide gradient slab gels (SDS-PAGE). Visualization of radio-
activity was performed by scintillation autoradiography according to 
Bonner and Las key (4). 
Fig. 1. A) Thin section of IlIH-Swiss-ЗТ'а cells infected with Rauscher leu­
kemia virus. Several stages of the morphogenesis of the virus can be 
identified. The preparation shows two types of virions: a mature type 
with an enveloped dense nucleoid (arrow -*), and an immature type with 
two concentric shells surrounded by the viral envelope (arrow •*-+). 
B) Intact Rauscher murine leukemia virus particles, isolated as descri­
bed in Materials and Methods, prefixed with glutaraldehyde and. stained 
with uranyl acetate. The particles are penetrated by the stain, so that 
an internal structure is revealed. 
C) SDS-PAGE-analysis of the polypeptides of isolated virions; Coomassie 
Brilliant Blue staining. 
D) Thin section of a preparation of virions disrupted with sodium dode­
cyl sulfate and ether as described in Materials and Methods, tlondisrup-
ted virus particles present in the preparation, have the morphology of 
immature virions. It should be noted, that because of differences in 
sedimentation, the distribution of virions and substructures as shown 
in the figure is not representative for the whole pellet. 
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Fig·. 2./lJ Thin section of R-MuLV cores isolated after treatment of the 
virions with sodium dodecyl sulfate and ether. The envelope of the 
virions has been removed. 
B) Same preparation as A) at higher magnification. 
h? 
3§аІ2ІНГ,У0о.а§§аУ._В£9£2£!ЦЕё§ 
The structural polypeptides of R-MuLV, p30, p15, ρ 12 and plO (gi*t from 
125 
Dr. J.R. Stephenson) were eacn .abeled with I ar high specific acti-
125 
vity by the chloramine Τ method of Greenwood et al. (9); ( I from Ra­
diochemical Септге, Amersnam, England). Competition radioimmunoassays 
were performed as described by Barbacid et al. (1). 
Briefly a limiting amount of antiserum against the appropriate viral 
antigen was incubated with serial dPutions of unlabeled antigen for 
1 hour at 37 C. l-labeled antigen (about 10,000 cpm) was then added, 
and ¡ncuoation continued for 3 hours at 37 С and a further 18 hours at 
4 C. Thereafter, 0.025 ml of undiluted pig anti-goat immunoglobulin G 
was added to each reaction mixture and samólos were ircubated 1 hour at 
37 С followed by 3 hours at 4 C. After cent-i fucation at 2500 rpn for 
125 15 minutes and aspiration of the supernatant, l_radioactι ν ιty in the 
precipitate was measured ir a Searle 1285 gamma courher. 
§І§!:ІЕ2С_тІ£Г2§£22У. 
P
or thin section electron m'croscopy, purified virus and subviral frac­
tions were fixed in 2.5$ (w/v) g Iutaraldehyde in sodium cacodylate buf­
fer, pH 7.4, for 1 hour (21), washed twice in sodium cacodylate buffe', 
and posTfixed with 0s0.. Before dehydration the preparations were trea­
ted with 0.5? (w/v) uranyl acetate (8). After dehydration in a graded 
series of ethanol ard propylene cx'de, + re preparations were embedded 
in Epon 812. Ultrathin sections cut with a LKB microtome (glass knives) 
were stained with uraryl aceta-e ana lead citrate (20). Alternatively, 
for negative staining a drop of virus suspension, prefixed with g Iuta­
ral dehyde, was placed on a Formvarcarbon-coated grid. After 1 minute 
7ne excess fluid was removed by touching the grid with a oiece o i filter 
paper and the preparation was stained immediately with uranyl acetate, 
a negative stain'ng method whicn had previously been applied for exa­
mination of the morphology of the virions (18). The preparations were 
examined in a Philips FM 200 electron microscope. 
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Fig. 3. A) Thin section of R-MuLV envelopes isolated through flotation 
after treatment with Nonidet P-40 and ether. Note the homogeneity of 
the preparation. 
B) Same preparations as A) at higher magnification. 
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RESULTS 
R-MuLV virions used in this study were isolated from tissue culture 
medium of chronically infected NIH-Swiss-3T3 cells (Fig. 1A). Samples 
of virions purified by sucrose gradient centri fugation were examined 
by thir section and negative staining (Fig. IB) electron microscopy. 
From these studies, it appears that in the virion preparations, two 
types of virions are present (not shown); a mature type with an enve­
loped dense nucleoid, and an immature type with two concentric shells 
surrounded by the viral envelope (22) (see also Fig. 1A). The purified 
virions are morphologically intact since no viral substructures can be 
observed and the morphology of the isolated virions resembles that of 
free iптегсеI Iular virus particles. The virion preparations are very 
pure, as can be seen from SDS-PAGE analysis of the samples (Fig. 1С). 
lL§Etd!§!3Í_SÍÍt!_^§í§E9§[!Í_3Dd_et!]eE 
In order to strip the viral envelope from the virion two different sur-
face active agents were used, namely Nonidet P-40 and sod i urn dodecyI 
sulfate. Additional treatment with ether was performed in order to pre-
vent trapping of the viral cores in reconstituted viral membrane frag-
ments (2). 
Treatment of R-MuLV virions with sodium dodecyl sulfate and ether resul-
ted in the disruption of the virions. Electron microscopic examination 
(Fig. ID) revealed that the viral envelope was stripped from the virions, 
leaving core particles (diameter of 70-80 nm) and membrane structures, 
representing the viral envelopes or fragments thereof. Furthermore, non-
disrupted virions could be observed. The morphology of these virions 
always resembled the structure of immature particles. Disruption of 
R-MuLV virions with Nonidet P-40 and ether gave the same results as 
treatment with sodium dodecyl sulfate and ether. By subsequent density 
gradient centri fugat¡on viral core particles could be isolated (16, and 
Fig. 2). Purifiea viral envelopes could be obtained by purification 
through flotation in a discontinuous sucrose gradient. The envelope 
fraction (Fig. 3) was banded on the sucrose layer with a density of 
1.12 g/cm . Even after ether treatment, viral cores were found in the 
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viral envelope fraction when the preparation was sedinenred irsteac of 
floated. As can be seen in Fig. 3, tne viral envelope preparation ;rom 
a flotation experiment is pure and the morphology (triple layer) of the 
memorare structures is preserved. 
Analysis of the viral envelope fraction 
In order to compare the amount o f the gag-gene encoded structural poly­
peptides in the viricn ard tne isolated envelope fraction, sensit've 
competition radioimmunoassays for p30, pl5, ρ 12 ard ρ 10 were used. The 
results are summarized in Table 1. 
Table 1. Amounts of gag-gene enaoded structural polypeptides in 
purified viral enveloves of R-!4uLV relative to R-i-tuLV 
. . a) 
ъгъопв 
Structural polypepzide 
ρ 30 
pl5 
pl2 
plO 
Relative associated antigenic 
reactivity in purified viral , , 
envelopes (%) 
2 
40 
2 
2 
a) Associated levels of antigenic reactivity of gag-gene en­
coded structural polypeptides in R-MuLV virions and puri­
fied viral envelopes were assayed as described in Materi­
als and Methods. 
b) The associated antigenic reactivity in purified viral en­
velopes is expressed as % of the reactivity present in 
the same amount (mg protein) of R-MuLV virions. Protein 
determinination was performed according to the Lowry 
method (17). 
Only r e l a t i v e l y small anraunts of t h e gag-gene encoded s t r u c t u r a l polypep­
t i d e s p30, ρ 12 and ρ 10 we^e present in t h e envelope f r a c t i o n . However, a 
l a r g e r amount of t h e gag-gene product p15 was detected in t h i s f r a c t i o n . 
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The e n v e l o p e p r e p a r a t i o n s w e r e f u r t h e r a n a l y z e d by SDS-PAGE a f t e r immu-
n o p r e c i p i t a t i o n w i t h p o l y v a l e n t and m o n o s p e c i f i c a n t i s e r a d i r e c t e d 
a g a i n s t R-MuLV p r o t e i n s . The s e r o l o g i c a l a c t i v i t y o f t h e s e a n t i s e r a was 
t e s t e d as p r e v i o u s l y d e s c r i b e d ( 3 1 ) i n a r a d i o i r r n u n o p r e c i p i t a t i o n a s s a y 
w i t h c e l l l y s a t e s o f R-MuLV i n f e c t e d NI H - S w i s s - 3 T 3 c e l l s l a b e l e d w i t h 
14 
a C-amino a c i d m i x t u r e . The r e s u l t s a r e shown i n F i g . 4 . 
p r 8 2 . 
pr75-
g p 6 9 / 7 1 " 
p r 6 5 -
fc" 
ρ 3 0 -
p15CEl_ 
p15r 
p12tE) 
Chase in hr 0 
В С D E F G 
20 20 20 20 20 20 
Fig. 4} Characterisation of the antisera. „ „ 
Subconfluent monolayers of NIH-Swiss-ЗТЗ cells (10 cells/25 cm ) infec­
ted with R-MuLV were •pulse-labeled for 30 minutes with 100 \iCi (2S\iCi/ml) 
of a *^C-amino acid mixture and radioactivity was chased for 0 or 20 
hours as indicated in the figure. After lysis of the cells as described 
in Materials and Methods, virus-specific polypeptides were analyzed by 
SDS-PAGE and scintillation autoradiography after immunoprecipitation 
with: anti-R-MuLV serum (A,B), with anti-gp70 serum (C), with anti-plS(E), 
pl2(E) serum (D}3 with anti-рЗО serum (E), with anti-plS serum (F), or 
with anti-BSA serum (G). 
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In F i g. 4A the env- D recurso г polypeptide рг82 and the gag-p-ccursor poly­
peptides pr75 and pr65, irrrrunopreci pitated with anti-R-KuLV serurr from 
pulse labeled cells, are shown. In adai~ion two nigh nolecjlar weight 
polypeptides (Marked · in Fig. 4A) were precipitated. Immunopreciρ ita-
tion analysis with antl-рЗО serjT and WITH anti-p15 serum revealed, that 
¡n addition to pr75 and pr65, also these high molecular weight polypep-
tides were precipitated. сигтпегтоге, the envelope precursor was preci­
pitated only with anti-gp70 serum and anti-p15(E),p12(E) serum (results 
not shown). In pulse-chase experiments after a chase period of 20 hours, 
all major virion po'ypeptides, with the exception of p12 ard p10, were 
precipitated by the anti-R-MuLV serum (Fig. 43). Anti-gp70 serum preci­
pitated cp70, ρ15(Ξ) and p12(E) (Fig. 4C); p15(E) and p12(E) coorecipi-
tated with gp70 because of strong association wi1h the latter protein 
(31). For the same reason ant i-p15(Ε),p12(E) seruT a'sc p^ecipi-axed 
gp70 (Fig. 4D). In addition, an unknown, probably cellular high molecu­
lar weighl polypeptide (Marked* in Fig. ¿D) was precipitated with the 
anti-pl5(E),p12(t) serum. This polypeptide was never observed in ¡sola-
tec virions. Anti-рЗО serum precipitated on'y p30 (r'g. 4E) and anti-
pΤ5 serum only ρ 15 (Fig. 4F). None of the virus-specific polypeptides 
we^e precipitated with an anti-serum di-ected agairs- bovine serum al­
bumi η (Fig. 4G). 
35 
The .mmunopreciρitation ana.ysis of L-( S)neThion¡ne labeled R-MuLV 
virions ard viral envelopes is showr in r'g. 5. Immunopreci ρ"tat ions 
were performed under conditions that no precipitable virion polypepTides 
35 
we^e left. It should be no^ed that in L-( SJmethionine labeled R-MuLV 
virions no ρ 15 and ρ 10 can be detected, because these proteins lack 
methionine. gp70, p30, ρ 15 С E) anc ρ 12(E) were the only structural pro­
teins that could be detected with anti-R-MuLV serum in L-( S)methioni-
ne lapeled v'rions (Fig. 5B). Tne iden~ity of these virion polypept'des 
was furthe^ con-firmed in an i mmunopreci ρ itation analysis with monospe­
cific antisera (no* shown). In agreement with the resjlts of the •"adio-
¡mmunoassays is the low amount of p30 in the viral envelope fractions 
(Table 1; Fig. 5A and 5D). In the viral envelope p-eparations variable 
amounts of gp70 relative to p15(E) and pl2(E) were observed (not showr). 
However, tne amourt of p15(t) relative to ρ 12(Ξ) in the virions as well 
in the purified viral envelopes was always the same (Fig. 5). Both low 
molecular weight polypeptides in the envelope preparations were iaenti-
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fied as pi 5(E) and p12(E), using ant ¡-pi 5(E),p12(E) serum (Fig. 5C). 
gp69/71-
p30-
p15[E]-
p12tE3-
« M » * - g p 6 9 / 7 l 
. * - p 1 5 [ E ] 
-— p12(El 
Fig^ 5) Polypeptide composition of R-MuLV virions and envelopes. 
L-( S)-methionine labeled R-MuLV virions were used to study the env-gene 
encoded structural polypeptides in virions and purified viral envelopes. 
R-MuLV envelopes were isolated after treatment of the virions with lionidet 
P-40 and ether. The viral polypeptides were characterised by immunopreai-
pitation with antisera as described in Materials and Methods. 
A and D) R-MuLV envelope polypeptides immunopreaipitated with anti-R-MuLV 
serum. 
B) R-MuLV virion polypeptides immunopreaipitated with anti-R-MuLV serum. 
CI R-MuLV envelope polypeptides immunopreaipitates with anti-plS(E)>pl2(E) 
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DISCUSSION 
We have shown that R-J^JLV disrjpted virions after treatment w;th sodiuT 
dodecyl sulfate of Nonidet P-40 in combination with ether can be fractio-
natec into a vira! core fraction and a viral envelope fractior 'Fig. 2 
and 3). The fact that in preparations of disrupted virions, in contrast 
to mature virions, always intacT immature vigors are fojnd is interes­
ting and suggests that stripping of the viral envelope from immature 
virus particles is probably more difficult. Ir order to obtain pure pre­
parations, isolation of viral envelopes has to be performed by flotation 
in a discontinuous sucrose gradient rathe1" than by sedimentation. Puri­
fication of the viral envelopes by flotation was acequate since only a 
relative small amount of p30, a major component of the viral core (3,16), 
was present in the purified vi-al envelope preparations (Fig. 5). Fur­
thermore, similar results were obtained for the internal structural po­
lypeptides ρ30, ρ 12 and plO using sensitive competition гасioirmunoassays 
(Table 1). Howover, a relatively high amount of the gag-gene product, 
p15, was found in the envelope preparations. According to Bolognesi et a I. 
(3), p15 is not located in the viral envelope but is associated with the 
viral core or represents the inner coat. The polypeptide, however, is 
very hydrophobic and has the terdercy to aggregate and to fo^m specific 
complexes with hydrophobic membrane proteins (26). Therefore, ρ 15 is 
possibly -e-roved from the internal structure during treatment with de­
tergent and ether and forms a complex with the hydrophobic proteins in 
tne viral envelope. Alternatively, it might be possible that tne asso­
ciation between p15 and the envelope is functional in that it links the 
N-terminus of the gag-precursc^ polypeptide to the ervelope reelecting 
an early step in virion assembly. In a study with avian oncornaviruses 
(23) an association between the NFL-terminaI gag-polypeptide, p19, and 
the viral glycoprotein complex was observed, ¡n the murine system, the 
primary env-gene product is a glycosylated precursor polypeptide, which 
is processed to gp70 anc p15(E) from which a pol ypep-1-ice p12(F) is clea-
ved (13,31). From the present study it appeared that the amount of p15(E) 
relative to p12(E) in the virion and the viral envelope is approxiTatelу 
the same (Fig. 5). Apparently, there is no preferential loss of one of 
these components during the isolation procedure of the viral envelopes. 
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The amount of gp70, relative to ρ 15(E) and pl2(E), howeve^, is variab!e; 
this is ir agreement with the observation that by treatment with deter­
gents gp70 can easily be removed from the surface of the virions (7). 
In the murine system the hydrophobic p15(E) component is embedded in 
the lipid b'layer while the glycosylated cp70 seems to be more exposed 
at tne virion surface (3,14); gp70 is attached to p15(E) by disulfide 
bonds but the biological significance of this structure is not known at 
this time. In contrast to p15(E), p12(E) seems not to be linked by disul­
fide bonds to gp70 (3). Furthermore, in a previous study (3C) we showed 
that p12(E) is formed a-1- a later s_age of viral assembly since ат the 
restrictive temperature, in cells infected with ts-mutants of R-MuLV the 
envelope precursor polypeptide is cleaved into gp70 and p15CE), but ρ 12(E) 
is rot formed. Therefore, it is of interest to further characterize the 
synthesis ard the biological of this low molecular weight viral envelope 
protei η. 
ACKNOWLEDGEMENT 
These investigations we^e supportée in part by the Foundation fcr Medical 
Research FUNGO which is subsidized by the Netherlands Organization for 
Advancement of Pure Research (Z.W.O.). We thank Dr. A.M. Stadhouders 
(Department of Electron Microscopy, Nijmegen) for providing electron 
microscopic facilities, and R.K. Reynolds for performing the competition 
rad¡о immunoassays. 
LTERATURE CITED 
1. Barbacid, M., J.R. Stephenson, and S.A. Aaronson. 1976. Gag gene of 
mammalian type-C "!"umor viruses. Nature 262, 554-559. 
2. Bolognesi, D.P., H. Gelderblom, К. Celling, anc G. Heubner. 1972. 
Polypeptides of avian RNA tumor viruses. V. Analysis of the virus 
core. Virology £7, 567-578. 
71 
3. Bolognesi, D.P., R.C. Montelaro, H. Frank, and W. Schäfer. 1978. 
Assembly of type-C oncornaviruses: A model. Science 199, 183-186. 
4. Bonner, W.M., and R.A. Laskey. 1974. A film detection method for tri-
triumlabeled proteins and nucleic acids in Polyacrylamide gels. 
Eur. J. Biochen. 46, 83-88. 
5. Coffin, J.M., and H.M. Temin. 1971. Comparison of Rous sarcoma virus 
(RSV)-specific DNA polymerases in virions of RSV and in RSV-infec-
ted chicken cells. J. Virol. 7, 625-634. 
6. Duesberg, P.H., and W.S. Robinson. 1966. Nucleic acid and protein 
isolated from the Rauscher mouse leukemia virus (MLV). Proc. Natl. 
Acad. Sci. USA 55, 219-227. 
7. Duesberg, P.H., G.S. Martin, and P.K. Vogt. 197C. Glycoprotein сотро-
nents of avian and murine RNA tumor viruses. V i го I ogy 4J_, 631-646. 
8. Farquhar, M.G., and G.E. Palade. 1965. Cell junctions on amphibian 
skin. J. Cell Biol. 26, 263-291. 
9. Greenwood, F.C., W.M. Hunter, and J.S. Glover. 1963. The preparation 
of l-labeled human growth hormone of high specific activity. 
Biochem. J. 89, 114-123. 
10. Hunsmann, G., M. Claviez, V. Moennig, H. Schwarz, and W. Schaefer. 
1976. Properties of mouse leukemia viruses: X. Occurrence of viral 
structural antigens on the cell surface as revealed by a cytotoxi­
city test. Virology 69, 157-168. 
11. Ihle, J.N., M.G. Hanna, Jr., W. Schaefer, G. Hunsmann, D.P. Bolognesi, 
and G. Hüper. 1975. Polypeptides of mammalian oncornaviruses: III. 
Localization of ρ 15 and reactivity with natural antibody. Virology 
63, 60-67. 
12. Ikeda, H., W. Hardy, Jr., E. Tress, and E. Fleissner. 1975. Chromato­
graphie separation and artigenic analysis of proteins of oncorna­
viruses. V. Identification of a new murine viral protein, p15(E). 
J. Virol. ^ 6, 53-61. 
13. Karshin, W.L., L.J. Arcement, R.B. Naso, and R.B. Arl'nghaus. 1977. 
Common precursor for Rauscher leukemia virus gp69/71, p15(E), and 
p12(E). J. Virol. 23, 787-798. 
14. Kennel, S.J., B.C. Del Villano, R.L. Levy, and R.A. Lerner. 1973. 
Propert'es of an oncornavirus glycoprotein: evidence for its pre­
sence on the surface of virions ard infected cells. Virology 55, 
464-475. 
72 
15. Laemmli, U.K. 1970. Cleavage of structural proteins during the assem­
bly of the head of bacteriophage T4. Nature (London) 227, 680-685. 
16. Lange, J., H. Frank, G. Hunsmann, V. Moennig, R. Wol Iman, and W. 
Schaefer. 1973. Properties of mouse leukemia viruses. VI. The core 
of the Friend virus, isolation and constituents. Virology 53_, 457-
462. 
17. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Pro­
tein measurement with the Fol in phenol reagent. J. Biol. Chem. 
193, 265-275. 
18. Luftig, R.B., and S.S. Kilham. 1971. An electron microscope study of 
Rauscher Іеькетіа virus. Virology 4-6, 277-297. 
19. Nowinski, R.C., N.H. Sarkar, and E. Fleissner. 1973. Methods in Can­
cer Research, Ed. Busch, H. V;I. VIII, Chapter VII, pp 237-285. 
New York: Academic Press Inc. 
20. Reynolds, E.S. 1963. The use of lead citrate at high pH as an elec­
tron opaque stain in electron microscopy. J. Cell Biol. 17, 208-
212. 
21. Sabatini- D.D., К. Bensch, and R.J. Barrnett. 1963. Cytochemistry and 
electron microscopy. The preservation of cellular ultrastructure 
and enzymatic activity by aldehyde fixation. J. Cell Biol. 17, 
19-58. 
22. Sarkar, N.H., D.H. Moore, and R.C. Nowinski. 1972. RNA viruses and 
host genome in oncogenesis Ed. p. Emmelot and P. Bentvelzen, North 
Holland, Ansterdam p71. 
23. Scnlesinger, M.J. 1976. Formation of an infectious virus-antibody 
complex with Rous sarcoma virus and antibodies d'rected against 
the major virus glycoprotein. J. Virol. _T7» 1063-1067. 
24. Schwarz, H., G. Hunsmann, V. Moennig, and W. Schaefer. 1976. Proper­
ties of mouse leukemia viruses: XI. Immunoelectron microscopic 
studies on viral structural antigens on the cell surface. Virolo­
gy 69, 169-178. 
25. Steeves, R.A., M. Strand, and J.T. August. 1974. Structural proteins 
of marmai¡an oncogenic RNA viruses: murine Іеикетіа virus neutra­
lization by antisera prepared against purified envelope glycopro­
tein. J. Virol. Г4, 187-189. 
26. Stephenson, J.R., S.G. Devare, and F.4. Reynolds, Jr. 1978. Transla-
73 
tional prodjcts of type-C RNA tunor viruses. Advances in Cancer 
Research. (Ι η press). 
27. Strand, M., and J.T. August. 1976. Structural proteins of ribonucleic 
acid tumor viruses. J. Biol. Chem. 251, 559-564. 
28. StroTbe-g, K. 1972. Surface active agents for isolation of tne core 
component of avian myeloblastosis virus. J. Virol. 9, 684-697. 
29. Todaro, G.J., and H. Green. 1963. Quantitativo studies of tne grcwtn 
cf mouse embryo cells in culture and their development into estab-
lisned lines. J. Cell Biol. \J_, 299-313. 
30. Van de Ven, W.J.M., D. van Zaare, C. Onnekink, and H.P.J. BloeTers. 
1978. Impaired processing of precursor polypeptides of temperature-
sensitive mutan+s of Rausche- murine leukem'a virjs. J. Vi-ol. 25, 
553-561. 
31. Van Zaane, D., M.J.A. Dekke—Michie I sen, and H.P.J. Bloemers. 1976. 
Virus-specific precursor polypeptides in cells infected with 
Rauscher leukemia virus: synthesis, identification anc processing. 
Virology 75, 113-129. 
CHAPTER I I I 
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The effects of 2-deoxy-D-glucoae (deoxyglucose) and cytochalasin В on t h e synthesis of 
Rauscher m u r i n e leukemia viral envelope proteins were investigated JLS-V9 cells 
infected with and producing Rauscher m u r i n e leukemia virus (R-MuLV) were cultured 
in t h e presence of deoxyglucose (15 mM) or of varying concentrat ions of cytochalasin В 
(0 1-25 ¿ig/ml) and the synthesis of virus-specific polypeptides was examined in pulse-
chase exper iments Overal l protein synthesis was inhibited to some ex ten t by cytochal-
asin B, at a concentrat ion of 25 ¿ig'ml an inhibit ion of about 70% was observed 
Incorporation of D-[l-3H]glucosamine, however, was almost completely inhibited (97%) 
at the same concentrat ion of the drug Newly formed virus-specific polypeptides were 
analyzed by sodium dodecyl sulfate-polyacrylamide-gel electrophoresis after immuno-
precipi tat ion with polyvalent and monospecific ant i sera agains t R-MuLV proteins No 
specific effect on the synthesis o f t h e g a ^ gene product p30 was observed The synthesis of 
the precursor of the envelope polypeptides, eni--pr82, however, was prevented in the 
presence of cytochalasin В Instead, the synthes is of a new glucosaminc-deficient 70,000-
molecular weight polypeptide (елг-рг70*) was observed Ent?-pr70* could be lmmunopre-
cipitated with anti-gp69/71 serum and ant i-pl5lE),pl2(E) serum and, therefore, proba­
bly represents the protein moiety of env-prS2 In pulse-chase exper iments in t h e pres­
ence of cytochalasin B, eni--pr70* was converted to a polypeptide with a molecular weight 
of about 75,000 which was slowly lost dur ing the chase period Production of virus-
specific gp69/71, pl5(E), a n d pl2(E) was inhibited under these conditions Similar 
resul t s were obtained with deoxyglucose, except t h a t the inhibition of glycosylation by 
t h e la t ter compound is irreversible 
INTRODUCTION plague, Sindbis, and Semliki Forest virus 
Virus replication can be inhibited under almost completely (Kaluza et al , 1972). 
conditions that interfere with viral glyco- On the other hand, herpes simplex virus 
protein synthesis (for review see Scholtis- particles are still produced after treatment 
sek, 1975). Interference with glycoprotein with deoxyglucose but these particles are 
biosynthesis, caused by elevated concen- not infectious (Courtney et al., 1973). In 
trations of glucosamine or by sugar ana- the case of avian RNA tumor viruses, inhi-
logs such as 2-deoxy-D-glucose (deoxyglu- bition of virus replication by elevated con-
cose), 2-deoxy-2-fluoro-D-glucose, or 2- centrations of glucosamine has been re-
deoxy-2-fluoro-mannose, was shown to in- ported (Hunteretal . , 1974; Haymanei a/., 
hibit the virion synthesis in several virus- 1976); Lewandowski et al. (1975) found that 
host cell systems (Kaluza et al., 1972; under these conditions an incompletely 
Courtney etal., 1973; Schmidte<a/., 1976). glycosylated 70,000-molecular weight poly-
For example, a glucosamine concentration peptide was formed instead of the major 
of 20 mM inhibits the production of fowl glycoprotein of Rous sarcoma virus, gp85. 
1
 Author to whom reprint requests should be ad- Similar alterations in glycosylation of 
dressed viral glycoproteins have often been ob-
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served after treatment with glucosamine 
or with sugar analogs (Klenk et al , 1972, 
Courtney et al , 1973, Courtney, 1976, 
Shapiro et al , 1976) and, therefore, the 
described inhibition of virus replication is 
probably caused by an altered glycosyla-
tion 
An even more pronounced interference 
with glycosylation can be obtained with 
cytochalasin В (Dix and Courtney, 1976), a 
metabolite produced by the fungus Hel-
minthosporium dematwideum In con­
trast to sugar analogs, cytochalasin В in­
terferes with glycosylation mainly 
through inhibition of the transport of cer­
tain monosaccharides across the plasma 
membrane (Kletzien and Perdue, 1973) 
In this study, we have investigated the 
effects of cytochalasin В and deoxyglucose 
on the synthesis and processing of the gly­
cosylated precursor polypeptide ели-рг82 
of Rauscher murine leukemia virus (R-
MuLV) (Van Zaane et al , 1976, Shapiro et 
al , 1976, Arcementeía/ , 1976, Naso étal , 
1976) Епь -pr82 is the precursor of the 
viral envelope polypeptides gp69/71, 
pl5(E), and pl2(E) 
MATERIALS AND METHODS 
Materials L-[a5S]Methionine (sp act, 200 
Ci/mmol) and D-U^Hlglucosamine (sp act, 
3 Ci/mmol) were purchased from The Radi­
ochemical Centre, Amersham, England 
The glucose analog deoxyglucose was ob­
tained from Sigma Chemical Co , St 
Louis, Mo Cytochalasin В was bought 
from Aldnch Chemical Co , Milwaukee, 
Wis , and dimethyl sulfoxide (DMSO) 
from Merck, Darmstadt, Germany Stock 
solutions of cytochalasin В in DMSO (10 
mg/ml) were stored at -20" 
Cells, virus, and media JLS-V9 cells, 
derived from bone marrow cells of BALB/c 
mice (Chopra and Shibley, 1967) infected 
with and producing R-MuLV were cul­
tured as monolayers in maintenance me­
dium consisting of Eagle's minimal essen­
tial medium supplemented with 10% calf 
serum Cells are labeled in labeling me­
dium consisting of Hanks' basic salt solu­
tion supplemented with dialyzed calf se­
rum and amino acids For experiments 
with L-[35S]methionine, labeling medium 
lacking methionine was used For experi­
ments with D-|l-1Hlglucosamine, labeling 
medium lacking glucose was used 
Treatment of JLS-V9 cells with cyto­
chalasin В was performed in medium con­
taining the desired concentration of cyto­
chalasin В and a final DMSO concentra­
tion of 1% 
Labeling of cells and preparation of ly-
sates Labeling of JLS-V9 cells with L-
[G5S]methionine or D-[l-3H]glucosamine in 
the presence of DMSO and cytochalasin В 
was performed as follows Subconfluent 
monolayers of JLS-V9 cells infected with 
R-MuLV and growing in plastic tissue cul­
ture flasks (Falcon Plastics, 25 cm1), were 
preincubated at 37° in 5 ml of Dulbecco's 
phosphate-buffered saline, pH 7 2 (DPBS) 
(Dulbecco et al , 1954), for 4 hr in order to 
reduce intracellular sugar pools Then 
DPBS was replaced by 4 ml of mainte­
nance medium, containing 1% DMSO and 
an indicated concentration of cytochalasin 
B, and the cells were incubated for another 
2 hr Thereafter, the cells were starved for 
10 min in 3 ml of labeling medium lacking 
methionine or glucose but containing 
DMSO and cytochalasin В Subsequently, 
L-PSlmethionine or D-[l-3H]glucosamine 
was added and the cells were incubated for 
appropriate times Following pulse-label­
ing, the cells were washed once and 4 ml of 
maintenance medium containing DMSO 
and cytochalasin В were added, thereafter, 
the cells were either lysed immediately or 
radioactivity was chased for various times 
In the absence of DMSO and cytochalasin 
В the same labeling procedure was used 
Pulse-chase experiments in the pres­
ence of 15 mili deoxyglucose were per­
formed according to the same procedure 
but preincubation in DPBS was omitted 
After pulses as well as after chases, the 
cells were lysed by the addition to the cul­
tures (l e , cells and medium) of 1 ml of a 
buffer containing 50 mM sodium phos­
phate, pH 7 2, 4 5% sodium chloride, 5 0% 
Triton X-100, 2 5% deoxycholate, and 0 5% 
sodium dodecyl sulfate [fivefold-concen­
trated immunoprecipitation buffer (Van 
Zaane et al , 1976)] After clearing of the 
lysates through centrifugation at 220,000 g 
for 10 min in a Ti-50 rotor of a Spinco L-50 
centrifuge, the lysates were stored at -80° 
To study the effect of various concentra-
78 
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tions of cytochalasin В on the total incor­
poration of L-[3,iS]methionine or D-[1-
3Hlglucosamine, cells were labeled accord­
ing to the procedure described above ex­
cept that labeling with L-[15Slmethionine 
was performed in maintenance medium 
instead of labeling medium, in order to 
prevent exhaustion of methionine during 
long incubations. Incorporation of L-
[35S]methionine and D-fl-1Hlglucosamine 
was determined after lysis of pulse-labeled 
cells. Aliquote of lysates labeled with L-
[35S [methionine or with D-d-'Hlglucosa-
mine were precipitated with trichloroace­
tic acid (TCA). Before TCA precipitation, 
lysates labeled with L-I^SJmethionine 
were preincubated with 1 ml of 0 1 W 
NaOH for 15 mm at 37°. The TCA-insolu-
ble material was collected on Millipore 
filters and radioactivity was counted. 
Protein concentrations were determined 
according to Lowry et al. (1951). 
Immunoprecipitation and polyacryl-
amide-gel electrophoresis. Detection of R-
MuLV-specific polypeptides in cell lysates 
was performed with polyvalent and mono­
specific antisera against R-MuLV proteins 
according to the immunoprecipitation pro­
cedure described by Van Zaane et al. 
(1976). Anti-gp69/71 serum was a generous 
gift of M. Strand and J T. August. Char­
acteristics of this antiserum were de­
scribed by Strand and August (1976). The 
other antisera were prepared and de­
scribed by Van Zaane et al. (1976) Analy­
sis of the immunoprecipitation was per­
formed by sodium dodecyl sulfate-poly-
acrylamide-gel electrophoresis (SDS-
PAGE) according to Laemmli (1970) on 7-
18% Polyacrylamide gradient slab gels. 
Radioactivity was visualized by scintilla­
tion autoradiography (Bonner and Las-
key, 1974). 
RESULTS 
Effect of Cytochalasin В on the Incorpora­
tion of L-[3bS]Methionine and D-[l-
3H]Glucosamine 
The effect of cytochalasin В on the incor­
poration of L-[3,iS]methionine and D-[l-
3H]glucosamine into TCA-precipitable ma­
terial was examined in R-MuLV-infected 
JLS-V9 cells. The results are summarized 
TABLE 1 
E F F E C T OF CYTOCHALASIN В ON THE INCORPORATION 
OF L - I ^ S J M E T H I O N I N E AND D-[l-3H]GLUrOSAMINE IN 
JLS-V9 CELLS INFECTED WITH R-MuLV e 
Treatment L-[MSlMethionine D-[l-3H]Glucoaamine 
Counte per Percent- Counte per Percent-
minute per age of minute per age оГ 
microgram control microgram control 
of protein' of protein* 
None 
DMSO 
(1%) 
Cytochal­
asin В 
1 »ig/ml 
5 /ig/ml 
10 μκ/ml 
25 / íg/ml 
860 
660 
600 
440 
320 
280 
100 
77 
70 
51 
37 
31 
2865 
2118 
935 
293 
106 
78 
100 
74 
33 
10 
4 
3 
0
 Subconfluent monolayers of JLS-V9 cells in-
fected with R-MuLV were preincubated in DPBS for 
4 h r and thereafter cultured for 2 hr in maintenance 
medium or main tenance medium containing 1% 
DMSO and cytochalasin В Cells were labeled e i ther 
with L-[ 3 5S]methionine (3 μ θ / m l l for 2 hr or with D-
[l- 3 H]glucosamine (20 /iCi'ml) for 20 hr, lysed, and 
t rea ted with trichloroacetic acid as described in Ma­
ter ia ls and Methods, then overall incorporated ra­
dioactivity was determined 
β
 Incorporation is expressed as count per m i n u t e 
per microgram of protein present in t h e lysate In 
the case of glucosamine, the incorporated label may 
be present in lipopolysaccharides as well as in glyco­
proteins. 
in Table 1. Labeling of the cells for 2 hr 
with L-[35S]methionine revealed that, at 
increasing concentration of the drug, the 
incorporation of L-[3,S]methionme de­
creases. A reduction of the incorporation to 
about 30% was observed at a concentration 
of 25 μg/ml. The reduction of incorporation 
was maintained throughout a labeling pe­
riod of several hr (Fig. la). The inhibitory 
effect of cytochalasin В on the overall in­
corporation of D-[l-1H]glucosamine was 
much more pronounced (Fig. lb). Even at 
low concentrations of the drug, inhibition 
of overall incorporation was drastic (Table 
1). 
Effect of Cytochalasin В on the Synthesis 
of Virus-Specific Precursor Polypep­
tides 
The effect of cytochalasin В on the syn­
thesis of virus-specific precursor polypep-
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FIG 1 Effect of cytochalasin В on the incorporation of L ["Slmethionine and D 11 3H]gluco9amine into 
TCA precipitable material Subconfluent monolayers of JLS V9 cells infected with R MuLV were preincu-
bated in DPBS for 4 hr and thereafter cultured for 2 hr in maintenance medium or maintenance medium 
containing 1% DMSO and cytochalasin В (5 or 25 μg/ml) Cells were labeled either with L-["S]methionine (3 
дСі/тІ) (a) or with D-[l 3H]glucosamine (20 jiCi/ml) (b) as described in Materials and Methods At indicated 
intervals, incorporated radioactivity was determined 
tides was studied in pulse-chase experi­
ments After preincubation in DPBS, R-
MuLV-infected JLS-V9 cells were cultured 
in the presence of various concentrations 
of cytochalasin В and pulse-labeled with L-
[MS]methionine, lysates were prepared for 
radioimmunoprecipitation with polyvalent 
and monospecific antisera The solubihzed 
precipitates were subjected to gel electro­
phoresis 
The control experiments (Fig 2A and B) 
showed that the precursor polypeptides 
eni>-pr82, gag-ρτΊϋ, andgag-pr65 had been 
synthesized [the identification of these 
products is based on analysis with mono­
specific antisera and tryptic digests (cf 
Van Zaane et al , 1976)] At increasing 
concentrations of cytochalasin В a progres­
sive disappearance of env-pr&2 was ob­
served (Fig 2C-H) Concomitantly, poly­
peptides with greater electrophoretic mo­
bility appeared (Fig 2F-H) At a concen­
tration of 25 Mg/ml, cytochalasin В pre­
vented the synthesis of enu-pr82 com­
pletely while a new polypeptide of 70,000 
molecular weight was formed (Fig 2H) 
The same polypeptide was precipitated 
with both monospecific anti-gp69/71 serum 
and anti-pl5(E),pl2(E) serum (Fig 21 and 
J), indicating that it earned antigenic de­
terminants of the virus-specific polypep­
tides gp69/71, pl5(E), and pl2(E), the same 
set of antigenic determinants is present in 
erei'-pr82 (Van Zaane et al , 1976) The 
70,000-molecular weight polypeptide is not 
precipitated in control experiments using 
bovine serum albumin antiserum (Fig 
3F) Since the precursor polypeptide env-
pr82 is glycosylated (Van Zaane et al , 
1976, Shapiro et al , 1976, Arcement et al , 
1976, Naso et al , 1976), the effect of cyto­
chalasin В on the incorporation of D-[l-
3H]glucosamine into virus-specific poly­
peptides was investigated Therefore, ra­
dioimmunoprecipitation analysis with 
anti-R-MuLV serum was performed on ly­
sates from cells cultured in the presence or 
absence of cytochalasin В and labeled with 
D-[l-3H]glucosamine for 20 hr 
The results of this experiment were com­
pared with those obtained under the same 
conditions except that labeling was per­
formed with L-[ar'S]methionine for 30 min 
In the absence of the drug, the glycosyl­
ated virus-specific polypeptides env-pr&2 
and gp69/71, labeled with D-[l-
'Hjglucosamine, were synthesized as could 
be seen after immunoprecipitation with 
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anti-R-MuLV serum (Fig. ЗА and В). In а 
control experiment none of these polypep­
tides was precipitated with antiserum to 
bovine serum albumin (Fig. 3G). 
In the presence of cytochalasin В no Ο­
Ι l-3H]glucosamine-labeled polypeptides 
could be precipitated with anti-R-MuLV 
serum (Fig. 3C). Comparison with L-
[ ^ SJmethionine-labeled immunoprecipi-
tates revealed that the failure of D-(l-
^Hlglucosamine to be incorporated into the 
virus-specific glycoproteins eny-pr82 and 
gp69/71 was accompanied by the appear­
ance of the 70,000-molecular weight poly­
peptide and the absence of еп -рт 2 (Fig. 
3D). From these data we conclude that the 
70,000-molecular weight polypeptide, syn­
thesized in the presence of cytochalasin В 
(25 μg/ml) is an uncompletely glycosylated 
or nonglycosylated form of eni?-pr82. 
Therefore, this polypeptide will be indi­
cated as env-prlO*, the asterisk indicating 
that it is formed under abnormal condi­
tions (notably in the presence of an inhibi­
tor of glycosylation). In contrast to the ef­
fects on env polypeptides, cytochalasin В 
had no effect on the electrophoretic mobil­
ity in SDS-PAGE of the precursor poly­
peptides gag-prlb and gag-pr65 (Fig. 3D 
and E). 
Effect of Deoxyglucose on the Synthesis of 
Virus-Specific Precursor Polypeptides 
Shapiro et al. (1976) also reported the 
synthesis of a 70,000-molecular weight 
polypeptide with gp69/71 antigenic deter­
minants in cells infected with R-MuLV 
when glycosylation was inhibited with 
deoxyglucose. In order to compare the 
70,000-molecular weight polypeptide syn­
thesized in the presence of cytochalasin В 
with the one synthesized in the presence of 
pr82-
pr75" 
pr65- -pr70 
Cyt.BCpg/ml) Э І Ш 
A 
: 0 0.1 0.5 1 
В С D E 
5 
F 
10 
G 
25 25 25 
H 1 J 
F I G . 2. Effect of various concentrat ions of cytochalasin В on the synthesis of R-MuLV-specific precursor 
polypeptides. Subconfluent monolayers of JLS-V9 cells infected with R-MuLV were preincubated in DPBS 
for 4 h r and thereaf ter cultured for 2 hr in m a i n t e n a n c e medium (Αι or m a i n t e n a n c e medium containing 1% 
DMSO and various concentrat ions of cytochalasin В as indicated (B-J). After labeling for 90 min with L-
[ : , 5 S]methionine (25 ¿iCi/ml) as described in Mater ia ls and Methods, cells were lysed and virus-specific 
polypeptides were analyzed by SDS-PAGE and scintil lation autoradiography after immunoprecipi tat ion 
with anti-R-MuLV serum (Α-Hi, anti-gp69/71 serum (I), or anti-pl5(E>,pl2(E) serum (J). 
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ffiÜs 
p r 8 2 ^ 
ш. pr75—*· 
рг70 g p 6 9 / 7 î ~ * 
р г 6 5 
ЖЕ 
- р г 6 5 
-рЗО 
В 
F G H Μ Ν 
F I G . 3. Comparison of t h e effects of cytochalasin В (cyt. B) (25 ¿ig/ml) and deoxyglucose (15 mM ι on the 
synthes is of R-MuLV-specific precursor polypeptides. In pulse-chase exper iments JLS-V9 cells infected 
with R-MuLV were labeled with L-[ 3 SS]methionine (25 /¿Ci/ml) for 30 min. In other experiments , cells were 
labeled with D-[l-3H]glucosamine (20 ¿tCi/ml) for 20 hr. After lysis of the cells, immunoprecipi tat ion was 
performed as described in Mater ia ls and Methods. The immunoprecipi tates were analyzed by SDS-PAGE 
and scinti l lation autoradiography. Exper imental detai ls are listed in the following columns. 
Lane 
A 
В 
с 
I) 
к 
F 
О 
}( 
I 
J 
к 
L 
M 
Ν 
Label used 
[ 3 H]Glucosamine 
[ 3 H]Glucosamine 
[ 3 H]Glucosamine 
[ 3 s S]Methionine 
[ 3 s S]Methionine 
[ 3 5 S]Methionine 
[ 3 H]Glucosamine 
[ 3 5 S]Methionine 
T S l M e t h i o n i n e 
[ 3 1 S]Methionine 
| 3 s S]Methionine 
[ 3 5 S]Methionine 
[ 3 s S]Methionine 
[ 3 s S]Methionine 
Chase 
(hr) 
_ 
_ 
-
0 
0 
0 
_ 
0 
2 
20 
0 
2 
D 
2 
T r e a t m e n t dur ing experi­
ment 
None 
1 * DMSO 
14 DMSO, cyt. 
1 * DMSO, cyt. 
None 
1% DMSO, cyt. 
None 
Deoxyglucose 
Deoxyglucose 
Deoxyglucose 
Deoxyglucose 
Deoxyglucose 
Deoxyglucose 
Deoxyglucose 
В 
В 
В 
Antiserum 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-BSA 
Anti-BSA 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-gp69/71 
Anti-gp69/71 
Anti-BSA 
Anti-BSA 
deoxyglucose, the latter compound was 
used in parallel experiments. Radioimmu-
noprecipitation analysis with anti-R-
MuLV serum of lysates of cells cultured in 
the presence of 15 mM deoxyglucose and 
pulse-labeled with L-['15S]methionine for 30 
min revealed that the synthesis of env-
pr82 was inhibited (Fig. 3H). Simultane-
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ously, not one but several new polypep­
tides of about 70,000 molecular weight 
were immunoprecipitated with monospe­
cific anti-gp69/71 serum (band b in Fig 3H 
and K). There is a slight difference in the 
electrophoretic mobilities of these polypep­
tides and the 70,000-molecular weight 
polypeptide, synthesized in the presence of 
cytochalasm В (Fig. 3D and H). 
Effect of Cytochalasm В on the Synthesis 
of the env Gene Products gp69/71, 
pl5(E), andpl2(E) 
The env gene products gp69/71, pl5(E), 
and pl2(E) are formed after proteolytic 
cleavage of the glycosylated precursor 
polypeptide enu-pr82 (Van Zaane et al , 
1976, Arcementef α/., 1976; Shapiro étal., 
1976; Naso et al., 1976). The effect of cyto-
chalasin В on the production of these 
structural polypeptides was studied in 
pulse-chase experiments described in Fig 
4. Synthesis and processing of the virus-
specific polypeptides еш>рг82, gag-ρτΤδ, 
and gag-pr65 in JLS-V9 cells cultured in 
the presence or absence of 1% DMSO (the 
solvent for cytochalasm B) are shown m 
Fig. 4A, B, D, and E. In the presence of 
cytochalasm B, erau-pr70* was synthesized 
(Fig. 4C). After a chase period of 2 hr, still 
in the presence of cytochalasm B, env-
pr70* had disappeared and a new poly­
peptide of about 75,000 molecular weight 
was precipitated with anti-R-MuLV serum 
(Fig. 4F). In a separate experiment (not 
shown) the 75,000-molecular weight poly­
peptide was also precipitated with anti-
gp69/71 serum and anti-pl5(E),pl2(E) se­
rum but not with anti-рЗО serum. It there­
fore has the same serological properties as 
елк-рг82. After longer chase periods the 
new polypeptide disappeared gradually 
(Fig. 4G and H). Furthermore, production 
of the ели-gene products gp69/71, pl5(E), 
and pl2(E) was inhibited |traces of pl5(E) 
and pl2(E) were visible in the original 
autoradiogram]. The 75,000-molecular 
weight polypeptide was not synthesized de 
novo during the chase period because inhi­
bition of protein synthesis with cyclohexi-
mide did not prevent its formation (not 
shown). In another experiment, cytochal­
asm В was present during the pulse but 
absent during a chase period of 2 and 20 hr; 
under these conditions enu-pr70* disap­
peared and polypeptides varying in molec­
ular weight between 75,000 and 82,000 
were formed (Fig 4N and O). These poly­
peptides carried gp69/71 antigenic deter­
minants (not shown). Furthermore, pro­
duction of the env gene-related structural 
viral proteins gp69/71, pl5(E), and pl2(E) 
was observed (Fig. 4N and O). Production 
of these polypeptides was also observed 
when DMSO or cytochalasm В (Fig. 41 and 
J) was present during the chase period 
only. 
Very similar results were obtained with 
15 mM deoxyglucose instead of cytochal-
asin В (Fig. 3H-N). Polypeptides with 
gp69/71 antigenic determinants, formed 
during the chase period in the presence of 
deoxyglucose, were only slightly higher in 
molecular weight than 70,000 (band a in 
Fig 3D and these polypeptides also disap­
peared during a chase period (Fig. 3I-J). 
In that case, however, no virus-specific 
gp69/71, pl5(E), and pl2(E) were formed 
(Fig. 31, J, and L). 
DISCUSSION 
Cytochalasin В interferes with various 
cellular functions (Carter, 1972; Spooner et 
al., 1971; Zigmond and Hirsch, 1972), in­
cluding the transport of certain monosac­
charides across the plasma membrane 
(Kletzien and Perdue, 1973), and in this 
way depresses glycoprotein synthesis in 
cultured cells (Sanger and Holtzer, 1972). 
The sugar analog deoxyglucose inhibits 
glycoprotein synthesis in a different way. 
It enters the cell and becomes incorporated 
into glycoproteins (Kaluza et al., 1973). 
Once incorporated, elongation and/or 
branching of the carbohydrate chain of the 
glycoprotein is irreversibly blocked (Schol-
tissek, 1975) apparently because glycosyl 
transferases fail to recognize the deoxysu-
gar (Dix and Courtney, 1976). In studying 
the effect of cytochalasin В on protein syn­
thesis m JLS-V9 cells, the observed reduc­
tion in L-t^SJmethionine incorporation 
(Fig. la) is in agreement with the results 
of previous studies (Koch and Opperman, 
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FIG. 4. Effect of cytochalasin В (cyt. В) (25 ^g/ml) on the synthesis of the viral envelope proteins. 
Subconfluent monolayers of JLS-V9 cells infected with R-MuLV were pulse labeled for 30 min with L-
f35S]methionine (25 /iCi/ml· and radioactivity was chased for various times. After lysis of the celle 
immunoprecipitation was performed as described in Materials and Methods. The immunoprecipitates were 
analyzed by SDS-PAGE and scintillation autoradiography. Experimental details are listed in the following 
columns. 
•ane 
A 
В 
С 
D 
E 
F 
G 
H 
I 
J 
К 
L 
M 
N 
0 
Chase 
(hr) 
0 
0 
0 
20 
20 
2 
7 
20 
20 
20 
0 
0 
0 
2 
20 
T r e a t m e n t dur ing 
None 
1 * DMSO 
1% DMSO, cyt. 
None 
1% DMSO 
1% DMSO, cyt. 
1% DMSO, cyt. 
1% DMSO, cyt. 
None 
None 
1% DMSO, cyt 
1% DMSO, cyt. 
m DMSO, cyt. 
1% DMSO, cyt. 
1 * DMSO, cyt. 
pulse 
В 
В 
в 
в 
в 
в 
в 
в 
в 
T r e a t m e n t dur ing 
-
-
_ 
None 
1% DMSO 
1% DMSO, 
1% DMSO, 
1% DMSO, 
1% DMSO 
1 * DMSO, 
_ 
-
-
None 
None 
cyt 
cyt 
cyt 
cyt. 
chase 
В 
В 
В 
В 
Antiserum 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-R-MuLV 
Anti-BSA 
Anti-gp69/71 
Anti-pl5(Ei, pl2(E) 
Anti-R-MuLV 
Anti-R-MuLV 
1975). Nevertheless, the effect of cytochal­
asin В on the incorporation of labeled 
amino acids can vary considerably with 
the cell line used; for instance, Koch and 
Opperman (1975) reported a 55-60% inhi­
bition of incorporation in poliovirus-in-
fected HeLa cells at a concentration of the 
drug of 50 Mg/ml; Dix and Courtney (1976) 
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on the other hand found no significant in­
hibition of incorporation in HSV-1-infected 
human embryonic lung fibroblasts at the 
same concentration of the drug Yet, in the 
latter case, the strong inhibitory effect of 
cytochalasin В on the overall incorpora­
tion of D-ll-'Hlglucosamine, as found in 
this study, was also observed 
In pulse-labeling experiments, the ef­
fects of cytochalasin В on the synthesis of 
virus-specific precursor polypeptides gag-
pr75, gag-pr65, and <vii/-pr82 was investi­
gated (Fig 2) While cytochalasin В did 
not affect the synthesis of gag-ρτΊο and 
gag-ртбЬ very much it strongly inhibited 
the synthesis of the glycosylated precursor 
polypeptide еп -ртЪ2 (Fig 2H) Instead of 
env-prS2, polypeptides with higher electro-
phoretic mobility appeared (Fig 2) From 
this kinetic relationship as well as from 
their serological properties we conclude 
that these intermediate bands between 
70,000 and 82,000 molecular weight are 
eni-pr82-related, partly glycosylated poly­
peptides We have not attempted to eon-
firm this result by analysis of 
(chymo)tryptic digests because of the low 
amounts of radioactivity incorporated in 
these polypeptides Ent.'-pr70* (formed at 
25 μg/ml of cytochalasin B) is probably not 
glycosylated at all since, even at a cyto­
chalasin В concentration of 50 μg/ml, no 
smaller pru'-pr82-related polypeptides 
were synthesized (result not shown) A mi­
nor degree of glycosylation of env-ρτΊΟ*, 
however, cannot be excluded, since carbo­
hydrate components for limited glycosyla­
tion may be available from intracellular 
sources 
Other evidence in favor of the assump­
tion that eni'-pr70* represents the bare 
protein moiety of *>лі.'-рг82 follows from our 
earlier work 22 S virus-specific mRNA 
from cells infected with R-MuLV was 
translated in a rabbit reticulocyte lysate 
and gave rise to the synthesis of a 70,000-
molecular weight polypeptide that reacted 
with anti-R-MuLV serum (Gielkens et al , 
1976) The 70,000-molecular weight poly­
peptide was not analysed with monospe­
cific antisera. In a later study with oocytes 
of Xenopui laens, it was established that 
the 22 S mRNA directs the synthesis of 
e/u-pr82 and its cleavage products gp69/71 
and pl5(E) (Van Zaanec¿a/ , 1977) There-
fore, the 70,000-molecular weight poly-
peptide formed in the reticulocyte cell free 
system is presumably identical or almost 
identical to env-ρτΊΟ* described in this pa­
per 
In the presence of 15 mM deoxyglucose, 
several similar carbohydrate-deficient 
polypeptides were formed with molecular 
weights of approximately 70,000 (Fig. 3H), 
they also possessed gp69/71 antigenic de­
terminants (Fig 3K) Furthermore, the 
molecular weights of these polypeptides 
were slightly higher than the molecular 
weight of елі>-рг70* formed in the presence 
of cytochalasin В (Fig 3D and H) The 
small difference in molecular weight may 
be due to difference in glycosylation, since 
inhibition of glycosylation with deoxyglu­
cose becomes effective only after incorpo­
ration of the sugar analog 
Cytochalasin В did not affect the proteo­
lytic cleavage of the virus-specific precur­
sor polypeptides gag-ртІЪ and gag-ртбЬ 
(Fig 4F-H) [The only detectable gag 
gene-related mature viral protein is p30; 
neither pl5 nor plO were detected because 
they lack methionine (Ikeda et al , 1975), 
furthermore, pl2 and plO were not de­
tected in our immunoprecipitation assay]. 
In contrast, cytochalasin В had an inhibi­
tory effect on the production of the enve­
lope proteins (Fig 4F-H) This inhibitory 
effect of cytochalasin B, however, is re­
versible After removal of the drug, glyco­
sylated ereL-pr70*-related polypeptides of 
higher molecular weight (MW, 75,000-
82,000) are formed as well as the env gene 
products gp69/71, pl5(E), and pl2(E) (Fig 
4N-0) 
The inhibitory effect of deoxyglucose of 
the synthesis of the envelope precursor 
polypeptide and the production of the en­
velope proteins is in agreement with the 
observations of Shapiro et al , (1976) They 
reported the synthesis of a 70,000-molecu­
lar weight polypeptide and no cleavage to 
specific smaller proteins The relationship 
between this 70,000-molecular weight 
polypeptide, the envelope precursor poly­
peptide, and gp69/71 was confirmed by 
these authors with tryptic digest analysis 
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In contrast to cytochalasin B, deoxyglu-
cose irreversibly inhibits glycosylation 
(Kaluza et ai , 1973), since its incorpora­
tion inhibits further addition of carbohy­
drate moieties to the oligosaccharide 
chain. 
The present data show the effect of in­
hibitors of glycosylation on the synthesis 
and processing of glycosylated R-MuLV-
specific precursor polypeptides A nongly-
cosylated precursor polypeptide of the en­
velope proteins, as synthesized in the pres­
ence of cytochalasin В or deoxyglucose, 
has not been detected under normal tissue 
culture conditions. Probably, the nascent 
chain of enu-pr82 is the normal substrate 
for glycosylation We have no direct proof 
for this assumption but in a study on vesic­
ular stomatitis virus a similar suggestion 
was recently made by Hunt and Summers 
(1976). Furthermore, Molnar (1975) has 
shown in a general model for glycosylation 
in the liver that glycosylation of plasma 
glycoproteins starts with the addition of N-
acetylglucosamine to the nascent poly­
peptide chain on the membrane-bound n-
bosomes. Other authors have concluded 
that correct glycosylation of certain pre­
cursor polypeptides is required for a cor­
rect processing (Shapiro et al , 1976, Shap­
iro and August, 1976) Our results seem to 
support that conclusion 
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CHAPTER IV 
IVPAIRED PROCESSING OF PRECURSOR POLYPEPTIDES OF 
TrM"ERATURE-Sr\SI T iVE MU"" AN1 S ΟΓ RAUSCHER MURINE 
LEUKEMIA V.RUS 

I iHNNU Ol· \ nini t u t K(l> l'ITH. μ "isl-Mi! Vul >\ No > 
т>1 1 ы\/>/1К12> níiri W)¿ (Η) О 
Сор пцііі ' 1'»7Н Arm πι .in S o u r i s for Ми nihiolog\ Puntatiti l S Л 
Impaired Processing of Precursor Polypeptides of 
Temperature-Sensitive Mutants of Rauscher Murine 
Leukemia Virus 
W .1 M \ A M ) K V K N . * I) VAN ZAANK.t С ONNKKINK. лм> Η 1' J IH.OKMKRS 
Department of НшеИетЫгу, Umiersity of Nijmegen, Nijmegen. The Sethetland^ 
Ree t'lved for publication 24 August 1977 
The synthesis and processing of virus-specific precursor polypeptides in 
NIH/3T3 cells infected at the permissive temperature (,41°C) with temperature-
sensitive (ts) mutants of Hauscher murine leukemia virus was studied in pulse-
chuse experiments at the permissive and nonpermissive (39CC) temperatures 
The newly synthesized virus-specific polypeptides were analyzed bv sodium 
dodecyl sulfate Polyacrylamide gel electrophoresis after immunoprecipitatmn 
with polvvalent and monospecific antisera against Rauscher murine leukemia 
virus proteins. In cells infected with ts mutants defective in early replication 
steps (the early mutants r.sl7 and r.s29), and ts mutants defective in postIntegration 
steps (the late mutants f.s-25 and fs26), the pro» essing of the primary gag gene 
product was impaired at the nonpermissive temperature gag-\>r75 of all four 
mutants was converted into gag-\irfâ, however, #п#-рг65 accumulated at the 
nonpermissive temperature, and the main internal virion polypeptide p30 was 
not formed Therefore, the proteolytic cleavage is blocked beyond gag-prdo 
Concomitantly, the formation of the env gene-related polypeptide pl2(E) of all 
four mutants was blocked at the restrictive temperature In contrast, cells infected 
with the late mutant t\s2H, which produced noninfectious virions at 39°C, showed 
a normal turnover of the gag and ent' precursor polypeptides 
In studies on the molecular biology of type С (for a review see 14) Thus, in the case of R-
RNA tumor viruses, the isolated conditional MuLV, the primary gag gene product, gag-ρτΊη, 
lethal mutants of avian (6, 9, 22, 2fi) and mam- is converted into gag-prí>5, which is split into 
malian (13, 15, 17, 25) RNA tumor viruses pro- certain intermediary products (with molecular 
vide useful markers for the analysis of the viral weights between 40,000 and 50,000) and, subse-
genome Temperature-sensitive (ts) mutants of quently, into the polypeptides of the viral core, 
murine leukemia virus (MuLV) have been de- pl5, pl2, p30, and plO (2). Likewise, gp69/71 
rived from the Kirsten (17), Rauscher (15), and and pl5(E), the virus-specific polypeptides lo-
Moloney (25) strains. The mutants of the cated in the viral envelope as well as in the 
Rauscher strain (H-MuLV) have been divided plasma membrane of infected cells, are derived 
into three different classes based upon the stage from the primary env gene product em-pr82. 
at which virus replication is impaired at the Finally, pl2(E), found in the viral envelope, is 
restrictive temperature (15) Through the cour- presumably derived from pl5(E) (12, 24, D. van 
tesy of J R. Stephenson, we have obtained Zaane, thesis. University of Nijmegen, 1977) 
representatives of the ts mutants of class I (at Using gel filtration columns that did not resolve 
39°C, defective in replication functions before the two gag precursor polypeptides gag-ртІЪ 
the synthesis of viral group-specific antigens), and gag-ρτβη, Stephenson et al (18) showed 
class II (at 39°C, defective in functions between that two ts mutants of R-MuLV, fs25 and fs26, 
the synthesis of viral group-specific antigens and possessed temperature-sensitive defects in the 
production of virions), and class III (noninfec- proteolytic cleavage of the gag gene-related pre-
tious virions produced at 39°C) cursor polypeptides These studies were under-
The virus-specific structural polypeptides of taken to localize the defects more precisely and 
the RNA tumor viruses are formed through to investigate whether the other thermosensitive 
proteolytic'cleavage of precursor polypeptides replication mutants of R-MuLV also possess 
thermosensitive defects in gene expression 
t Present address Department of Virology, Central Veter- Therefore, the gene expressions of two early 
іпагл Institute U-Kstad,'I he Netherlands (t\sl7 and f.s29) and one late (Лч2й) ts mutants 
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5 Ή VAN DI VLN KI ΛΙ I іноі 
w e i e s t u d i e d a n d t h e l e s u l t s wou* l o u i p a i c d 
w i t h ( h o s t o b t a i n e d wi th t h e ts m u t a n t s /s2r> 
a n d /s2i> a n d w i t h a c lona l s ( o ( k of wild t y p e 
(VVT) U Μ ι ι Ι Λ ' 
M A I K K 1 A L S A M ) M h T I I O D S 
M a t e r i a l e ι ( *s|int (Inolimi (spuide ai 11 vit ч 180 
( ι militi! ) .inri л Ч l i b t l i d unum ас ici u m t u n l spi 
ι ifu κ I іч il ν 'il ηι( ι malum) wc π nU um (1 hom lh< 
Itadiodu mu .il ( ( m ri' \nu ι sham Ь ligi nul Ani ι 
gp(»4 71 imi inti |)1"і s u a w i n lb» gì n u nus gilt ni 
M Strand and J I August ( liaiae u i is tus nl tht se 
ant isc ia W I K (Uscnlncl hv Strand ind Angus! (2(1) 
Anti ]{ ΜιιΙΛ scruni anli ρ U) ч ш т .mil 
|)1Ί(Ι ) pl2(l<) sc tuin and m «uilisuuin raw d agallisi 
bovini s u um illinium (.ml ι MSA scium 1 wire pi ι 
p a n d and describid hv van /,aane it al (21) 
Cel ls «nd v i r u s e s M i l ^ 11 t t i l l s (21) wt re cui 
lured as monoluwrs in Dul luccos modihention of 
hagli uncinuti supple n u n t u l with 'O'r ft tal call s t rum 
((.rand Island Biological ( о Hi" ( ult I td ) 
Hit virusts ustd included a donai isolait ol W'l 
Η ΜιιΙΛ (W'l 2IH) ind Ιι\< Κ ΜιιΙΛ /s mutants 
M " Ы > ь 2 6 /ч2М and /-2<> « 1 ~>> М М I M tell·· 
vvcii infitt i t i with virus is dest nht d l)\ ^ i i p h u i s o n 
.nid Aaronson (Г>) Infctlion wilh Λ К Mul V was 
pi rfnimed at il ( and thai with W I К Mul \ « , ь 
performed nt I7°( 
ILS VI t i l l s derived (rom hont marrow t i l l s (if 
HAIaVt mut (1) infilled with and producing It 
Mul V ( Ч К М п І ) win · ι n inni cl as ninnolivi гч 
in I iglt minimal issc niial ttudium supplì tut iited nil h 
10 call s t rum V*f It Mul V laht l id wilh ι ( ' S l i m 
tliifinint was isolated a s d i s i n h i d hv D u t s h u g md 
Kohinson (">) md w is use d is ι ι e lue m e 
L a b e l i n g of cells a n d p r e p a r a t i o n of lv s a t e s 
Suhtonline ni monolayers ul n>lls growing in plastic 
tissue culture fl.isks (Kilion 1'lustus 2") <m ) w i n 
starved for 10 nun in lain ling nitdium (Hanks basic 
suit solul ion supplì mini id with Hl'r dialv/id calf si 
runt and amino at ids t \ t ι pi for the radioattivi cuits) 
" I h m the nu duim was replaced h\ l.ihihng nit duini 
with a radioattivi amino atid(s) and Ihi i t IN w i n 
intubated for Ю nun Afltr being pulst laht l id tht 
tells were washed onci and 4 nil of nonna) culture 
medium was addid Ihertaf t t r the t i l l s u t hi г were 
Ivsid imnudia tdv oi ladioac livitv was t hast d for var 
mus turns In sonn ечре unit nts th t e m p t i a t u i t was 
shifted during tin с hast period Whin indicatiti (hi 
ttmperati irt shift from 14 to 11°( was ptr foinud 2 h 
afttr the beginning of tht chase pi nod tht t t m p i r a 
ture shift from 11 to J'i' ( was ]xrformed imnudiatdv 
afltr pulst l a b d i n g o f t h t t i l l s 
After points as wi II as afler t h ist s (ht ι ti ls wire 
Ivst'd bv tht addition to the e ultori s ( i t t t l l s and 
mi ilium) of 1 ml ol a buffi г containing r>0 inM M)diuin 
phos]>ha(t (plf 7 2) IV* sotlium clitoridi "> 0*r 1 riton 
X KM) 2.Vf dioxvtholalt and 0 Vf sodium d o d u v l 
sul fa le (fut fold tonet titrated immuno[)rttipitation 
buffer (241) Afttr t l i a n n g the K s i t t s hv tintrtfuga 
don al ¿20 000 x g Tor 10 min in a 11 >0 rotor of a 
Spinto L r>0 t tn ln lug t (he Ivsales wire stored at 
-НО С 
I m m u n o p r e t i p i l a t i o n a n d p o l > a < r \ l a m i d o gel 
e l e c t r o p h o r e s i s Delie lion of U Mul \ s p u d к 
pok pc pi nie s m и II l\- ile * w i-> pi iloinii d u u h pok 
\ ll( lil .111(1 llionospi < |(|( l l l l l s( | l |Ц ИіЫ |{ Mul \ 
pioti ms u ( o i d n y lo Ihc itnmuiiopie с ipil il um pi οι ι 
dun diselliteli b\ \ ιιι / ι ine e t al (21) lllimuiiupii 
apí la les u u c a n a k / t d hv sodium dodteU sulfite 
pok ai ι dannile g d с le t trophorcsis u
 t ording lu 
l a m i n i l i (10) on 7 to 18'> рок к г і mudi giaditnl 
slab ge Is Uadioae iivilv was visuali/ed hv si iniillation 
aulor uliogiapln ( )) 
RESULTS 
S>nthes is and identif ication of virus-spe­
cific polypept ides in N111/313 colls infected 
wi th WT R-MuLV (WT-248) I he synthesis 
ol vnus speiilu polypeptides m NIH/ Π'( n i l s 
mit с ted with W I И Mul \ was examined in 
pulse chase experiment*· al (7 С (big ІА-Ы 
Cells weie pulse labeled (or 10 min wilh a "C-
labeled amino ae id m u t i n e and (heteaftet ra 
dioatlivitv was chased loi 0 and 20 h The vital 
struttuial polypeptides weie identified thmugh 
lninuinopieiipitalion analysis with well dehned 
(see Matenalsand Methods) monospecific anti 
sera and a pol\valen! antiserum against Ц-
MuLV polypeptides Kadioimniunopiei ipila­
tion anaksis Ы pulse labeled tells with and [{ 
ΜιιΙΛ serum revealed (hat in addition lo the 
virus spet dit μι ее ш soi pol\ peptides gag pi To 
gag pr(V>, and rm pi 82 (il refeienies I 24), 
small amounts of two high molecular weight 
poh peptides (indicated with · ) were pieupi 
tat ed (Fig 1A) L pon anahsis wilh monospei ι Fu 
anlisera it appeareil (hat both high molecular 
weight polypeptides tarried antigenic deteimi-
nants of the gag related strut tin al poh pepi ides 
ρ 30 and ρ l'i, but nol of the e/i t related strut tui al 
polypeptide gpf>9/71 (not shown) These high 
molecular weight polypeptides arc theiefore 
probabh virus specific polvpeptides, which in 
addition to the antigenic determinants of the 
gag precursoi contain other virus speufu anti­
genic deteimmants (possibly of reverse (tan 
senptase [8]) The ν might represent vuus-spe-
tific precursor polypeptides whose synthesis is 
due to an occasional rcadthrough at the gag 
gene termination site on a viral niHNA (14) 
Moieovei aftei pulses as well as after ι hases, 
some additional high molecular weight polypep­
tides ОЧО.ООО) weie precipitated with the anti 
seia used especially with the anti Η ΜιιΙΛ se 
mm (Fig IA-O) and the anti-pl")(K),pI2(K) se-
rum (Fig 11), mdualed with *) Probably many 
of these polypeptides are not virus specilli and 
represent cross reacting host cell polvpep 
tides However, stnne of them might be degra 
dation produits ol (he high moleculai weight 
pi ecu ι sot polypeptides synthesized ae eoi ding to 
A reach hi ough mechanism We will not discuss 
the sigmlii am e oí these piodiuts h e u , because 
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Fie. 1. Normal processing of gag and env products of WT R-MuL V (WT-24H). Subconfluent monolayers 
of NIH/3T3 cells infected with WT R-MuLV were pulse labeled for 30 mm with 100 μΓι of a 1 4 C ammo acid 
mixture (Α-G) or with 75 μΟΪ of /.-/ №S]methionine (Η-O), and radioactivity was chased for 0, 2, 7, and 20 h 
as indicated- The pulse-chase experiments were performed at 31°С (H-K), 37°C (A~G), or 39°C (L-O). After 
lysis of the cells as described in the text, virus specific polypeptides were analyzed by sodium dodecyl sulfate 
Polyacrylamide gel electrophoresis and scintillation autoradiography after immunoprvcipitation with: anti 
R MuLV serum (A, B, Η-O). antigp69/71 serum (C); anti-pl 5(E) ,pl 2(E) serum (D); anti рЗО serum (E), anti-
pl5 serum (F); or anti USA serum (G) Bands marked with · and * are discussed in the text 
their synthes is does not seen» to he affected in 
any of the mutants we have investigated. After 
a chase period of 20 h, radioimmunoprecipita-
tion analysis of labeled cultures (i.e., cells and 
medium) with anti-R-MuLV serum showed that 
the gag and env precursor polypeptides had 
disappeared and that the viral structural poly­
peptides gp69/71, рЗО, pl5(E), and pl2(E) were 
formed (Fig. IB). These viral structural polypep­
tides were identified with monospecific antisera 
(Fig. 1C-F). In a control experiment none of the 
polypeptides could be precipitated with anti-
BSA serum (Fig. IG). It should be noted that 
the gag products pl2 and plO are not recognized 
by the anti-R-MuLV serum used. 
As a control for the analysis of the ts mutants, 
Fig. l(H-O) shows the results of a pulse-chase 
experiment at 31°C (Fig. 1H-K) and 39°C (Fig. 
lL-O) with NIH/3T3 cells infected with WT 
R-MuLV (WT-248). Cells were pulse-labeled 
with i.-[ l 'S]methionine for 30 min, and, there­
after, radioactivity was chased for 0. 2, 7, and 
20 h. Radioimmunoprecipitation analysis was 
performed with anti-R-MuLV serum. It ap­
peared that at both temperatures the precursor 
polypeptide e/ir-pr82, as well as gag-pr"ò and 
gag-ргвЬ, was cleaved into virus-specific struc­
tural polypeptides (Fig. lH-O). It should be 
noted that pl5 does not contain methionine (7) 
and consequently is not detected when cells are 
labeled with L-f'SJmethionine. 
Localization of the blockage in the cleav­
age of the gag gene-related precursor poly­
peptides of ts2b and fs26. The cleavage of 
the gag gene-related precursor polypeptides of 
ts25 and is26 was shown to be blocked at the 
nonpermissive temperature (2, 19). To localize 
the blockage in the cleavage scheme, the syn­
thesis and processing of virus-specific precursor 
polypeptides was examined in NIH/3T3 cells 
infected at 31°C with fs25 and te26. Pulse-chase 
experiments were performed at 31 and 39°C, 
and the virus-specific polypeptides were immu-
noprecipitated with anti-R-MuLV serum. The 
results obtained with /*25 are presented in Fig. 
2. At 31°C no differences in the synthesis and 
processing of the precursor polypeptides of fs25 
and WT-248 could be observed (cf. Fig. 2A-0 
and Fig. 1H-K). In a c c o r d a n c e with the work 
of Stephenson et al. (19), Fig. 2<E-H> shows 
that the processing of the gag gene precursor 
polypeptides was impaired at the nonpermissive 
9', 
5 5 6 VAN DE VEN KT Ab. 
p r 8 2 _ ^ 
p r 7 5 ^ 
g p 6 9 / 7 1 ^ 
pr 65 *" 
рЗО — 
PÎ51EJ-
pl2(E1~ 
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Chase in hr. О 2 7 
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Fu;. 2. Thermosensitive processing of gag products of ts25. Subconfluent monolayers of NIH/3T3 cel/s 
infected at 31°C with ts25 were pulse-labeled for 30 mm with 75 μΟι of ƒ.-f '\S}methionine, and radioactivity 
was chased for carious times as indicated (Α-P). Pulse-chase experiments were performed at 31°C (A-D, 
O-P) or 39°C (F-H). In some cases the temperature was shifted for a chase at ЗГС (I-K) or 39°C (L-N). as 
described in the text. Thus, "chase in h 2 ' , " indwates a 2-h chase at 39°C followed by a 0.25-h chase at 
31°C, etc. Virus specific polypeptides were analyzed as described in the legend to Fig. 1. Immunoprecipitation 
with: antiR-MuLV serum (Α-N); anti-BSA serum (O-P); reference V9R-MuLV labeled with i.-fv'S]methio 
nine (Q). 
temperature; gag-pr65 of ts2b is accumulated 
and no p30 is formed. On the other hand, like 
WT gag-prlb, the gag-pr75 of fs26 is converted 
into gag-priib. When the temperature was 
shifted to 31 °C 2 h after pulse-labeling the cells 
at 39°C (Fig. 2I-K), the proteolytic cleavage 
was resumed and p30 was produced. When, in 
another experiment, the temperature was 
shifted from 31°C (during the pulse) to 39°C 
(during the chase), the proteolytic cleavage was 
blocked (Fig. 2L-N). 
The results of parallel experiments with 
NIH/3T3 cells infected with Лч26 (not shown) 
were similar to those observed with /.s-25; again, 
at 39°C gag-prSb was accumulated, but the mu­
tation was slightly leaky: cells infected with ¿s26 
produced small amounts of p30 at the restrictive 
temperature (Fig. 3G-H). 
A more detailed analysis of the blockage in 
the proteolytic cleavage of the gag precursor 
polypeptides of Лч25 and fs26 was obtained after 
radioimmunoprecipitation analysis with mono­
specific antisera (Fig. 3). Cells infected with Лч25 
or Лч2(і were labeled for 30 min with a , 4C-amino 
acid mixture at 31 or 39°C, and radioactivity 
was chased for 20 h. Figure 3 shows that at the 
nonpermissive temperature gag-ргЪЬ was accu­
mulated in cells infected with ts2b (Fig. 3M-0) 
or ts'2ti (Fig. 3G-I); furthermore, the production 
of the gag-re\ated structural polypeptides p30 
and pl5 was inhibited. In addition to the im­
paired processing of the gag precursor polypep­
tides of te25 and £s26, a blockage in the produc-
tion of an env gene-related structural poly-
peptide was also observed at the restrictive tem-
perature. Radioimmunoprecipitation analysis 
with anti-H-MuLV serum (Fig. 2H and N; Fig. 
3G and M), anti-gp69/71 serum (Fig. 3K and 
Q), and anti-pl5(E),pl2(E) serum (Fig. 3J and 
P) revealed that production of pl2(E) was in-
hibited. Production of the structural envelope 
polypeptides gp69/71 and pl5(E), however, 
seemed to be normal (Fig. 2F-H and Fig. 3G, J, 
K, M, P, and Q). It should be noted that some-
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F i e 3. Leaky thermosensitiie processing of gaff products of ts26; tkermosensitive production of the cm 
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or 39°C ((ì-Q) Virus specific polypeptides were analyzed as described in the legend to Fig 1- Immunoprecip 
itatton with: anti R MuLV serum (A. G, M); antt p30 serum (li. H, N); anti pió serum (С, I. О): anti 
ρ 15(F),ρЩК) serum (D, J, Ρ); anti-gpß9/7J serum (F. К. Q); anti USA serum (F. L) 
times pl5(E) seemed to be composed of two 
components (Fig. 1, 2, and 3). Both polypeptides 
were immunoprecipitated with anti-R-MuLV 
serum (Fig. 1,2, and ЗА, G, and M), anti-gp69/71 
serum(Fig..'ìE.K.andQ),andanti-pir){K).pl2(K) 
serum (Fig. 3D, -I, and P). (Incidentally, the 
precipitation of pl5(E) and pl2(B) with anti-
gp69/71 serum is presumably due to the pres-
ence of a complex between gp(>9/71, pl5(E), and 
pl2(E) as discussed by van Zaane et al. (24) and 
Leamnson et al. (11).] 
Synthes i s of virus-specific po lypept ides 
in NIH/3T3 cells infected with f*17, ¿s28, 
and /s29. Two early temperature-sensitive mu-
tants of R-MuLV, /.sl7 and /.s29, were shown to 
be defective in one or more functions before the 
synthesis of group-specific antigens (15). To ex-
amine the possibility that these mutants also 
had a defect in the proteolytic cleavage of their 
precursor polypeptides, the synthesis of virus-
specific polypeptides was studied at 31 and39°C, 
after infection at the permissive temperature. 
Cells were labeled with i,-[''SJmethionine, and 
radioimmunoprecipitation was performed with 
anti-R-MuIA' serum. The results obtained with 
tel7 and Лч29 are presented in Fig 4 and 5, 
respectively. In both cases, gag-prlb was proc­
essed to #a#-pr65 al the nonpermissive temper­
ature. However, proteolytic cleavage was blocked 
beyond ¿>«#-prf)5, since no p30 was formed. 
When the temperature was shifted from 39 to 
31°C. cleavage was resumed, as could be con-
cluded from the production ofp30. Furthermore, 
the inhibition of the production of pl2(E) at the 
restrictive temperature, as found in cultures in-
fected with Лч25 and ts26. was also observed. On 
the other hand, the late mutant /,s28, similarly 
analyzed in parallel experiments, was not defec­
tive for the processing of its precursor polypep­
tides. The relevant pulse-chase experiments at 
31 and 39°C are shown in Fig. 6. 
DISCUSSION 
Some temperature-sensitive mutants of R-
MuLV are partially characterized (15, 16, 18, 19, 
23, 27). Among them are the mutants /.sl7, ¿,s25, 
ts2fi. ts2S, and f.s29. which were used in this 
study. 
At 39°C, some of these mutants are defective 
in either early replication steps (class I repre-
sented by t.s\7 and Лч29) or postintegration steps 
(class II represented by f.s25 and i.s26, and class 
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FIG. 4. Thermosensitive processing of gag products of tsl7 and concomitant failure to produce the env 
product ρ 12(E). NIH/3T3 cells infected at 31°C with tsl7 were pulse-labeled with 75 fid of \.-f ^methionine 
for 30 min, and radioactivity was chased for various times as indicated (Α-M). Pulse-chase experiments 
were performed at 39°C (Α-D) or 3I°C (Η-M). The temperature was shifted from 39 to ЗГС (Ε-O), as 
described in the text (see also legend to Fig. 2). Virus specific polypeptides were analyzed as described in 
the legend to Fig. I. Immunoprecipitation with: anti-R-MuL V serum (Α-K); anti-BSA serum (L-M); reference 
V9-RMuLV labeled with ¡.[''SJmethionine (N). 
Ill represented by fs28) (15). te25 and te26 are 
post intégrât ion defective mutants whose defect 
is known to involve the cleavage of the gag 
gene-related precursor polypeptides {2, 19). Mu-
tant /s29 possesses a thermolabile reverse tran-
scriptase (23) and te28 has an unidentified ts 
defect at a late step in its replication (15, 27). 
In this study cells were infected with these 
mutants at the permissive temperature (31 °C), 
and subsequently the synthesis and processing 
of virus-specific precursor polypeptides were ex-
amined at the permissive and nonpermissive 
temperatures. At 31°C no differences in the 
processing of the gag and env gene-related pre-
cursor polypeptides were observed in cells in-
fected with either WT R-MuLV or one of the 
ts mutants (Fig. 1, 2, 4, 5, and 6). However, at 
39°C, a blockage in the processing oí agog gene-
related precursor polypeptide of the mutants 
tel?, f.s-25, f,s26, and ts29 was observed (Fig. 2, 
3, 4, and 5). When the temperature was shifted 
down to 31°C after pulse-labeling the cells at 
39°C, processing of the gag precursor polypep-
tides to the internal structural virion polypep-
tides p30 (Fig. 2, 3, 4, and 5) and pl5 (Fig. 3) 
was observed. The impaired processing of the 
gag precursor polypeptides at the restrictive 
temperature was localized beyond #a#-pr(i5, 
since #a#-pr75 disappeared but gag-pr(io accu-
mulated and p30 was not produced (Fig. 2, 3, 4, 
and 5). In all analyses, impaired production of 
pl2 and plO escaped detection, since these virus-
specific polypeptides were not recognized by the 
anti-K-MuLV serum. However, presumably 
none of the gag gene-related structural polypep-
tides is produced at 39°C since all four subgene 
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FIG. 5. Thermosensitive processing of gag products of ts29 and concomitant failure to produce the env 
gene-related product ρ i 2(E). NIH/3T3 cells infected at ЗГС with ts29 were pulse-labeled for 30 min with 75 
μ Ο of i.-f^S]methionine, and radioactivity was chased for various times as indicated (A-L). Pulse-chase 
experiments were performed at 31°C (Α-D) or 39°C (F-H). The temperature was shifted from 39 to 31°C 
(I-L), as described in the text (see also legend to Fig. 2). Virus-specific polypeptides were analyzed as 
described in the legend to Fig. 1. Immunoprecipttation with: anti-R-MuLVserum (A-L). 
products, pl5, pl2, p30, and plO, are present in 
the smaller gag precursor polypeptide gag-pr65 
(van Zaane, thesis). This conclusion does not 
exclude the possibility that eventually gag-pr65 
is degraded and may give rise to an incomplete 
set of gag subgene products (cf. Barbacid et al. 
[2]). The impaired processing of the gag precur­
sor polypeptide of ts2b and Лч26 is consistent 
with the observations of Stephenson et al. (19). 
The presence of the same defect in the mutants 
tsYJ and r.s29 is quite unexpected, since both 
were characterized as early mutants (class I). In 
the case of Лч29 the early replication defect is 
associated with a thermolabile reverse transcrip­
tase (23). Further evidence for a second replica­
tion defect in Лч29 is obtained from an electron 
microscopic study by Yeger et al. (27). 
Upon a shift to the nonpermissive tempera­
ture after infection at the permissive tempera­
ture, these authors found an accumulation of 
immature virions at the cell surface. The im­
mature virions were in an early stage of budding, 
suggesting a replication defect at an early stage 
of virion assembly. Whereas cultures infected 
with ts\l, f,s25, fs26, and f.s-29 revealed an im­
paired processing of the gag precursor polypep­
tides at the nonpermissive temperature, produc­
tion of the em gene-related polypeptide pl2(E) 
was also inhibited (Fig. 2, 3, 4, and 5). It is not 
yet clear whether or not there is a relation 
between these defects. For instance, the defect 
could be primarily in virion assemblage, and, as 
a consequence, the cleavage of different precur­
sor polypeptides could be blocked. As discussed 
above, two of the mutants of this phenotype 
( ts 17 and ts29) possess an additional early defect 
on the basis of which they were listed as class I 
mutants. Again, it is not known whether they 
are double (or triple) mutants or single pleio-
tropic mutants. 
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Finally, the structural polypeptides of ts28 are 
produced normally at the restrictive tempera­
ture (Fig. 6). However, the distorted morphology 
of the virions formed at 39°C (27) suggests a 
defect in a late stage of the assembly. 
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CHAPTER V 
TRANSLATION OF """YPE-C VIRAL RNAs IN XENOPLS LAFVIS OOCYTES: 
EVIDENCr THAT THE 120,000 MOLECULAR WEIGHT POLYPRO^EIN EXPRESSED 
IN ABELSON LEUKEMIA VIRUS TRANSFORMED CELLS IS VIRAL CODED 

TRANS LA" I ON CF TYPE-C VIRAL RNAs IN XE40PUS I.AEVIS OOCYTES: 
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SUMMARY 
The genomic RNA of Abelson leukemia virus (AbLV) has been purified and 
translated in Xenopus laevis oocytes. ~he эгіпзгу AbLV-speci£¡c p-otein 
synthesized is a polyprcteir cor-espcndi ng in rrolocular weight (Mr) and 
¡rrrunologfc properties to a previous I y-desc-ibed, ρ 15 and p12 containirg 
110,000-130,000 Mr polyprctein expressed in AbLV-t-ansformed cells. Ir 
ν i^ ro translation of woolly monkey sarcoma virus (WSV) genomic RNA resul­
ted in syntnesis o x a 55,000 Mr ao'ypro^eir analogous to a э-ote'n expres­
sed in WSV-transformed cells containing woolly helper-virus p30, ρ 15 and 
103 
ρ 12. These findirgs estabi¡sn -he viral-coded na'u^e of the nonstructural 
component of the polyprotein expressed in AbLV-transformed cells and indi-
cate that a polyproteir contairing structural and nonstructura' components 
is either not present in WSV-transformed cells or Is subject to rapid 
post-trans I ationaI c'eavage. 
Wamnalian RNA type-C transforming viruses irduce tumors of a variety of 
histologic type in vivo, frequently cause morphologic al~eration of embryo 
fibroblasts in cell culture, and require leukemia helper viruses for com-
pletion of their replicatlor cycle (1). These -ер I i cat ion-defect i ve viru­
ses appear to represent recorrbi rants between a portion of +he leukemia 
helper virus депоте and cellular genes coding for mal'gnart transforTation 
(15, 20). In view of the poss¡bilí_y that the cellulai—acquired transfoi— 
ming sequences of sjch viruses тау эе etnologica I I y irvolved in spontane­
ous tumors of their natural hosts, efforts have been undertaken to iden­
tify and develop immunologic assays for their trans I ат lena I products. 
Cell lines nonproduct i vel y-transforrred by each of several such viruses, 
including one isolate of cat origin, namely fe.ine sarcoma virus (FeSV) 
(6, 18) and two mouse-cerI ved viruses, ADelson murine leukemia virus (AbLV) 
(9) and the T-8 MCF AKR-derived leukemia virus (13), express polyproteins 
of 100,000-130,000 t-'r containing the two amino terminal gag-gene proteins, 
ρ 15 and p12. In the feline system, the FeSV-associateG 130,000 Mr polypro­
tein is efficiently ¡mmuroprec'pltacI e by select FeLV-absorbed cat sera 
with high-titered antibody directed against the feline oncornavirus-asso-
clated cell membrane artigen (F0CVA) (17, IS) raising tne possibility 
that this polyprotein may contain transformation (src)-specific sequences. 
In ar effort to resolve whether the ronst^uc^ural coTporents of such poly-
proteins are coded in entirety by the transforming virus genome, we have 
undertaken to translate AbLV genomic RNA in Xenopus I aevi s oocytes. A. si-
rrilar approach is used for characterization of translat iona I product(s) 
of a sarcoma virus isolate of woolly топкеу origin. 
Viruses used were sucrose gradient-purified preparations obtained through 
the courtesy of Dr. R.V. Gilder (Frede^'ck Cancer Research Center) ard 
included Rauscher murine leukemia virus (R-MuLV) grown on JLS-V9 cells 
ard the WR334 strain of woolly morkey virus (WSV) propagated on normal 
rat kidney (NRK) cells. This latter virus consists of approximately equal 
104 
titers of repli cat:on-defeet i ve WSV and amphctropic mouse helper virus 
(16). Superinfection of an AbLV nonproducti vel y transformed mouse cell 
line, ANN-1 (14) with wild mouse anphotropic type-C virus, 4070-A, gene-
-ously provided by J.W. Hartley, NIA'D (5), led to prcduc*ior o* v'rus 
stocks containing approximately equal infectious titers of leukemia hel-
per virus and Dseudotype virions containing the AbLV-geiome in the ampho-
tropic virus coat. A rat cell line nonproductive!y transformed by WSV, 
designated WSV-NRK in the present study, was provided by E.M. Scolnick, 
NCI. 
Viral genomic RNA was extracted by resuspension of 5-10 mg pelleted virus 
in TNE buffer (COI M _ris-HCl, ph 8.0, ]% NaC:, C.001 M ED~A) conta'ning 
1% sod i urn dodecyl sulfate (SUS), 0.5 mg/ml pronase (Calbiochem, La Jol la, 
Calif.) anc \% ß-mercaptoe-hanol. The sample was incubated at 37 for 30 
min prior тс sed'mentation through a 15-35? (w/w) sucrose gradient in TNE 
at 40,000 rpm fc- 5 hrs at 4 ina SW-41 rotor. Gradients were fractioned 
usifg an ISCO Density Grac'ent Fracticrator Vodel 640 (Lircoln, Neb.) and 
absorbance at 260 nrr was recorded by an ISCO Model UA-5 Absorbance Moni­
tor. Appropriate f ••act" ons were pco'ed, and precipitated twice with 2 
volumes of ethanol and 0.1 volume of 2.0 M sodium acetate, pH 5.0, at 
-20 . RNA was pelleted 'rom the alcohol by ce">tr'fugar'on at 8,000 rpm 
at -20 in a Servali SS-34 rotor. After removal of the alcohol, the pel­
let was dried briefly in a dessicator under vacuum before resuspension 
of the RNA in H„0 to a concentrat'on of 1 mg/ml. 
Female Xenopus laevis frogs were acquired from C.W. Fletcher, Hampstead, 
Md. After removal from the frog, oocytes were ma'ntaired in Barth's me­
dia (4) and injections were performed using an MM 358 Special Microposi-
t'orer (Bunton Instruments, Rockville, Vd.) and a 10 pi syringe attached 
to a micrometer screw. Oocytes were injected with 40 nl of the RNA solu­
tion, incubated for 20 hrs at 20 in 5 μΙ Barth's media containing 1 mCi/ 
ml i H)-leucine (New Fnglard Nuclear, Boston, Mass. ) (>110 Ci/mmol), 
washed 3 times with unlabeled Barth's media and dounced in 250 ul PBSTDS 
(10 mM NaPO., pH 7.2, \ .0% T-iton X-1C0, 0.9? NaC1 , 0.5Í? deoxycholate and 
0.\% SDS) buffer containing 0A% leucine. Following clarification of the 
extracts to remove lipid anc cell debris, 2 χ 10 trichloroacetic acid 
precipitable counts were incubated with 5 μΙ antiserum in order to immuno-
Drecipitate vi ral-speci f *c trans'at ional products. After 12-15 h>-s, 50 μ I 
of a 20% suspension of 3rcteir A-Sepharose CL-4B (Pharmacia, Piscataway, 
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(Ί. J.) in ^ BSTDS was added to absorb the immure complexes. Sepha-ose-
bound protein A immune complexes were washed three times in PBSTDS buf­
fer, resuspended in 20 μ I sample buffer (0.0625 M Tris-HCI, pH 6.7, \% 
SOS, 10$ glycerol, 2.5% ß-mercaptoerhanoI ard 0.1$ bromophenol blue), 
heated for 2 τ in at 90 , and analyzed by sod ' jrr dodecyl su Ifate-oolyacryI-
amide gel electrophoresis accordirc to LaemmI i (7) or 5 to 20$ Polyacryl­
amide gradient gels. Radioactivity was visualized by scintillation auto­
radiography (3). 
Competition irrrunoassays for woolly monkey leukemia VÍTLS (WLV) structu-
ral proteins including p30, p15, p12 and plO were performed according to 
previously-described methods (19). These assays measure the ability of 
unlabeled viral antigens, titrated at serial twofold dilutions, to com-
125 pete witn I - ! abe I ed viral proteins for binding limiting aTOunts of 
antiserum directed against detergent-cisrjpted WIV. 
Initial studies were undertaken to pur'fy and characterize R-MuLV, WB334 
and AbLV(4070-A) genomic RNA. The RNA profile obtained from SUS-pronase 
treatment of density-gradient purified R-MuLV and subsequent sedimentation 
tnrough a 15-35? (w/w) succose gradient (Fig. 1A) shows a single prominent 
peak of absorbancy at 260 nm in the 70S region of the gradient. WB334 
RNA similarly purified gave a major peak of absorbarcy at around 70S in 
addition to a slower sedimenting peak of absorbancy in the 45-50S region 
of the gradient (Fig. IB). This latter peak has been shown by Scolnick 
et a I . (16) tc contain genetic sequences ccrrespord irg to those c1- the 
woolly sarcoma virus genomic RNA, while the 70S peak represents the ampho-
tropic helper virus RNA. While Abl_V(4070-A) pseudotype virion RNA was also 
characterized by a peak of absorbancy in the 45-50S region and in the 70S 
region of the gradient this was not as well resolved as with R-MJLV or 
WB334 RNA (Fig. 1С). 
Fractions 'rom The 70S region of the R-MuLV RNA gradient were alcohol-
precipitated, redissolved in water at a concentration of 1 mg/ml, and 
irjected into Xenopus laevis oocytes as described in Methods. After in-
Fig. 1) Sedimentation profiles of RNA extracted from A) R-MuLV; B) WB3Z4; 
C) AbLV(4070-A) density gradient-purified virus. The RNA was subjected 
to centri fugati on through 25-35% (w/w) sucrose gradients at 40,000 rpm in a 
Beekman SW 41 rotor for 5 hrs at 4 . Gradients were collected from the top 
by displacement with 60% (w/v) sucrose in 0,5 ml fractions. Fractions used 
for translation in the oocyte system were A) 13-17; B) 11-13 and 15-18; 
and C) 13-18. 
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cubation of the oocytes in ( H)-Ieucine-I abel ing media, extracts were 
subjected to immunoprecipitation by various sera in order to separate the 
virus-specific proteins from the endogenous translation products. Immuno-
precipitates were analyzed on SDS-polyacryI amide slab gels and the protein 
bands visualized by f Iuorography. As shown in Figure 2, the major product 
of R-MuLV RNA translation was a 65,000 Mr protein which was ¡mmunoprecipi-
tated by antisera directed against disrupted R-MuLV p30, p15, ρ 12 and plO 
but not by either normal goat serum or by anti-R-MuLV gp70 (Fig. 2A-G), 
and therefore appears to represent the previously-described 65,000 Mr 
R-MuLV gag-gene coded precursor polyprote i η (10,13). 
A B C D E F G H I J K L M N 
Pr 65 gag w Jii 
135,000 
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Fig. 2) Immunoprecipitation and SDS-PAGF analysis of ( H)-leuaine-labeled 
viral proteins translated in Xenopus laevis oocytes from R-MuLV (Α-G) and 
AbLV (4070-A) pseudotype (Η-N) genomic RNA. Sera included goat anti-R-MuLV 
(A, H); anti-R-MuLV gp?0 (B, I); anti-R-MuLV pZO (C, J); anti-R-MuLV pl5 
(D, K); anti-R-MuLV pl2 (E, L) ; anti-R-MuLV plO (F, M) and normal goat 
sera (G, N). 125i-labeZed molecular weight standards included ζ,-galactosi-
dase (135,000) bovine serum albumin (69,000) and R-MuLV p30 (20,000). 
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The appearance of protein bands at 30,000, 15,000 and 12,000 Mr, which 
were efficiently irmunopreci ρ ¡tabi e by antisera α i rected against R-MulV 
рЗО, ρ15 and ρ12, respectively (Fig. 2С-Г), demonstrates post-trans Ia-
tional cleavage of a portion of the pr65 into its compenent structural 
proteins and defines the specificities of the antise-a used. For instance, 
while p30 was the major protein precipitated oy ant¡-R-MuLV рЗО, a smal­
ler amount of ρ 12 (Fig. 2C) was also observed. Anti-R-XuLV p15 was the 
least specific of the sera used in that it precipitated not only p15, 
but also рЗО and ρ 12 (Fig. 20). In contrast, an^i-R-MuLV p12 only recog­
nizee p12 (Fig. 2E), while anti-R-MuLV plO did rot precipitate рЗО, p15 
or ρ 12 to significant extents (Fig. 2 C ) . While this 'atte^ serum did pre­
cipitate plO, the band was not sufficiently intense to be seen in the 
gel shown ir Figure 2. 
In both mink and mouse cells nonp^oducti vely-transformed by AbLV, we have 
previously reported the expression of a 110,000-130,000 Mr polyprotein 
containing MuLV ρ 15 and ρ 12 as well as a possible transformation-specific 
nonstructural component (9). In addition, a 25,000 Mr intermediate clea­
vage product containing p15 and ρ 12 as well as lesser amounts of p15 and 
ρ 12 ir a fully processed form were observed (9). Translation of AbLV ge­
nomic RNA, in the present study resulted in synthesis of a 120,000 Mr 
polyproteir which was efficiertly immuroprec'ρ itated by antisera to de­
tergent-disrupted R-MuLV, anti-R-MuLV ρ 15 and anti-R-MuLV p12 but not by 
anti-R-MuLV plO or gp70 (rig. 2H-N). This latter protein coelectrophoresed 
35 
with a high Mr ( S)-methion i ne-I abel ed polyprotein ¡mmunopreci ρitable 
from AbLV-transforrred mink cells by eithe·- anti-R-yjLV ρ 12 of p15 (cata 
not shown). While the AbLV-specif¡с polyprotein was also ¡mnunopreciρ¡ta-
ble, although to a lesser extent by anti-R-VuLV рЗО, this latter serum 
also contained significant anti-p12 reactivity (Fig. 2C). Thus the ques­
tion as to whether the AbLV-specific oolyprotein conta'ns a portion of 
MuLV рЗО remains unresolved. In addition to the 120,000 ^r polyprotein, 
translation of genomic RNA from AbLV(4070-A) pseudotype virions 'n the 
oocytes system resulted in synthesis of a 65,000 Mr precursor polyprotein 
analogous to that obtained frorr translation of R-MuLV genomic RNA anc pre­
sumably representing a trans lational product of the 4070-A amphotropic 
helper virus genome. In contrast tc +he extensive processing of the R-
MuLV gag-gene coded precursor polyprotein, Pr65, no significant post-
trans I aziona I cleavage of the 120,000 Mr AbLV-soecI fic polyprotein was 
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observed. These f i n d i n g s thus i n d i c a t e t h a t in t h e oocyte in v : t r o Trans­
l a t i o n system, AbLV депотіс RNA codos f o r a p o l y p - O t e ' η s i m i l a r in mole­
c u l a r weig-r and immunologic p r o p e r t i e s t o t h a t expressed in A s L V - t r a r s -
formed eel I s . 
S t u c i e s were next extendec t o a n a l y s i s of t r a i s I a t ionaI products of WSV, 
the c n i y p r i m a t e - c e ^ ! v e d mammal¡ar t r a n s f o r m ! r g v r u s ' s o l a t e p resen t l y 
a v a i l a b l e . Molecular s ize ana l ys i s of r a t c e l l s nonproduct i v e l y - t r a n s -
xormed by WSV ^evealed a major peak of a n t ' g e n i c r e a c t i v i t y a t 55,0C0 v r 
c o n t a i r i n g WLV p30, p15 and p12, a 40,00C Vp peak с о п т з і п ' п д p30 and p12, 
and a 25,000 Mr peak c o n t a i n i n g ρ 15 and ρ 12 ( F i g . 3 ) . Lesser amounts of 
p30, pi 5 and ρ 12 were observed in a f u l l y cleaved f o r T . S i m i l a r l y , a ma­
j o r 55,000 Mr precursor p o l y p r o t e i n c o n t a i n i n g WLV gag-gene coded s t r u c ­
t u r a l corponents was detected by SDS-PAGE a n a l y s i s of С S)-net h¡on ine -
labeled WSV-transforTed r a t c e l l s (data not shown). Moreover, i n o c u l a t i o n 
of the slower sediment ing 45S-50S WB334 RNA descr ibed in Figure 1B in to 
Xenopus laev is oocytes resu l t ed in s y r t h e s i s of a major p r o t e i n at arourd 
55,000 Кг which was ¡гшіьпоргесі ρ ¡ t ab le by an t i se ra to ce te rgen t -d i srupted 
R-MuLV, WLV, R-MuLV p30, and t o a l i m i t e d ex ten t by h i g h - t i t e r e d a n t i - R -
MLLV plO ( F i g . 4 F - I ) . In c o n t r a s * , t r a n s l a t i o n of the more r a p i d l y s e d i -
menting (70S) v i r a l RNA resu l t ed in s y r t h e s i s not cn i y of the 55,0C0 Mr 
p o l y p r o t e i n , but a lso a 65,000 Mr p ro te in which was p r e c i p i t a b l e by a n t i -
sera t o de te rgen t - c "s rup ted R-MuLV, WLV, R-MuLV p30, and R-MuLV э10, but 
Fig. 3) Molecular size analysis of helper virus-specific antigens expres­
sed in WSV transformed cells. Twenty mg cell extract, prepared by sonica-
tion of cells for 20 sea in an equal volume of 10 mM Tris-HCl, pH 7.8, 
buffer containing 100 mM NaCl, 0.S mM EDTA, and 0.5% Triton X-100 was 
clarified by centri fug ation in a Beekman type-30 rotor for 60 min, 
lyophilized, resuspended in 1 ml of 0.05 M Tris-HCl, pli 8.5, buffer con­
taining 8M guanidine hydrochloride (GuHCl), 1 mlA EDTA, and 20 mM 
dithiothreitol (OTT), heated at 45 for 30 min and applied to an A-15 m 
agarose (100-200) mesh, (BioRad) column (1.5 by 90 cm) in the presence of 
6 M GuHCl, 0.01 M OTT and 0.02 M sodium phosphate buffer (pH 6.5). One ml 
fractions were collected and tested at serial twofold dilutions in compe­
tition immunoassays in which antibody to density gradient purified WLV 
was used for precipitation of IZSl-labeled WLV A) p30; B) pl5; and C) pl2. 
Results are expressed as the percentage of total antigenic reactivity in 
each fraction and are based on the degree of displacement of competition 
curves relative to known standards. "ί^Ι-labeled molecular weight markers 
included tracer amounts of boline serum albumin (69,000), R-MuLV p30 
(30,000) and R-MuLV pl2 (12,000). The vertical dotted lines represent the 
elution positions of Pr55 (p30, pl5 and pl2), Pr42 (p30 and ρ12) and Pr25 
(plb and pl2) WSV-coded gag-gene precursors. 
I l l 
not by normal goat se-um (Fig. 4A-E) indicating it то represent an anpro-
tropic gag-gene coded polyprotein analogous to that shown in Figure 2. 
No evidence for a high (>55,000) Mr polyprotein containing WLV structural 
compenents was obtainec either эу analysis of WSV transformée cells (Fig. 
3) or by in vitro translation of the WSV genome (Fig. 4). 
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Fig. 4) Immunopreoipitation and SOS-PAGE analysis of ( H)-leucine-ldbeled 
viral proteins translated in Xenopus laevis oocytes from WB334 70S RNA 
(A-EJ 'and WB334 4S-S0S RNA (F-I). Sera included normal goat (A); anti-R-
MuLV (B, F); anti-R-MuLV plO (C, G); anti-R-MuLV p30 (D, H) and anti-WLV 
(E, J). 125l-labeled molecular weight standards include (¡,-galactosidase 
(135,000), bovine serum albumin (69,000) and R-MuLV p30 (30,000). 
In the present study we repor t in v i t r o t r a n s l a t i o n of the genomic RNA of 
two rep resen ta t i ve -"ep I i cat ion -de fec t i ve mammalian t rans fo rm ing v i r u s e s , 
one (AbLV) of mouse, and the second (WSV) of pr imate o r i g i n . AbLV-t rans-
formed c e l l s express a 110,000-130,000 Mr precursor p o l y p r o t e i n con ta in i ng 
MuLV p l5 and p l2 and nons t ruc tu ra l componert(s) c o n t a i n ! r g poss ib le t r a n s -
fo rmat ion ( s r c ) - s p e c i f ¡ с sequences ( 9 , 12). Suggest ive evidence t h a t t h e 
n o n s t r u c t u r a l component(s) of t h i s l a t t e r p o l y p r o t e i n i s AbLV-speci f ic 
was oDtained by t n e demonstrat ion of i t s express ion in both mouse and 
mink c e l l s non-product i vel у t ransformed by AbLV ( 9 ) . More d i r e c t evidence 
f o r t h e v i r a l - c o d e d n a t u r e of t h i s p o l y p r o t e i n was o b t a i n e d in t h e p r e ­
sent study by ' t s in v i t r o t r a n s l a t i o n f o l l o w ' n g i n o c u l a t i o n of AbLV ge-
112 
nomic RNA '. n^o XeropLS laevis oocytes. An al xe mar 've, although less 
likely possibility, is that the AbLV polyprotein represents a transla-
tional product of a spliced T.RNA species containing genetic sequences 
corresponding to the 5' terrrinus of the AbLV gag-gene covalently linked 
to cellular sequences located adjacent to the integrated viral genome. 
Precedent for spliced type-C viral messenger RNA species containing non­
contiguous RNAs has been recently reported (8, 11). If the latter were 
the case, however, it would be necessary to postulate either the incor­
poration of this spliced mRNA species into pseudotype virions with equal 
efficiency as the amphotropic helper virus genomic RNA or, alternatively, 
less efficient incorporation but more efficienT translation of the spliced 
mRNA. 
As ir the case of AbLV, type-C transforming viruses such as FeSV (17, 18) 
and T8-MCF (12) also express polyproteins which contain both structural 
ana nonstructural components. In contrast to """hese viruses, however, the 
WSV gerome codes both in ν i vo and in ν i tro for a protein of around 55,000 
containing WLV p15, p30 and ρ 12. The fact that tnis latter protein was 
weakly immunopreci ρ¡tabi e by anti-R-MuLV ρ 10, but failed to conpete in 
a hignly sensitive ρ 10 competition imnurcassay suggests that it nay con­
tain a small portion of WLV p10 and thus, presumably the p30-p10 cleavage 
+ -
зіте. In this respect, WSV closely reseTbles the S L strair of Voloney 
murine-sarcoma virus (2, data rot shown). The inab'lity to demorstrate 
a precursor роіурготеіг either in WSV-trarsformed cells or by in vitro 
translation of the WSV genome may indicate either that such a protein 
does not exist, or alternatively, that it is subject to rapid post-t^ans-
lational processing and that its norstructuraI component, presumably 
containing transformation-specific sequences, is no-1" recognized by pre­
sently available antisera. If the latter n-odel were correct, the trans­
lation of a nonstructural WSV-coded protein in Xenopus laevis oocytes, 
at levels coordinate with those of the WSV gag-gene proteins, would be 
predicted. Such a protein snoula be aetectaole in a fully cleaved form 
in the event that appropriate sera for its recognition Ьесоте available. 
The possibility, however, tha~ the WSV-transforming protein is coded by 
a spliced mRNA species, aralogoLS to that coding for type-C viral enve­
lope glycoprotein (Э, 11) which does not become incorporated into mature 
virions, cannot be excluded. 
The results of tne present study thus provide direct evidence favoring 
из 
the possibility that the nonstructural portion of the 110,000-'30,000 
Mr polyprotein expressed in AbLV-transformed cells is viral-coded. The 
ability both in the present, and in previous studies, to identify trans­
forming virus-coded precursor polyproteins containing structural and 
nonstructural components has been I inrted to those transforming viruses 
which code only for ρ 15 and p12. The in vitro translation system descri­
bed should facilitate further analysis of such viral-coded polyproteins 
and may provide a means of testing sera from various sources for anti­
body directed against their nonstructural components. 
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CHAPTER VI 
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DNA RELEASE PRCGENV VIRUS INFECTIOUS AT THE NCAPERMISSI VE TEMPERATÜRE 
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SUMMARY 
The isolation is described of infectious procer.y murine leukemia virus 
(MuLV) from cells infected with temperature-sensitive MuLV and trans-
fected with wild-type MuLV proviral DNA. fragments synThesized in vitro. 
DNA fragments were synthesized in the presence of actinomycin 0 by pri­
ming the endogenous reverse transcriptase reaction of purified Moloney 
MuLV with added random ol igodeoxynucl eoti ces obtained from DNAse digested 
Present address: NCI, Frederick Cancer Research Center, Frederick, 
Maryland 21701, USA. 
*To whom requests for reprints should be addressed. 
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calf thymus DNA. Recipient cultures of mouse errbryo fibroblasts were 
treated with DNA fragments after infection w;th ar early yeTpe^ature-
sensitive mutant of Rauscher MuLV (Mutant ts29) defective in reverse 
transcriptase and in the process'rg of the gag-precu"sor polypeptides. 
Infectious progeny virus replicating at the nonpermissive temperature 
was isolated. 
INTRODUCTION 
In 1972, hill and Hi I lova demonstrated that susceptible chicken cells 
undergo morphological transformât'on and produce infectious progery 
ROJS sarcoma virus upon treatment witn DNA isolated fron Rous sarcoma 
virus infected cells (1,2). Extensive studies have been carried out on 
t^ansfection with DNA ext^ac^ed f^ om cells infected with oncoviruses 
of several groups (for reviews see Graham (3) and Hill and Hi I lova (4)). 
With sensitive methods available for detection and characterization of 
progeny viruses, the transfection technique appeared to be ar useful 
tool for the study of the properties of integrated proviral DNA and a 
number of aspects of the interaction between cells and viruses. However, 
experiments designed in this way are limited to the study of DNA that 
cortains intact viral genoTes, since subgenomic v'ral DNA fragments did 
not give rise to the release of infectious virus (5,6). Cooper and Cas-
tel lot (7,8) overcame this limitation in marker rescue exper'ments. In 
these experiments, They transfected recipiert cells wiTh subgeromic 
viral DNA fragments isolated from cells infected with wild-type Rous 
sarcoma virus and, a-ter infection with ts mutants and a subsequent 
shift to the nonpermissive temperature, they selected for virus of the 
wild-type phenotype. 
Using the same approach, we have investigated whether treatment of eel Is 
with proviral DNA fragments of wild-type Moloney MuLV syrthesized i η 
vitro in combination with infection with a thermosensiti ve mjtant of 
Rauscher MuLV could give rise to the production of progeny virus repli­
cating at the rest^'ctive temperature. 
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MATERIALS AND METHODS 
Cel I s_and_v_[ruses 
NIH-3T3 cells (the clonal line NCL5611P3) were grown in Dulbecco's modi­
fied Eagle's med i urn or in Eagle's basal medium supplemented with 10? fe­
tal calf serum (Grand Island Biolog'cal Co, Biocult, Ltd). 
Clonal isolates of wild-type Moloney MuLV, wild-type Rauscher MuLV and 
temperature-sensітіve Rauscher murine leukemia virus (mutant ts29) were 
used. Ts29 is an early mutant, which is defective in polymerase and pro­
cessing of the gag-precursor polypeptice (9,10,11). 
Pre2aratj_on_of DNA 
To obta'n high molecular weight DNA from cells ¡rfected with murine leu-
kemia virus, the DNA extraction procedure of Gross-Bel Iard et a I. (12) 
was used. After extraction, the DNA was precipitated with two volumes 
of ethanol, sterilized by submerging the precipitate in 10% ethanol over-
night at 4 C, dissolved 'n 0.1 χ Standard Saline Citrate and stored at 
4 С The DNA preparation had an A_,.:A__- ratio of 1.8 to 1.9 and a mole-
cular weight of about 50 mil':on daltons as déterminée by centri fugat¡on 
in a neutral sucose gradient (13). 
DNA fragments of murine leukemia virus were synthesized in the presence 
of actinomycin D according to the procedure of Fan and Baltimore (14) 
using the endogenous reverse transcriptase reaction of purified mur i re 
leukemia virus with added random ol igodeoxynucleotides from DNAse-diges-
ted calf thymus DNA as a primer (15). The purified reaction product was 
precipitated with two volumes of ethanol and stored at -20 C. As deter-
mined эу agarose gel e Iectropnoresis (16), the average molecular weight 
5 
of the DNA fragments was about 2 χ 10 daltons. 
Transfect ion and virus rescue_assay_ 
In transfec'tion experiments, NIH-3T3 cells were plated in Dulbecco's 
modified Eagle's med ' um ar a density of 10 cells pe-- tissue culture 
2 
flask (Falcon Plastics, 25 cm ). Twenty four hours later the med i um was 
removed and 4 ml of freshly prepared Eagle's basal Ted i um (pH 7.05) was 
added to the cells, immediately followed by inocculation of 1.0 ml of a 
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DNA-calcium phosphate suspension (17), which was freshly prepared accor­
ding to the procedure of Graham and Van der Eb (18). Unless otherwise 
noted, DNA (with or without carrier calf thymus DNA) was adjusted to 
100 ug/rrl in HEPES buffer (pH 7.05) (18) and sheared by forcing it in 
and out 10 times through a 21 gauge needle, both before and after calcium 
phosphate precipitation. F'fteen hours after DNA inoccuI at ion, the cells 
were washed twice and medium was replaced by Dulbecco's modified Eagle's 
medium containing polybrene (2ug/ml). When cells became confluent, they 
2 
were passed to 75 cm tissue culture flasks. When these cells became con­
fluent they were passed at a dilution of 1:10 for the first suocul^ure 
and, thereafter subcultures were made at the same dilution every five 
days. Release of virus was assayed by reverse transcriptase assay using 
poly(rA) and ol igo(dT).__.„ (Collaborative Research) as described by 
Stephenson et a I• (19). 
In virus rescue assays, cells, plated 24 hours before in Dulbecco's modi-
5 
fied Eagle's med i urn at a density of 10 cells per tissue culture flask 
(Falcon Plastics, 25 cm ), were infected at 31 С with Rauscher murine leu­
kemia virus ts29 at a multiplicity of irfection of about ore. Afte"" incu­
bation for 90 minutes the cells were treated with DNA fragments as des-
crioec above and incubation was continued at 31 C. After six hoj^s tissue 
culture medium was replaced and cell culturing was continued in Dulbecco's 
modified Eagle's med!UT. Twenty four hours later, the temperature was 
shifted to 39 C. Cells were subcultured as described above and virus pro­
duction at 39 С was assayed by the reverse transcriptase assay as already 
described. Supernatant media harvested from cells growing at 39 С and 
producing virus at that temperature, were assayed on fresh cells at 39 С 
to select for progeny able to initiate infection at the nonpermissive 
temperature. 
|mmunogrec22ltat_[on_and_£oJ_y_açryJ am|de g.e_[_e_[ectrophores^s 
Murine leukemia virus-specific polypeptides were detected by the radioim-
munoprecip¡tat ion procedure as described previously (11). Antiserum di-
rected against bovine serum albumin (BSA), against disrupted Rauscher 
MuLV or Rauscher l^ uLV p30 were prepared and described by Van Zaane et al • 
(20). Analysis of the immunopreciρ¡tates were performed by Polyacrylamide 
gel electrophoresis according to Laemrrl i (21) on a sod i urn dodecyl sulfate 
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containing Polyacrylamide slab gel gradient. Visualization of radioac­
tivity was performed by sciητi I Iation autoracicgraphy according to Borner 
and Laskey (22). 
Rad i о immunoassay 
Conpetitior immunoassays for the structural oolypept'des ρ 12 and gp70 of 
AKR virus, Rauscher MuLV and Moloney MuLV were performed according to the 
methods described by Barbacid et al. (23) and Reynolds et al. (24). These 
assays measure the ability of unlabeled viral antigens to compete with 
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l-labeled viral proteins for binding limiting amounts of antiserum 
against honolcgous detergent disrupted murine leukemia virus. 
RESULTS AND DISCUSSION 
Although transfection with oncoviral DNA has already been described (3), 
we have performec pilot experiments in order to determine ~he optimal 
conditions for the transfection procedure and to tost the specificity 
of the transfection assay. Based upon the studies of Graham and Van der 
Eb (18) we have used the calcium phosphate precipitation procedure as 
described in Materials and Methods and according to this procedure we 
nave treated recipient cultures of NIH-3T3 cells with integrated pro-
v
;
ral DNA derived fron murine leukenia virus infected cells. The results 
are listed in Таэіе 1. Treatment of recipient NIH-3T3 cell cultures with 
100 ug of oncoviral DNA isolated from cells producing high titers of 
either wild-type Rauscher MuLV or wild-type Moloney MuLV, resulted in 
the production of progeny virus as determined by assaying the tissue 
culture medium of the second subculture for sedimentable reverse trans­
criptase activity. 
In other experiments, we have tested lower amourts of oncoviral DNA in 
the transfection assay, namely 5 and 10 ug. In these experiments onco­
viral DNA isolated from NIH-3T3 cells infected with a temperature-sen­
sitive mutant of Rauscher MuLV (mutant ts29) was used ard transfection 
was performed at 31 C. By assaying the tissue culture med i urn for reverse 
transcriptase activity p^oductlor of progeny virus was observed in both 
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'ABLE 1 
REVERSE TRANSCRIPTASE ASSAY ON TISSUE CULTURE MEDIUV CF CELLS 
TRANSFECTED WITH DNA FROM MURINE LFUKEMIA VIRUS PRODUCER CELLS 
Experi­
ment 
1 
2 
3 
4 
Control s 
A 
В 
С 
Source of DNA 
NIH-3T3 cel Is 
produci ng wi1d-
type Rauscher 
vi rus 
NIH-3T3 cel Is 
producing wi1d-
type Moloney 
ν i rus 
NIH-3T3 cel Is 
producing ts29 
Rauscher virus 
NIH-3T3 eel Is 
produci ng ts29 
Rauscher virus 
uninfected NIH-
3T3 eel Is 
Cal f tnynjs 
DNA 
No DNA 
Amount 
of DNA 
ICO vQ 
100 μα. 
5 pg 
10 ug 
100 ug 
100 ug 
Tempe­
rature 
37°C 
37°C 
31 °C 
31°C 
37°C 
37°C 
37°C 
Virus production in sub-
cu1 tures 
1 2 3 4 5 
NT 60 
N" 60 
NT 0.02 9 NT 70 
NT 6 60 NT 72 
NT <0.02 <0.02 NT <0.02 
NT <0.02 <0.02 N~ <0.02 
NT <0.02 <0.02 N T <C02 
At the temperature indicated, NIH-3T3 cells were transfected with DNA 
using the calc'um precipitation technique and reverse transcriptase as­
says were performed en tissue culture medium of subcultured cells. Re­
sults are expressed as pmole H-TMP (6000 cpm/pmole) incorporated per 
ml tissue culture fluic. All DNA samples were assayed in duplicate. 
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cases. Furthermore, as can be seen in Table 1, there is a clear relation-
ship oetween the amount of DNA transfectec (5 or 10 pg) and the amount 
of progeny virus released in the successive subcultures. Control experi-
ments w'th cells transfected with DI\A from unirfected NIH-3T3 cells, or 
transfected with calf thymus DMA as well as control experiments with 
cells treated with a calcium precipitate without DNA gave negative re-
sults. 
The use of DNA preparations from Rauscher MuLV ts29 infected cells pro-
vided a marker for assessing the specificity of transfection. We have 
studied this specificity of transfection by comparing the oncoviral gene 
expression in cells either infected witn Rauscher MuLV ts29 or trarsfec-
ted with DNA isolated from cells producing high titers of the tempera-
ture-sensitive mutant. Therefore, pulse-chase experiments were performed 
at the permissive ard nonperm¡ssive temperature and the newly synthesi-
zed virus-specific polypeptides were analyzed by sod i urn dodecyI sulfate 
Polyacrylamide gel electrophoresis after immuncprecipitaTion with anti-
sera raised against Rauscher MuLV structural polypeptides. The results 
of the ¡mrrunoprec i ρ i tat ¡on analysis a-e depicted in Figure 1. 
In NCL5611P3 cells infected with mutant ts29 the synthesis and proces-
sing of virus-specific precursor polypeptides at the permissive and non-
permissive temperature (Figure 1, Α-M) was in accordance with our previ­
ous observations using another cell line (11). In NCL5611P3 cells trans­
fected with DNA from NIH-3T3 cells producing high t'ters of mutant ts29, 
we have observed at the nonpermissive temperature the same impaired 
processing of the gag-p-ecursor polypeptide and the lack of formation 
of pi2(E) (Figure 1, N-Q). Furthermore, at 39 С no sedimentable reverse 
transcriptase activity could be detected in the tissue culture med i urn 
of these cells (results not shown). 
From studies of Chattopadhyay et a I. (25) it appea-ed that the N14-Swiss 
mouse from which the NIH-3T3 lire was derived do not contain a complete 
ecotropic oncoviral genome. That might be a reason why transfection of 
DNA isolated from un infectée NIH-3T3 cells did never give rise to virus 
production (Table 1). The lafter observation is in agreement with the 
results of Lowy et al. (26) who used DNA isolated from uninfected N!4-
3T3 cells in control transfection experiments. In recent studies the 
transfectabi I ity of integrated proviral DNA of endogenous orcovlruses 
was examined. From these studies, it appeared that DNA Isolated from 
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LEGEND TO FIGURE I 
NIH-3T3 cells were either infected at 31 С with Rauscher MuLV ts29 or transfected with integrated 
proviral 'DNA isolated from ts29 infected cells. The synthesis and processing of virus-specific 
precursor polypeptides wore examined in pulse-chase experiments at the permissive and nonperrrissive 
temperature. The synthesized virus-specific polypeptides were analyzed by sodium dodecyl sulfate 
Polyacrylamide gel electrophoresis and scintillation autoradiography after immunoprecipitat¡on with 
a polyvalent or a monospecific antiserum directed against Rauscher KuLV polypeptides. To facilitate 
the interpretation of the figure we summarize the conditions in the following table: 
-
Lane 
A 
В 
С 
D 
E 
G 
H 
I 
treatment 
infection 
„ 
" 
temp. 
31° 
11 
II 
39° 
tl 
It 
II 
31° 
It 
label 
met 
" 
ι * 
1 eu 
met 
.. 
tl 
leu 
met 
It 
anti serum 
aMuLV 
" 
11 
II 
It 
11 
It 
aBSA 
11 
Lane 
J 
К 
L 
M 
N 
0 
Ρ 
Q 
treatment 
i nfcct ion 
tl 
II 
II 
transfect ion 
M 
II 
11 
temp. 
39° 
11 
31° 
If 
» 
II 
39° 
II 
label 
met 
anti serum 
арЗО 
II 
II 
II 
ctMuLV 
арЗО 
aMuLV 
арЗО 
Note: leucine was used in two experiments instead of methionine in order to analyse the formation 
of pi5 which does not contain methionine. 
avian (27), feline (28), or baboon (29) cells gave rise to progeny virus 
only when DNA was derived from cells that were releasing high titers of 
these oncoviruses. Progeny virus production was never observed when DNA 
was derived from cells that were not releasing high t;ters of these onco­
viruses. Apparently, transfection of repressed integrated proviral DNA 
does not give rise to release of progeny virus either. 
From transfection studies with integrated proviral DNA, it appeared that 
only intact oncoviral genomes were irfectious and could give rise to pro­
geny virus release (5,6). To arswer the question whether treatment of 
cells with noninfectious proviral DNA fragments of a murine leukemia 
virus in combiration with infection with a thermosenslti ve mutant could 
give rise to the production of progeny virus replicating at the restric­
tive temperature, we have performed virus rescue assays. In these experi­
ments, we have used two different oncoviruses, namely wild-type Moloney 
MuLV for the in vitro synthesis of provi^al DNA and Rauscher MuLV ts29 
as the temperature-sensitive mutant, in transfection experiments, we have 
first examined the biological activity of the _i_n vitro synthesized pro-
viral DNA. Under the reaction conditions used for their synthesis, mainly 
low molecular weight single stranded DNA fragments (about 400 nucleotides 
in lenght) were formed (result not shewn). These proviral DNA fragments 
were approximately representative for the whole genome of the virus (Dr. 
A.J.w. 3erns, personal communication; see also reference 30). Recipient 
cultures treated with these in vitro synthesized DNA fragments of Molo­
ney MuLV were never shown to release progeny oncoviruses (Table 2). 
Apparently, the proviral DNA fragments alone were biologically inactive. 
The observation that proviral DNA synthesized in the presence of actino-
mycin D is biologically inactive was also reported by Rotherberg et al• 
(31). Despite the fact that they usod reaction conditions to synthesize 
high molecular weight DNA, it appeared from their studies that only DNA 
synthesized in the absence of actonimycin D was biologically active and 
that the biologically inactive proviral DNA syrthesized in the presence 
of actinomycin D was 0.6 kllobases shorter and missed some genome sequen­
ces (32). In virus rescue assays, recipient cultures of NH-3T3 cells 
were infected at 31 С with Rauscher MuLV ts29 and, subsequently, cells 
were treated with fragments of in vitro syrthesized DNA of Moloney MuLV. 
In these cases calf thymus DNA was added as carrier DNA. The results of 
these experiments and of the control experiments зге summarized in Table 2. 
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TABLE 2 
VIRJS RESCUE ASSAY WITH FRAGMENTS OF MOLONEY vjRiNE LEUKEMIA VIRUS DNA 
SYNTHESIZED IN VITRO 
Experinent 
1 
2 
3 
4 
5 * 
6 
7 
8 
9 
10 
Vi rus 
none 
ts29 
none 
ts29 
none 
ts29 
ts29 
ts29 
ts29 
ts29 
Calf тпу-
mus DNA 
none 
none 
50 ug 
50 ug 
50 ug 
50 yg 
50 ug 
50 ug 
50 ug 
50 yg 
Molorey virus 
DNA fragments 
none 
none 
none 
none 
0.8 pc 
0.8 ug 
0.8 ug 
0.8 ug 
0.8 ug 
0.8 ug 
Vi rus pro­
duction at 
39°C a) 
<0.02 
<0.02 
<0.02 
<0.02 
<0.02 
39 
21 
¿1 
¿0 
2* 
Released progeny 
virus infectious 
at 39°C b) 
<0.02 
<0.02 
<0.02 
<0.02 
<0.02 
NT 
13 
29 
32 
5 
NIH-3T3 cells were mock infected or infected with Rauscher MuLV ts29 at 
31 С Ninety minutes afte- infection, cultures were treated with DNA as 
indicated in the Table according to the procedure as described in Mate­
rials and Metnods. After tne temperature was shifted to 39 C, cells were 
subcultured as described in Materials and yethods. 
a) P-oduction of progeny virus was assayed by reverse transcriptase as­
say after three subcultures. Results are expressed as pmole H-TMP 
(6000 cprr/pmole) incorporated per m! tissue culture fluid and repre­
sent mean value from two separate determinations. 
b) Infectivity of "'"he progeny virus was tested at 39 С on fresh MH-3T3 
cells and virus production was assayed by reverse transcriptase assay, 
after three subcultures. 
χ) Production of progeny virus was assayed by reverse transcriptase assay 
after one subculture. 
+) Experiment performed in triplicate. 
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No progeny virus rep I icating at 39 С was produced by control cultures 
(Table 2, experiments 1 - 5 ) . Apparently, reversion of the parental ts29 
nutant did пот occur (Table 2, experiments 2 and 4). It shoulc oe noted 
that mutant ts29 is probably a double mutant (9,10,11) and even in long 
те
г
гл cultures we have never observed any reversion of this mutant (unpu­
blished observations). In contrast to the control cultures, all cell 
cultures infected with Tutant ts29 anc subsecuently "~reatec with DNA 
fragments of Moloney VuLV (Table 2, experiments 6-10) released progeny 
virus replicating at 39 C, as was determined by assaying the culture 
fluids for segmentarle DNA polymerase activity. Supernatant media о~ 
these cultures contained virus infectious at 39 С as appeared upon in­
fection of fresn NIH-3T3 cells (Table 2). Aralysls of lysates of these 
eel Is in corrpetition rad io Immunoassays for the gag-gene related struc­
tural polypeptide ρ12 and the env-geno related structural polypeptide 
gp70 revealed the presence of Moloney MuLV specific antigenic determi­
nants. In all five lysates about equal amounts of either Moloney MuLV 
ρ 12 or Moloney MuLV gp7C were fojnd and these values were similar to 
those observed in NIH-3T3 cells productively infected with Moloney MuLV 
(Vcloney MuLV irfected NIH-3T3 cells contain about 3000 ng p12 and 5000 
ng gp70 per mg total cellular рготеіп; uninfected NH-3T3 eel's соптзi η 
less than 30 ng ρ 12 and 4C ng gp70 per mg total cellular protein). No 
reactivity was observed in similar assays -or the same structural poly­
peptides of AKR virus or Rauscher MuLV. This result indicates that in 
all five cultures at least tne sequences coding for the type-specific 
antigenic determinants of pi 2 and gp70 were derived from the large excess 
of Moloney MuLV proviral DNA fragments added ;n tnese experiments. S'nee 
the Moloney MuLV proviral DNA fragments alone did not give rise to any 
progeny virus release, factors required for the observed oncovirus pro-
c'ucTicn were apparently introduced by mutant ts29. The presert cata do 
not allow any conclusion on a possible mechanism involved. It cannot be 
excluded that the progeny virus is derived from niror amounts of gerome 
lenght proviral DNA which, although not infectious alone, became infecti­
ous with the aid of an infecting oncovirus. In view of the observations 
of Rothenbe^g от al • (31 ,32) synthes's of genome lenght proviral DNA ir 
the presence of actinomycin D is rather unlikely. However, the biological 
inactivity of the proviral DNA alone may also be a corsequence of its 
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single stranded character, if at least partial double strandedness were 
requirec for infectivity. FjrThermore, it canrot be excluded that the 
progeny virus release occurred as a result of recombination between 
Moloney KuLV seqjences and Rajscher V,j'_V sequences. To study the latter 
possibility, virus rescue experiments with defined proviral restriction 
fragments are presently under :nvestigation. In This way we hope to de-
velop a method for the study of the biological activity of subgenomic 
DMA fragments. 
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S!WARY 
Oncoviruses constitute a group of widely spread oncogenic RNA viruses. 
They can irduce turners of various histológica' tyaes wher iroculated in-
to appropriate hosts. Upon infection oncoviruses convert their genomic 
RNA irto cellular genes wi~h the aid of the virjs-speci fic RNA-deperdent 
DNA polymerase or reverse transcriptase. Thus, the newly acquired genes 
are 3assed "гог parent to orogeny cell. Oncoviral geres can also be pre­
sent latently in the genomes of a large number of species, their expres­
sion apparertly being subjectec to the sarre regulatory mechanisms tha* 
affect cellular genes. Although norma I I у repressed, such endogenous 
viral genes car be activated by a variety of factors and can soTetimes 
escape from host control. Released infectious oncoviruses ran be trans­
mitted horizontally to animals of the same species. During """he course 
of evolution they can even become stably integrated in the детг line of 
species that are only remotely rela+ed phylogenet'cally. Consequently, 
oncoviruses e-able the cell to donate or to receive genetic sequences 
encapsidated into viral particles. A survey of these and other basic 
properties of oncoviruses is given in the introductory cnapter of tnis 
thesi s. 
In chapter II we describe a new method to fractionate virions into cores 
and viral envelopes. In contrast to older methods, viral envelopes could 
now be obtaired wit-iout detectable ai-ourts of core material, -lotation 
rather than sedimentation appeared to be a crucial step in the purifica­
tion procedjre. New data en the structjre of the virions were revealed 
by an electronmicroscopic and biochemical analysis of the purified frac­
tions. 
Chapter III focuses on the precursor to the viral envelope polypeptides. 
Tnis precursor pol ypep^'de is ^he pr'mary trans'at'or produc""- of the 
viral env-gene. Its post-trans lationaI cleavage is dependent upon its 
correct g IycosyIation at the level o' the nascert protein as cou ' d be 
shewn with the aie of a reversible and an irreversiole inhibitor of 
glycosyI at ion. It aopea^d from these experiments that the protein TOiety 
of the envelope precursor polypeptide has a molecular weight of about 
70,000 dal+on. 
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Chapter 'V deals with terrperature-sensit i ve mjtants of Rajscher murine 
leukemia virus. Apart from other phenotypical characteristics some of 
theT appearec to be defect in the processing of the precursor to the 
internal viral polypeptides, Pr65 , at the restrictive temperature. 
Concomí tait I y, the same mutants die not produce p'2(E), an envelope 
polypeptide coded for by the env-gene. 
Many replication-defective mammalian oncoviruses are аэіе to transform 
fibroblasts in cell culture, a property which presumably closely corre­
lates with the induction o-f tumors by these viruses. They apparently 
have acquired this property as a result of genetic recombination between 
an autonomously ^ep''eating oncovirus and genetic information present in 
the host cell. Translation experiments are the most direct way to study 
the coding properties of tne genome of these viruses. In chapter V we 
describe translation experiments with oocytes of Xenopus laevis, a pro­
tein synthesizing system krown for its faithful translating and D'oces-
sing capacity. Thus, we showed that the polyprotein expressed in Abelson 
nur'ne leukemia virus-transforTed cells was viral-coded and that it con­
tained pi 5 and pi 2 moieties derived from leukemia helper virus cova Ient-
ly linked to an unknown polypeptide sequence. Ar analogous polyprotein 
either was absent in woolly monkey sarcoma virus-transformed cells or 
was subjected to ~apid post-trans lationaI cleavage. 
Finally, in chapter VI we report that by transfection oncoviral genes can 
be introduced into appropriate recipient cells. Furthermore, usirg non­
infectious proviral DNA we could rescue oncovirus when recipient cells 
were coinfected with a temperatjre-sensiti ve oncov'rus. In a continuation 
of this study we hope to discover exactly how virus rescue took place so 
that we will be able to apply this type of experiments as a biological 
assay. 
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STELLINGEN
1
Virus specifieke polyproteinen in nonproducer cellen geïnfec­
teerd met replicatie-defectieve oncovirussen lijken in het al­
gemeen opgebouwd te zijn uit structurele en niet-structurele 
componenten. Door karakterisering van dergelijke polyproteinen 
kan de subgenvolgorde in het gag-gen van aviaire oncovirussen 
definitief bepaald worden.
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V .J .  Sk&aly an aR .R .  RtmcJueJit [1978) J .  VxAol. 26, 
380-388.
II
Karakteristieke eigenschappen van de 5'-terminale nucleotide 
sequenties in het genoom van type-C helper virussen maken con­
servering van deze sequenties in gerelateerde recombinant on­
covirussen waarschijnlijk.
L.C. WcuteAA, B.C. Maltin, T. Ho and W.K. Vang [1975] 
?ftoc. Hatt. Acad. Sca.. U.S.A.  72, 2155-2159.
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E. RotkmboAg, V .J .  Vonogkue. a W  V. Ba&ttmosie [1978] 
CeLt 13_, 435-451.
III
Het is betreurenswaardig dat Kirkwood zijn beschouwing geti­
teld "Evolution of ageing" in de laatste alinea ontsiert door 
de volgende ongefundeerde veronderstelling:
"...we may hope to gain insight into the abnormalities represen- 
ted by (....) the apparently immortal transformed cells of ma- 
lignant tumours. It may, for example, be possible that oncoge- 
nic viruses interfere with these processes (commitment of cells 
to limited growth) to enhance the accuracy of their own repli- 
cation in a way that restores some error-committed cells to 
stability".
T.B .L .  Klnkwood (1977) Noïivkl 270, 301-304.
IV
De juistheid van de door Okasinski en Velicer geponeerde 
translatie volgorde voor de interne structurele eiwitten van 
katte-leukemie virus moet betwijfeld worden.
G.F. OkaiJ-nskZ and L.E. I/eJUceA {1977}
J. V-óioZ. 22, 74-85.
V
Uit de qualitatieve variatie in expressie van het gag-gen in 
nonproducer cellen getransformeerd door verschillende sarco- 
mavirus-isolaten mag men niets afleiden omtrent de eventuele 
afwezigheid van bepaalde leukemievirus specifieke sequenties 
in de sarcomavirus-genomen.
K.C. Robb-Lyu>, H. Oka.be, S.R.  TA.oiu.ck, R. I/. Geiden 
and S.A. Aanonion [1978] J. IIa J lo I .  25j  471-478.
VI
De lymfocyt is als testsysteem voor het meten van de genetisch 
bepaalde gevoeligheid voor longkanker door sigarettenrook niet 
zeer geschikt.
8. PaZgen, H.L. GuJitoo, 3 . flinowad and K. Paigen 
ln:MicAoAom<u> and dAug oxA.datx.oni). Pn.ocee.cU.ngA o{ 
tke TfuAd International Sympo^^um, BQALin, Jaly 
1976. EcU>.:V. UWxLch, 1. Rooti, A. HiJLdeJotuindt,
R.W. Ei>tabh.ook and A.H. Conney. Oxfaotid, PeAgamon 
P^eó* (7977).
VII
Dysplastische veranderingen van het bronchusepitheel na toe­
diening van carcinogeen worden snel opgespoord door raster- 
electronenmicroscopisch onderzoek van het oppervlak. Dit type 
onderzoek maakt een goed inzicht mogelijk in de driedimen­
sionale opbouw en expansieve groei van toekomstige tumoren.
VIII
De synthese van het variabele gedeelte van de lichte keten
(V^) van het muize myeloma IgA protein 315 door Gavish et al.
wordt onvoldoende gesteund door hun experimentele gegevens; 
bovendien wekken de auteurs ten onrechte de indruk*een semi- 
synthetisch antilichaam te hebben bereid.
M. Gav-cih, R. lakuX, M. WZlchzk and V. GZvoZ (1978) 
BZochzmli&iy 17_, 1345-1351.
IX
In verband met de datering van Korinthisch aardewerk, verdient 
het aanbeveling nader te onderzoeken in hoeverre de datering 
van Kirua's nederlaag in 696 voor Christus kan gelden als da­
tering voor de invallen van de Cimmeriers in Anatolië en daar­
door als datering voor het Middel Protokorinthisch aardewerk, 
gezien de afwezigheid ervan in Smyrna en Sardes.
Hanfimann, G.M.A. Tü/tk A/ike.oZojZ 24, 115-
114 [ 1977 ]
Ande^m , J .K. Annuat ofi the. Bfvótish Schoot at 
A t h & M  53/54, 138-151 (1958-1959)
X
Het zoeken van cellulaire kankerverwekkende genen met behulp 
van oncovirussen is als het zoeken van een speld..jn een hooi­
berg met behulp van een magneet: een niet volstrekt onmoge­
lijke opgave.
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